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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Summary 
Cyclins are a family of highly conserved proteins that activate Cyclin-dependent 
kinases (Cdks) to regulate the cell cycle, transcription, and other cellular processes. In 
metazoans, the well-characterized cyclins include CycA, CycB, CycD, and CycE, which 
play major roles during cell cycle regulation, and CycH, CycT, CycK, and CycC, which 
are mainly involved in transcriptional regulation. Several additional proteins with the 
characteristic domain of the cyclin family remain poorly or completely uncharacterized. 
In Drosophila one of these is encoded by a gene named CG14939, which I recently 
renamed Cyclin Y (CycY). CycY is a highly conserved protein that has not been 
functionally characterized in Drosophila, or any other model organism. Only minimal 
information is available for the human ortholog, CCNY. In this project, I used a reverse 
genetics approach to characterize the function of Drosophila CycY. I set out to generate 
and characterize loss-of-function mutants to determine the role of CycY during 
development. I generated a deletion of the CycY gene (CycY) using a technique in 
which a P-element transposon is mobilized to create an imprecise excision. This 
deletion, E8, removed the entire CycY transcript along with non-coding portions of the 
adjacent genes. I provided multiple lines of evidence showing that CycY is the only 
gene influenced in E8 and hence renamed this deletion as an allele of CycY, CycYE8. I 
also generated transgenic flies that can express dsRNA targeting CycY in specific 
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tissues. The combination of the phenotypic characterization of the CycY null mutant and 
tissue-specific CycY knockdown provided initial clues about CycY function in 
Drosophila. I demonstrated that CycY plays important functions during multiple 
developmental stages, from embryogenesis to adult viability. The major mutant 
phenotypes of the zygotic null were visualized during metamorphosis. I also identified 
the binding partner of CycY, Eip63E (also known as Cdk14), a Cdk induced by 
ecdysone. Finally I established a connection between CycY and the Brm chromatin-
remodeling complex in regulating gene expression. In this chapter, I will introduce 
background information about cell cycle regulation, CycY, Eip63E and their human 
orthologs, ecdysone signaling, and Brm complex functions. 
 
1.2 Cell cycle regulation, cyclin-dependant kinases, and cyclins 
A number of potentially fatal human diseases like cancer involve cell cycle 
defects (Hunter and Pines, 1991). Cell cycle control is regulated by an evolutionarily 
conserved family of serine/threonine protein kinases called cyclin-dependent kinases 
(Cdks) and their regulatory subunits, the cyclins (Edgar and Lehner, 1996; Morgan, 
1995). Critical cell cycle events are both positively and negatively regulated by specific 
Cdks, whose activities oscillate throughout the cell cycle. Cdk activities are controlled by 
several different mechanisms, including binding of the positively activating cyclin 
subunits, inhibition by Cdk inhibitor proteins, phosphorylation by Cdk activating kinases 
(CAKs) or inhibitory kinases, and dephosphorylation by cell-cycle regulated 
phosphatases (Petersen et al., 1999).  
In the human genome, there are 21 genes encoding Cdks and 5 genes encoding 
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distantly related proteins known as Cdk-like kinases (CdkLs). These have recently been 
renamed Cdk1-20 and CdkL1-5 on the basis of similarities in sequence and function, 
although cyclin partners have not yet been identified for a few of them (Malumbres et 
al., 2009). Cdks regulate cell cycle progression (Cdk1-4, Cdk6), transcription (Cdk7-10), 
differentiation (Cdk5), and other cellular processes as well. The activation of a Cdk 
relies on the binding of a cyclin and on the phosphorylation of specific Cdk residues. For 
example, Cdk1 by itself is inactive due to a distortion of the ATP-binding site and 
blockage of the substrate binding by the “T-loop”. The binding of CycB to the highly 
conserved PSTAIRE helix of the upper kinase lobe causes a conformational change 
that allows phosphorylation of the tip of the “T-loop” by a Cdk activating kinase (CAK) 
which is itself a Cdk. This results in movement of the “T-loop” to a group of positively 
charged amino acids to open the active site. Cyclin binding also activates 
phosphorylation of the inhibitory site, which holds the Cdk still in an inactive state. 
Removal of the inhibitory phosphate by the Cdc25 phosphatase finally triggers the 
activation of Cdk1 (De Bondt et al., 1993; Millar and Russell, 1992). In the absence of a 
cyclin, the Cdk is inactive regardless of its phosphorylation state. Thus, cyclins are 
critical regulators of Cdk. 
The founding members of the cyclin family, cyclins A and B, were first discovered 
as proteins that oscillated throughout the cell cycle, peaking in late G2 and M phase 
(Evans et al., 1983). These proteins were later shown to be required to activate Cdk1, 
(also known as Cdc2), which is required for entry into M phase in most eukaryotes 
(Morgan, 1997). At the N terminus of these mitotic cyclins, there is a 9-amino acid 
destruction motif (RXALG[D/N/E/V]IXN) (D box), which targets the protein for ubiquitin-
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dependent degradation by the 26S proteasome during mitosis (Hunt, 1991b). 
Ubiquitination is mediated by an E3 ubiquitin ligase known as anaphase promoting 
complex (APC), which has several key targets during mitosis (King et al., 1996). For 
example, securin, the inhibitor of separase, needs to be degraded at the onset of 
anaphase to promote sister chromatid separation (Nasmyth, 2002; Nasmyth et al., 
2000). 
Other cyclins with sequence similarity to cyclins A and B were subsequently 
identified and shown to be required at other points during the cell cycle (see Table 1-1) 
(Murray, 2004). The best characterized of these in metazoans include D-type cyclins, 
which partner with Cdk4 to control G1 phase events, and E-type cyclins, which partner 
with Cdk2 to control the transition from G1 to S phase. Many of the cellular signals that 
control entry into S phase function by promoting the stability or degradation of CycD or 
CycE. D-type cyclins are synthesized in response to growth factor stimulation and 
persist as long as the stimulation still exists. The protein levels do not show strong 
oscillation during cell cycle but only form a weak peak near G1-S. Upon serum 
starvation, they are rapidly degraded (Sherr, 1994). The half-life of these proteins is only 
about 30 minutes (Hunter and Pines, 1994). The levels of CycE, on the other hand, 
oscillate with the cell cycle, peaking in late G1. These G1 cyclins do not contain the N-
terminal destruction signals found in mitotic cyclins but do contain PEST sequences 
(enriched for the amino acids Pro, Glu, Ser, Thr) at the C-terminus, which have been 
suggested to target proteins for rapid degradation (Lew et al., 1991). It was later shown 
that binding of Cdk2 protected free CycE from degradation by the ubiquitin-proteasome 
pathway. Phosphorylation of CycE by its cognate Cdk promotes its recognition by 
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Table 1-1. The regulation of cyclin protein levels during the cell cycle 
 
Cyclina (Drosophila 
/human) Oscillation? 
Destruction 
signal 
Ubiquitin 
ligase References 
CycA Starts to accumulate during S phase and diminishes at mitosis. destruction box APC 
(Evans et al., 1983; Hunt, 1991a; 
Hunt, 1991b) 
CycB Synthesized during late S and G2 and degraded at the transition to anaphase. destruction box APC 
(Evans et al., 1983; Hunt, 1991a; 
Hunt, 1991b) 
CycC No No No (Loyer et al., 2005) 
CycD Synthesized in response to growth factor stimulation. Forms a weak peak near G1-S. PEST unknown 
(Hunter and Pines, 1994; Sherr, 
1994) 
CycE Peaks at G1/S PEST SCF (Clurman et al., 1996; Koepp et al., 2001; Lanker et al., 1996) 
CycF 
Starts to accumulate during S phase, peaks in 
late G2, and declines sharply as cells enter 
mitosis. 
unknown SCF?b (Tetzlaff et al., 2004) 
CycG Expression induced at G2/M under stress condition. No No (Shimizu et al., 1998) 
CycH No No No (Loyer et al., 2005) 
CycJ Not degraded during mitosis. No No (Althoff et al., 2009) 
CycK No No No (Loyer et al., 2005) 
CG16903/CycL No. Expression induced upon extracellular signal stimulation. No No (Loyer et al., 2005) 
CycT No No No (Loyer et al., 2005) 
CycY Peaks at G2/M. unknown unknown (Davidson et al., 2009) 
Koko/FAM58 unknown unknown unknown not available 
aA generic name for both Drosophila and human cyclins is used in most cases, whereas a species-specific name is used when the gene is not 
characterized and named as a cyclin in that species. The definition of such proteins as specific cyclins is based on sequence analysis. Drosophila 
does not have CycF. 
bCycF is an F-box protein that is part of an SCF complex; therefore, it has been predicted to aid in self degradation. 
  
6
the protein degradation machinery. The Ser within the PEST sequence is at least one of 
the phosphorylation sites, which is consistent with the assumption that PEST is part of 
the destruction signals for G1 cyclins (Clurman et al., 1996; Lanker et al., 1996). This 
phosphorylation-mediated degradation mechanism provides a self-limiting control of 
protein level. The ubiquitin ligase responsible for CycE ubiquitination is SCF, which is 
composed of Skp1, Cul1 (Cdc53), Rbx1, and an F-box containing protein (Koepp et al., 
2001).  
Several other members of the cyclin family do not show cell-cycle-dependent 
degradation or synthesis and some have been shown to play roles in cellular processes 
that are not directly related to cell cycle regulation (Table 1-2). One group of cyclins, for 
example, regulates transcription by activating Cdks that can phosphorylate the carboxy-
terminal tail of the large subunit of RNA polymerase II (Loyer et al., 2005). Several 
additional members of the cyclin family remain uncharacterized or poorly characterized.  
The defining feature of the cyclin family is a homologous region of about 100 
amino acids called the cyclin box (Hunt, 1991b), which includes the domain responsible 
for interaction with a Cdk. Detailed studies on specific Cdk/cyclin complexes have 
shown that the cyclin box domain is essential and sufficient for interaction with and 
activation of the Cdk partner (Morgan, 1996). Thus, while specific Cdk partners have not 
yet been identified for every cyclin, the presence of a cyclin box suggests that all cyclins 
play the role of activating one or more Cdks. In addition to activating kinase activity, the 
cyclins may also influence the substrate specificity or determine the subcellular 
localization of the active complex (Miller and Cross, 2001). Although there are certain 
specific functions for some cyclins, gene redundancy is also common in the cyclin
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Table 1-2. Summary of cyclins, Cdk partners, and the major functions of the 
cyclin/Cdk complex 
 
Cyclina  
(Drosophila /human) Cdk partners Cellular functions 
CycA Cdk1, Cdk2 CycA/Cdk2 complex is implicated in the control of DNA replication 
whereas CycA/Cdk1 complex is involved in mitosis by 
phosphorylating Cdh1 to prevent CycB degradation by APC/Cdh1 
(Yam et al., 2002). The S phase role for CycA in Drosophila has 
also been reported, while in Drosophila, CycA only interacts with 
Cdk1 (Sprenger et al., 1997).  
CycB Cdk1 CycB/Cdk1 complex is the M phase promoting factor (MPF) in all 
eukaryotes (Draetta et al., 1989). 
CycC Cdk3, Cdk8 CycC/Cdk3 complex phosphorylates pRB to promote G0-arrested 
cells to reenter the cell cycle (Ren and Rollins, 2004). CycC also 
forms a complex with Cdk8 to phosphorylate the C-terminal 
domain (CTD) of the largest subunit of RNA polymerase II and the 
CycH subunit of the TFIIH to regulate transcription both positively 
and negatively (Loyer et al., 2005). 
CycD Cdk4/6 CycD/Cdk4/6 complex promotes G1 progression by 
phosphorylating pRB (Sherr, 1994). In Drosophila, this complex 
has been shown to promote cellular growth through mRpL12 and 
Hif-1 Prolyl Hydroxylase (Hph) (Datar et al., 2000; Frei and Edgar, 
2004; Frei et al., 2005; Meyer et al., 2000). 
CycE Cdk2 CycE/Cdk2 complex promotes G1 to S phase transition by 
phosphorylating pRB, which then releases E2F to activate 
transcription of genes needed for S phase (Dynlacht et al., 1994; 
Hinds et al., 1992; Koff et al., 1992). 
CycF no CycF plays a role in S/G2 that has a subsequent positive impact 
on G0 cells to reenter cell cycle or G1 to S phase transition. It 
contains an F-box and assembles into an SCF complex in vivo, 
suggesting it may function in proteolysis (Tetzlaff et al., 2004). It is 
recently identified to mediate the degradation of CP110, a protein 
essential for centrosome duplication, and therefore plays a role for 
mitosis (D' Angiolella et al., 2010). 
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Table 1-2. Summary of cyclins, Cdk partners, and the major functions of the 
cyclin/Cdk complex (continued) 
 
Cyclina  
(Drosophila /human) Cdk partners Cellular functions 
CycG Cdk5 (non-Cdk 
interactors: 
GAK and 
PP2A) 
CycG associates with Cdk5 and CycG-associated kinase 
(GAK) (Kanaoka et al., 1997). CycG also associates with 
PP2A phosphatase to dephosphorylate Mdm2 and hence 
promotes the degradation of p53 (Okamoto et al., 1996; 
Okamoto et al., 2002). 
CycH Cdk7/Mat1 CycH/Cdk7/Mat1 complex can function as Cdk activating 
kinase (CAK) to phosphorylate CycA/B/Cdk1, CycE/Cdk2, and 
CycD/Cdk4/6. This complex also phosphorylates the CTD of 
the largest subunit of RNA polymerase II to promote 
transcriptional elongation as a component of the general 
transcription factor IIH (TFIIH) (Loyer et al., 2005). 
CycJ Cdk1, Cdk2 CycJ/Cdk2 complex plays a role in the rapid nuclear division 
cycles of early Drosophila embryogenesis (Kolonin and Finley, 
2000) and plays a role in oogenesis (G. Atikukke and R. 
Finley, unpublished). It has also been reported that CycJ 
forms a complex with Cdk1 (Althoff et al., 2009). 
CycK Cdk9 CycK/Cdk9 complex phosphorylates CTD of the largest 
subunit of RNA polymerase II to promote transcriptional 
elongation (Loyer et al., 2005). 
CG16903/CycL Cdk11 CycL/Cdk11 complex is involved in pre-mRNA splicing (Loyer 
et al., 2005). 
CycT Cdk9 CycT/Cdk9 complex phosphorylates CTD of the largest 
subunit of RNA polymerase II to promote transcriptional 
elongation (Loyer et al., 2005). 
CycY Cdk14 This work. 
Koko/FAM58 Cdc2rkb Koko may be required for germline stem cell maintenance 
(Baker and Kernan, 2007). In human, mutation in FAM58A 
causes x-linked “STAR syndrome”, while the molecular 
function is unknown (Unger et al., 2008). 
 
aA generic name for both Drosophila and human cyclins is used in most cases, whereas a species-
specific name is used when the gene is not characterized and named as a cyclin in that species. The 
definition of such proteins as specific cyclins is based on sequence analysis. Drosophila does not have 
CycF. 
bD. Liu and R. Finley, unpublished data.
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family. In Drosophila for example, deletion of either CycA, CycB or CycB3 individually 
causes no major defects, whereas deletion of both CycB and CycB3, or CycA and 
CycB3, results in mitotic defects (Jacobs et al., 1998), suggesting substantial overlap 
among the function of these cyclins. In addition to regulating other downstream 
substrates, a cyclin can also be the phosphorylation target of its Cdk partner. The 
phosphorylation may trigger the proteolytic degradation of the cyclin (Ceccarelli and 
Mann, 2001; Clurman et al., 1996; Lanker et al., 1996) or aid in substrate recognition 
(Waters et al., 2004).  
In summary, a number of proteins in the cyclin family have been identified by 
virtue of their conserved cyclin box domain (Tables 1-1 and 1-2). Some of these 
proteins oscillate with the cell cycle like the founding members of the family, while 
others do not (Table 1-1). Almost all members of the family are thought to partner with 
specific Cdks. Some cyclin/Cdk complexes regulate the cell cycle, while others regulate 
transcription or unknown processes (Table 1-2). 
 
1.3 CycY 
Several members of the cyclin family, including Drosophila CG14939 (CycY), 
have not been characterized. In this project, I choose to characterize the biological 
functions of CG14939 and recently renamed it Cyclin Y (CycY) (Liu and Finley Jr, 
2010). CycY is highly conserved in metazoan species. This conservation extends 
throughout the length of the protein, even outside of the cyclin box, and is more 
extensive than the conservation of any other type of metazoan cyclin, except for CycC 
(Liu and Finley Jr, 2010). This level of conservation suggests an important function, yet 
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prior to last year CycY had not been studied in any organism. Aside from genome 
sequences, the gene had only been noted in a limited number of functional genomics 
experiments and genome-wide association studies. A few of these are worth 
mentioning. A large-scale phosphoproteome study in Drosophila embryos identified 
several phosphorylated peptides from the CycY protein (Zhai et al., 2008). One of the 
phosphorylation sites, S389, is highly conserved and has also been found to be 
phosphorylated in human CycY, both in nuclear and cytoplasmic fractions (Beausoleil et 
al., 2004; Olsen et al., 2006). The human CycY gene, CCNY, was identified as a 
potential susceptibility factor for inflammatory bowel disease (IBD), a complicated 
genetic disorder affecting the intestinal mucosa. A single nucleotide polymorphism 
(SNP) located in an intron of CCNY was found to be strongly associated with the two 
IBD subphenotypes, Crohn’s disease and ulcerative colitis (Franke et al., 2008; 
Weersma et al., 2009). Another study found that human CycY is among a number of 
proteins that are significantly upregulated in metastatic colorectal cancer cells (Ying-Tao 
et al., 2005). While these results are intriguing, functional studies are needed to 
determine whether CycY plays any causal role in these diseases. 
Recently a handful of independent groups including our own made discoveries 
about CycY, each from a different starting point (Davidson et al., 2009; Jiang et al., 
2009; Li et al., 2009; Liu and Finley Jr, 2010). Combined, these studies have identified a 
Cdk that is regulated by CycY (Eip63E/PFTK1/Cdk14), found that CycY has a novel 
plasma membrane localized isoform, demonstrated that it is essential for Drosophila 
development, and identified a potential role for a CycY-associated kinase in Wnt 
signaling. These recent findings will be described further in section 1.6 and Chapter 2. 
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1.4 Eip63E/Cdk14 
An initial clue about CycY function came from the fact that Drosophila CycY was 
isolated through a physical interaction with a Cdk named ecdysone-induced protein 63E 
(Eip63E) in a high throughput yeast two-hybrid (Y2H) screen (Stanyon et al., 2004). The 
Eip63E gene encodes five highly related and apparently functionally redundant protein 
isoforms, all of which have homology to cyclin-dependent kinases (Sauer et al., 1996; 
Stowers et al., 2000). The proteins are most similar to the poorly characterized 
mammalian Cdk called PFTAIRE, so named because of the amino acid sequence in the 
conserved helix that binds to cyclins. Although a cyclin partner for Eip63E had not been 
identified, rescue experiments using mutant variants of the protein have suggested that 
its activity depends on cyclin binding (Stowers et al., 2000). In those experiments 
mutation of a conserved glycine adjacent to the PFTAIRE (G243), which in other Cdks 
is required for cyclin binding, abolished the ability of an Eip63E transgene to rescue null 
mutant embryos to adulthood. Similarly, mutation of a conserved isoleucine (I249), 
which is also required for cyclin binding in other Cdks, diminished the ability of Eip63E 
to promote development. A directed yeast two-hybrid screen by Rascle et al., identified 
two potential regulators of Eip63E, PIF-1B and PIF-2 (PIF stands for PFTAIRE 
Interacting Factor), but neither of these proteins has any similarity to cyclins. Both PIF-
1B and PIF-2 are cysteine-rich proteins, interacting with the same non-conserved N-
terminal histidine-rich domain of Eip63E. It has been proposed that the function of the 
binding of PIF to the long N-terminal extension of Eip63E, which may inhibit its kinase 
activity, is to counter the inhibitory effect (Rascle et al., 2003). Subsequent identification 
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of the Eip63E-CycY interaction in the high throughput yeast two-hybrid screen is not 
surprising given that Y2H screens are rarely saturating (Schwartz et al., 2009). 
Furthermore, because Y2H screens can result in false positives, further characterization 
was needed to show that Eip63E and CycY are functional partners.  
The name of Eip63E derives from the fact that one of the three transcription units 
of the Eip63E gene is induced in response to pulses of the steroid hormone 20-
hydroxyecdysone (hereafter referred to as ecdysone) (Stowers et al., 2000). Ecdysone 
triggers crucial developmental transitions, including metamorphosis, as described 
further below. Phenotypic characterization of Eip63E loss-of-function mutants has 
shown that it has essential roles in several developmental processes (Stowers et al., 
2000). The majority of zygotic null mutants die during larval development, while only a 
small percentage survive to pupation. The mutants that survive take 2-3 days longer 
than their heterozygous siblings to pupariate and are generally smaller than wild type 
pupae. These phenotypes point to a role for Eip63E in larval development and 
metamorphosis and further suggest that this Cdk may be involved in growth control. 
Mutant eye clones, however, showed no morphological or cell cycle defects, leading 
Stowers et al., to conclude that Eip63E does not regulate the cell cycle (Stowers et al., 
2000). Eip63E proteins have also been shown to be important for embryogenesis since 
zygotic null embryos from null mothers fail to hatch into first instar larvae. Interestingly, 
this maternal effect can be complemented by zygotic expression (Stowers et al., 2000). 
These findings indicate that this ecdysone-inducible gene is important for 
metamorphosis and other developmental events as well. 
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1.5 Ecdysone signaling and metamorphosis 
Since Eip63E encodes at least one ecdysone induced isoform, and I have shown 
that CycY plays a role in metamorphosis (Chapter 2) (Liu and Finley Jr, 2010), I will now 
introduce this important developmental process. Metamorphosis is characterized by 
striking developmental changes, including the degradation of obsolete larval tissues by 
programmed cell death and the construction of adult tissues and structures by 
controlled proliferation, differentiation, and morphogenesis of progenitor cells in the 
larvae (Riddiford, 1993). The external structures of the adult, such as the head, wing, 
eye, and leg, develop from larval tissues called imaginal discs or from other primordial 
cells called histoblasts. The specification of general cell fates (e.g. wing, eye, etc) 
happens in the embryo, while more specific cell fates are determined during larval 
development. It is during this stage that imaginal disc cells proliferate rapidly and 
undergo pattern formation (Cohen, 1993; von Kalm et al., 1995). At metamorphosis, 
these cells arrest cell division, start differentiation, and initiate the cell shape changes 
that drive the eversion and elongation to form adult structures (Condic et al., 1991). For 
example, the wing imaginal disc originates in the embryo within the larval epidermis as 
a cluster of ~ 50 cells (Bryant and Simpson, 1984; Garcia-Bellido, 1975). These cells 
are mitotically quiescent before the end of the first larval instar, after which they undergo 
continuous logarithmic cell proliferation until 24 hr after puparium formation, with an 
average 8.5 hr cell doubling time (Gonzalez-Gaitan et al., 1994). At the end of the third 
larval instar, most wing blade cells are arrested in G2 phase and wing margin cells are 
arrested in G1. These ~ 50,000 wing disc cells are fully grown and patterned to a great 
degree. After this point, there is still, however, at least one cell division that must occur 
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during pupal development. During the last 4 hr of the pupal time (20-24 h after puparium 
formation), there are mitotic events without further DNA synthesis. These cells are 
finally arrested at G1/G0 phase where they continue differentiation (Milan et al., 1996).  
To achieve the final adult structures, cell shapes need to be changed through the 
contraction of abdominal muscles that drive the eversion and elongation of the imaginal 
discs (Condic et al., 1991; Fristrom and Fristrom, 1993). For example, failure of the leg 
imaginal disc to change shape during prepupal development leads to legs not fully 
extended and/or legs elongated in the wrong direction (D'Avino and Thummel, 1998; 
Gates and Thummel, 2000). Many factors influence the cell shape changes, such as 
muscle contraction, rigidity of the pupal cuticle, and proteolysis (Fekete et al., 1975; 
Fortier et al., 2003). Muscle contraction provides an external force. A less rigid pupal 
cuticle and the de-attachment of disc cells from the extracellular matrix by protease 
hydrolysis provide a suitable external environment. Some genes have been reported to 
be involved in these processes, such as zip and sqh, encoding subunits of nonmuscle 
myosin II (Edwards and Kiehart, 1996; Young et al., 1993); ds, encoding a member of 
the cadherin superfamily (Clark et al., 1995); sb, encoding a serine protease (Appel et 
al., 1993); vlc, probably functioning at the septate junction; bl, encoding a RNA binding 
protein to regulate transcription or translation (Gates and Thummel, 2000); crol, E74, 
BR-C and βFTZ-F1, all of which encode transcription factors induced by ecdysone 
hormone (D'Avino and Thummel, 1998; Fletcher and Thummel, 1995b; Fortier et al., 
2003; Kiss et al., 1988). 
The steroid hormone ecdysone is the major insect molting hormone that controls 
metamorphosis. Ecdysone levels reach six peaks from embryogenesis to pupation 
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(Richards, 1981a; Richards, 1981b). At the end of third larval instar, the fourth pulse of 
ecdysone signals puparium formation and the onset of metamorphosis, a set of 
responses that includes eversion of the imaginal discs to form rudimentary adult 
appendages, larval tissue histolysis, and the apolysis of the larval cuticle as it forms the 
puparium (Cohen, 1993). About 12 hours after puparium formation, a brief ecdysone 
pulse triggers another set of metamorphic responses that includes eversion of the adult 
head, proliferation of the imaginal histoblast cells to form the epidermis of the adult 
abdomen, and further histolysis of larval tissues (Bate, 1993; Fristrom and Fristrom, 
1993; Skaer, 1993). The final ecdysone pulse lasts throughout the pupation stage and 
directs differentiation into the adult form. The general mechanism by which ecdysone 
regulates important transition events during the Drosophila life cycle, especially the 
larval to pupal transition, has been widely studied. The hormone first binds to a receptor 
consisting of a heterodimer of ecdysone receptor (EcR) and Ultraspiracle (Usp). 
Another novel receptor has also been reported (Costantino et al., 2008). The active 
complex then binds to DNA to induce early or primary response genes, a process that 
does not require protein synthesis. The protein products from these early genes in turn 
induce activation of the late genes (secondary response genes). The well characterized 
primary response genes include Broad-Complex (BR-C), E74, and E75, which are all 
transcription factors (Burtis et al., 1990; Crowley and Meyerowitz, 1984; DiBello et al., 
1991; Feigl et al., 1989; Fletcher and Thummel, 1995a; Segraves and Hogness, 1990; 
Thummel, 1990). Non-transcriptional regulators have also been reported, such as a 
calcium binding protein encoded by E63-1, an ABC transporter encoded by E23, and a 
lipoprotein binding protein encoded by IMP-E1 (Andres and Thummel, 1995; Hock et al., 
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2000; Natzle et al., 1988; Thummel, 1990). Late genes are initially repressed by the 
ecdysone-receptor complex and are later activated by primary response genes. 
Traditionally it was assumed that secondary-response genes provide effector functions, 
which directly affect the metamorphic response. Several well characterized secondary 
response genes support this assumption (Bayer et al., 1996). The Sgs family, for 
example, encodes glue proteins that are secreted from the salivary gland to help attach 
the pupae to a dry surface, which protects the animals during metamorphosis (Russell 
and Ashburner, 1996). L71 genes encode a series of secreted small polypeptides to 
provide an antimicrobial defense during metamorphosis (Wright et al., 1996). Other 
partially characterized secondary response genes, however, may play regulatory roles, 
such as the Cdk Eip63E. 
 
1.6 CycY, Eip63E/PFTK1, and Wg/Wnt signaling 
During the past year several independent groups made discoveries about CycY, 
each from a different starting point (Davidson et al., 2009; Jiang et al., 2009; Li et al., 
2009; Liu and Finley Jr, 2010). Here I will introduce some of these new findings. 
The human ortholog of Eip63E is PFTAIRE kinase 1 or PFTK1, named for the 
amino acid sequence in the cyclin-binding domain. The Eip63E/PFTK1 proteins are now 
known generically as Cdk14 (Malumbres et al., 2009), though the species-specific 
names will be used here to refer to studies in each organism. Similarly, the human 
ortholog of Drosophila CycY is CCNY. I will generically call these proteins CycY or use 
CCNY to refer to studies in human. Little was known about the function of PFTK1. It is 
expressed in many tissues and is particularly highly expressed in brain, testis, and 
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ovary in both mouse and human (Besset et al., 1998; Lazzaro and Julien, 1997; Yang 
and Chen, 2001). A number of PFTK1-interacting proteins have been identified by yeast 
two-hybrid screens, including CycD3, and more recently CycY (Davidson et al., 2009; 
Gao et al., 2006a; Gao et al., 2006b; Giot et al., 2003; Jiang et al., 2009; Liu and Finley 
Jr, 2010; Rascle et al., 2003; Shu et al., 2007; Stanyon et al., 2004). My own work 
confirmed this interaction for the Drosophila proteins, CycY and Eip63E. Chen and 
coworkers confirmed the human PFTK1/CycY interaction by co-AP assays from human 
cells and demonstrated that PFTK1 enhances the serine phosphorylation of CycY, 
suggesting that CycY may itself be one substrate for the PFTK1/CycY complex. 
Davidson and coworkers further identified that both Drosophila CycY/Eip63E complex 
and its human ortholog CCNY/PFTK1 phosphorylate the Wnt co-receptor, known as 
arrow in Drosophila and LRP6 in humans, and therefore may regulate Wnt signaling 
(described further below). 
One novel feature of CycY is that it spends at least some of its time tethered to 
the plasma membrane. Jiang et al. showed that human CycY with a C-terminal GFP tag 
localized to the plasma membrane, a finding confirmed by the Niehrs group (Davidson 
et al., 2009; Jiang et al., 2009). This localization was dependent on a conserved N-
terminal myristoylation signal. Mutation of the putative myristoylation site, glycine 2, to 
alanine abolished membrane localization, as did fusion to N-terminal tags such as GFP 
or HA. Jiang et al further showed that forced expression of CycY resulted in 
relocalization of GFP-PFTK1 from the cytoplasm to the plasma membrane, indicating 
that this cyclin is capable of recruiting the Cdk to the membrane (Jiang et al., 2009). 
CycY is the only member of the cyclin family that is known to contain a myristoylation 
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signal although two non-cyclin proteins that bind Cdk5, p35 and p39, are both 
myristoylated and require this signal to localize Cdk5 to the plasma membrane (Asada 
et al., 2008; Humbert et al., 2000; Patrick et al., 1999). The presence of a myristoylation 
signal and the localization of CycY to the plasma membrane make it likely that CycY 
functions at least in part by localizing Cdk activity to the plasma membrane to direct 
phosphorylation of membrane-associated substrates, such as the Wnt co-receptor 
LRP6/Arrow (Davidson et al., 2009). In cultured cells, myristoylation defective CCNY 
mutants showed decreased physical interaction with LRP6 and LRP6 S1490 
phosphorylation, suggesting the importance of the myristoylation signal and membrane 
localization for CCNY function, at least for its putative regulatory role of LRP6 (Davidson 
et al., 2009; Jiang et al., 2009). The human CCNY gene and one of its paralogs (CCNY-
like 1) each encode two splice isoforms, which differ in the presence or absence of the 
N-terminal 54 amino acids containing the N-terminal myristoylation signal. The shorter 
splice variant (isoform 2, originally named CycX) of human CycY was cloned and shown 
to be mostly nuclear (Li et al., 2009). Thus, it is possible that a form of CycY functions in 
the cytoplasm or nucleus to promote phosphorylation of substrates other than LRP6. 
In cultured cells, CCNY level oscillates throughout the cell cycle, peaking at 
G2/M. The protein also appears to be subject to ubiquitination mediated protein 
degradation (Davidson et al., 2009). PFTK1 also peaks at G2/M, coincident with the 
maximal LRP6 phosphorylation and Wnt signaling. The induction of Wnt signaling at 
G2/M by CCNY/PFTK1 phosphorylation has been proposed to orchestrate a mitotic 
program (Davidson et al., 2009). Besides CCNY, PFTK1 has also been shown to be 
activated by another cyclin, CCND3, and inhibited by p21Cip1, and to phosphorylate Rb. 
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Ectopic expression of PFTK1 in U2OS cells specifically promotes G1 to S transition, 
and PFTK1 knockdown in SH-SY5Y cells arrests cells at G1 phase (Shu et al., 2007). 
Consistently, in Drosophila S2 cells, Eip63E knockdown led to decreased mitotic index 
(Bettencourt-Dias et al., 2004). These cell cycle related phenotypes may be a 
synergistic effect from both LRP6 and Rb phosphorylation involving CCNY and CCND3 
respectively. It is still unclear why a Cdk that is enriched at G2/M has major cell cycle 
related effects during the transition from G1 to S phase. Whether there are other cyclins 
or substrates that also contribute to the PFTK1-related cell cycle regulation requires 
further investigation.  
The Wnt/Wingless (Wg) signaling pathway is conserved during evolution. All the 
components in the mammalian Wnt signaling have counterparts in the Drosophila Wg 
signaling pathway (Table 1-3). The pathway is required for pattern formation during 
embryonic development, cell proliferation, differentiation, and other biological 
processes. Wnt are secreted signaling molecules involved in multiple signaling 
pathways, one of which is the canonical Wnt/β-catenin cascade. In the absence of Wnt, 
the transcription factor β-catenin is phosphorylated at serine 45 by CK1, which is 
recruited by the scaffold protein Axin. This phosphorylation primes the subsequent 
phosphorylation by GSK3, another Axin binding protein, at β-catenin serine 41, 37, and 
33. The fully phosphorylated β-catenin is recognized and ubiquitinated by the β-TrCP 
E3 ubiquitin–ligase complex, and transferred by the adenomatous polyposis coli (APC) 
tumor suppressor gene product, a third Axin binding protein, from the Axin complex to 
the 26S proteasome to be degraded. The Dishevelled (Dvl) protein is also capable of 
interacting with Axin and inhibiting the Axin-mediated GSK3-dependent phosphorylation
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Table 1-3. Wnt/Wg pathway components 
Mouse/Human Drosophila Function 
Wnt Wingless (Wg) Secreted ligand 
Frizzled (Fz) Frizzled (Fz) Wnt/Wg receptor 
LRP5/6 Arrow (Arr) Wnt/Wg co-receptor 
Dishevelled (Dvl) Dishevelled (Dsh) Scaffold protein 
GSK3 Shaggy/Zeste-white 3 (Sgg) LRP6/Arr kinase 
CK1 Gilgamesh (Gish) LRP6/Arr kinase 
Axin Axin Scaffold protein 
APC APC Scaffold protein, tumor suppressor 
β-catenin (β-cat) Armadillo (Arm) Transcription factor 
Tcf/Lef dTcf/Pangolin (Pan) Transcription factor 
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and degradation of β-catenin (Kishida et al., 1999). Upon Wnt stimulation, the single 
pass transmembrane Wnt co-receptor LRP6 aggregates and recruits Dvl, GSK3, and 
Axin to the cell membrane to assemble a complex called the LRP6 signalosome. In the 
signalosome, the intracellular domain of LRP6 is phosphorylated by GSK3 on PPPSP 
motif and by CK1γ (a membrane-anchored member of the CK1 family) on other sites 
including T1479. This removes the autoinhibitory effect exerted by the LRP6 
extracellular domain on itself. These sequential translocation and phosphorylation 
events finally release β-catenin from the Axin degradation complex. The free 
cytoplasmic β-catenin then translocates to the nucleus and binds Tcf/Lef to regulate the 
transcription of Wnt target genes (Verheyen and Gottardi, 2010).  
In addition to the ligand-dependent phosphorylation of LRP6 by GSK3 and CK1γ, 
it had been noted that the LRP6 receptor also undergoes a ligand-independent 
phosphorylation at residue S1490, which may be required for or enhance the 
subsequent ligand-dependent phosphorylations (Davidson et al., 2005). To search for 
the kinase(s) responsible for ligand-independent S1490 phosphorylation, the group 
performed a screen in which they individually knocked down the expression of every 
kinase by RNAi in Drosophila S2R+ cells and screened for decreases in both Wnt 
signaling and LRP6 S1490 phosphorylation. The investigators identified Eip63E and 
were led to its potential partner (CycY) by the previously mentioned yeast two-hybrid 
data. Kinase assays using immunopurified Eip63E and CycY showed that in 
combination they significantly enhanced phosphorylation of LRP6. Using RNAi 
knockdown in Drosophila and human cells they were able to show that both Eip63E and 
CycY are required for maximal LRP6 S1490 phosphorylation and for maximal Wnt 
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signaling. These results are consistent with a model in which membrane-associated 
CycY recruits Cdk14 to the membrane where it phosphorylates LRP6 to help prime 
LRP6 for activation by Wnt. Although membrane localization has not yet been 
demonstrated for Drosophila CycY, it does have the N-terminal myristoylation signal 
and the signal is required for LRP6 S1490 phosphorylation in cultured cells (Davidson et 
al., 2009). 
 
1.7 Brm ATP-dependent chromatin-remodeling complex function 
CycY has been identified to physically interact with Snr1 in a high throughput 
yeast two-hybrid screen (Giot et al., 2003), which prompted us to investigate the 
relationship between CycY and Snr1, and to test the possibility that Snr1 is a 
downstream target of CycY/Eip63E complex. 
Snr1 (SNF5-related 1) is the Drosophila counterpart of yeast SNF5 and human 
hSNF5/INI1 (Integrase-interacting protein 1). It is one of the core subunits of the 
SWI/SNF ATP-dependent chromatin-remodeling complex, which in Drosophila is known 
as the Brahma (Brm) complex (Dingwall et al., 1995). Chromatin is mainly composed of 
DNA and histone proteins. In order to fit the relatively long DNA into a small nucleus 
while maintaining appropriate access to it, DNA is wound around a histone protein core, 
which together forms a highly compact structure. During the processes of DNA 
replication, recombination, repair and transcription, the chromatin has to be remodeled 
to make DNA accessible. There are four classes of ATP-dependent chromatin 
remodelers, SWI/SNF, ISWI, Mi-2, and Ino80, each of which has a unique ATPase and 
subunit composition (Mohrmann and Verrijzer, 2005). All of these use the energy from 
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ATP hydrolysis to modulate the relative position of DNA and histones. The ATPase in 
the SWI/SNF complex is SWI2/SNF2 or Sth1 in yeast, Brm in Drosophila, and hBrm or 
Brg1 in human. By modulating chromatin structures, SWI/SNF complex is involved in 
both gene activation and suppression. In yeast, about 5-7% of genes are regulated by 
SWI/SNF complex activity based on microarray studies in mutants (Monahan et al., 
2008; Sudarsanam et al., 2000)s. In Drosophila, about 2% of the genes are differentially 
regulated in Brm complex mutants (Zraly et al., 2006). The genes regulated by the 
SWI/SNF complex in metazoans include genes required for cell proliferation and several 
components of the Brm complex have been suggested to be tumor suppressors, 
including hSNF5, Brg1, and Brm (Reisman et al., 2009). One important mechanism by 
which SWI/SNF complex activity is regulated is phosphorylation. For example, Brg1 and 
BAF155 both have been found to be phosphorylated by the CycE/Cdk2 complex and 
the expression of CycE can overcome the ability of Brg1 to induce growth arrest 
(Shanahan et al., 1999). 
  
1.8 Project outline 
The goal of the studies described in this dissertation was to characterize the 
function of a novel conserved cyclin, CG14939 (CycY) in Drosophila. In Chapter 2, I 
describe the generation of a null mutant allele of CycY and show that its phenotype is 
similar to that of Eip63E mutants. I show that CycY plays major essential roles during 
metamorphosis, especially during pupariation. I also show that maternally provided 
CycY is essential for embryogenesis and that this requirement could be partially 
rescued by zygotic expression. Finally, I confirm that CycY and Eip63E specifically 
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interact and show that the interaction depends on a conserved phosphorylation target 
on CycY, Ser389. This part of work has been published recently (Liu and Finley Jr, 
2010).  
In Chapter 3, I describe the generation of transgenic flies for knocking down the 
expression of CycY in specific tissues. By combining data from the conditional 
knockdown and the null mutant allele, I show that CycY is required for wing growth and 
sustained adult viability. I also show that CycY genetically interacts with two 
components of the Brm ATP-dependent chromatin-remodeling complex, Snr1 and Brm, 
and that CycY and Snr1 can physically interact. Moreover, the downstream targets of 
Brm complex, Eig71Eh and Eig71Ei, are misregulated in CycY mutants. Taken together, 
these data suggest that CycY may be involved in gene regulation through modulating 
the Brm complex activity. 
Data presented in this dissertation have provided initial interesting findings about 
essential in vivo requirements for CycY. Perhaps more importantly, the establishment of 
the CycY null mutant strain and a variety of transgenic lines opens the door for further 
studies. In Chapter 4, I present the results of several additional experiments aimed at a 
better understanding of CycY function. In Chapter 5, I summarize the important 
conclusions from this study and discuss several interesting questions that it raised. I 
also propose future experiments to address some of the questions. 
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CHAPTER 2 
 
CYCLIN Y IS A NOVEL CONSERVED CYCLIN ESSENTIAL FOR DEVELOPMENT  
IN DROSOPHILA  
 
Part of the work described in this chapter has been published in Genetics 184: 
1025-1035, 2010. 
 
2.1 INTRODUCTION 
Cyclins are a superfamily of eukaryotic proteins that play a critical role in 
activating a group of S/T kinases called cyclin-dependent kinases (Cdks). Well studied 
metazoan cyclins have two major biological functions, regulating the cell cycle (CycA, 
CycB, CycD, CycE) and transcriptional regulation through RNA pol II (CycH, CycT, 
CycK, CycC). CG14939 (CycY) is one of the few poorly or fully uncharacterized cyclins 
in Drosophila. Alignment of the amino acid sequences of all cyclins from one species 
shows that there are two sequence classes that roughly correspond to the two major 
functional categories. CycY, however, does not fit neatly into either one of these two 
sequence classes. The sequence alone, therefore, has not provided any clues to 
CycY’s cellular functions. One powerful approach to elucidate the in vivo biological 
functions of a gene is to create loss-of-function mutants and examine their phenotypes. 
Here I set out to do this for CycY.  
In Drosophila, a number of in vivo mutagenesis techniques are available, 
including gene targeting by homologous recombination (Rong and Golic, 2000; Rong et 
al., 2002), creation of a deletion by FRT-mediated recombination (Golic and Golic, 
1996; Parks et al., 2004), P-element-mediated imprecise excision (Robertson et al., 
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1988), and conditional knockdown by using Gal4/UAS-RNAi systems (Lee and Carthew, 
2003). Gene targeting by homologous recombination is theoretically a great way to 
create specific mutations in the gene of interest (Rong and Golic, 2000; Rong et al., 
2002). However, due to uncertain technical issues, reports of successful mutant 
generation with this approach have been rare. Insertional mutagenesis using 
transposons is a useful gene disruption technique that is now being applied on a 
genome-wide basis in Drosophila (Bellen et al., 2004; Thibault et al., 2004), increasing 
the likelihood that a locus of interest will have a P-element in it or nearby. However, in 
many cases, the insertion itself will not cause any detrimental effect on the function of a 
gene. Looking through all available P-element or PiggyBac transposon insertion lines 
around the CycY genomic region, I found only one P-element insertion line, d03228, 
which is from the Exelixis mutant collection (Thibault et al., 2004). This P-element is 
inserted in between the CycY stop codon and the start codon of its neighboring gene 
crol. Adult flies bearing this insertion do not show any visible developmental defects, 
suggesting that the genes around this insertion site are still functional. However, this is 
a good candidate strain to be used for P-element imprecise excision. In this approach, 
the P-element is mobilized by transiently expressing transposase. At some frequency 
the P-element will be excised imprecisely, resulting in deletion of nearby sequences. 
The gene arrangement around the CycY region on the chromosome is very simple. 
There is no overlap between neighboring genes and they are not particularly close to 
each other. This should enable the creation of a CycY null mutant that has the 
neighboring genes intact. Finally, knocking down gene expression with dsRNA is 
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becoming a widely used and efficient approach, although the caveat of off-target-effects 
always exists. This approach will be discussed further in Chapter 3.  
In this chapter, I successfully generated a null mutant of CycY using the 
imprecise excision approach. I further show that the null mutant, CycYE8, is homozygous 
lethal with most mutant animals arresting during pupal development. The mutant 
exhibits delayed larval growth and major developmental defects during metamorphosis, 
including impaired gas bubble translocation, head eversion, leg elongation, and adult 
tissue growth. Heat shock-induced expression of CycY at different times during 
development resulted in variable levels of rescue, the timing of which suggests a key 
function for zygotic CycY during the transition from third instar larvae to prepupae. CycY 
also plays an essential role during embryogenesis since zygotic null embryos from null 
mothers generated with germline clones fail to hatch into first instar larvae. I provide 
evidence that the CycY protein (CycY) interacts with Eip63E, a Cyclin-dependent kinase 
(Cdk) for which no cyclin partner had previously been identified. Like CycY, the Eip63E 
gene has essential functions during embryogenesis, larval development, and 
metamorphosis. Our data suggest that CycY and Eip63E form a cyclin/Cdk complex 
that is essential for several developmental processes.  
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2.2 MATERIALS AND METHODS 
 
2.2.1 Fly stocks 
All fly stocks were maintained in vials containing standard cornmeal molasses 
medium and raised at 25°C unless otherwise stated. Fly strains used in this study are 
listed in Appendix A. 
 
2.2.2 Plasmid cloning for P-element transformation and expression in Drosophila 
tissue culture cells  
pAS1 (A. Soans, and R.L.F., unpublished) is a modified pUAST (Brand and 
Perrimon, 1993) vector encoding a myc-tag followed by 5’ and 3’ recombination tags 
(RTs) to facilitate cloning of open reading frames containing the same RTs from yeast 
two hybrid vectors (Giot et al., 2003; Stanyon et al., 2004). A map of pAS1 is available 
at http://www.proteome.wayne.edu. pAS1-CycY was constructed by subcloning a 
fragment of the CycY cDNA beginning with the ATG and ending with the stop codon. 
The fragment was generated by PCR from the yeast two-hybrid clone using 
oligonucleotides [Forward: 5' TTGACTGTATCGCCGGAATTC (5’RT-F, Finley lab # 
891); Reverse: 5' CCGGAATTAGCTTGGCTGCAG (3’RT-R, Finley lab # 892)], which 
provided the 5’ and 3’ RTs at either end, respectively. The fragment was subcloned by 
gap repair in E.coli (Parrish et al., 2004). The P{CycY} genomic clone was constructed 
by sequentially subcloning a 3.6 kb BamHI/NotI fragment and then a 4.0 kb AvrII/EcoRI 
fragment, each from BACR05B13 (BACPAC resources center), into pCaSpeR2 
(Thummel et al., 1988). The whole insert is 7.3 kb, which includes the entire CycY gene 
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and sequences 4,032 bp upstream of the CycY start codon, and 1,970 bp downstream 
of the stop codon, and includes none of the coding regions of crol or Pde1c. A P-
element carrying the CycY cDNA expressed from a heat shock promoter, pCaSpeR-hs-
CycY, was constructed by subcloning the 1.5 kb HpaI/StuI fragment encoding myc-
CycY from pAS1-CycY into the HpaI/StuI sites of pCaSpeR-hs (Thummel et al., 1988). 
P-element mediated transformation was performed as previously described (Rubin and 
Spradling, 1982).  
pDL4 is a derivative of pUAST-NTAP (Veraksa et al., 2005) containing the NTAP 
tag followed by the same 5’ and 3’ RTs found in pAS1. pDL2 is modified from pAS1 by 
replacing the myc tag with GST tag. pDL5 is modified from pAS1 and pCeMM-NTAP 
(GS) by replacing the myc tag with NTAP (GS) tag (Burckstummer et al., 2006). This 
NTAP tag (GS) is composed of two IgG binding domains of Staphylococcus aureus 
protein G and a streptavidin-binding peptide, separated by a TEV protease cleavage 
site. Coding regions from the ATG to the stop codon of various Cdks, cyclins, and other 
proteins were amplified from yeast two-hybrid clones (Stanyon et al., 2004) with primers 
that added the 5’ and 3’ RTs and the products were subcloned into pAS1, pDL4, pDL5, 
or pDL2 by gap repair in E.coli. Plasmids used or constructed in this study are listed in 
Appendix B.  
 
2.2.3 Establish stable transgenic fly strains  
All the fly embryo microinjections for P-element-mediated transformation were 
performed by Duke University. We received from Duke second or third instar larvae that 
developed from microinjected embryos. A few drops of sterile water were added to the 
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food surface upon receiving these vials. Each individual G0 male and female was 
crossed with w1118 females and males respectively. Red-eyed G1 progeny were crossed 
with a double balancer strain, Finley lab # 41 (w*; CyO/Sp; TM3 Ser/Sb). Red-eyed F1 
progeny with CyO and TM3 Ser balancer chromosomes were crossed again with the 
double balancer strain Finley lab # 41. For each F1 transgenic fly, a stable line was 
established by collecting the progeny with CyO and Ser balancer chromosomes and at 
least one marker chromosome (Sp or Sb). The genotype of the transgenic flies with 
transgene on the second chromosome is w*; CyO/transgene; TM3 Ser/Sb. The 
genotype of the transgenic flies with transgene on the third chromosome is w*; CyO/Sp; 
TM3 Ser/transgene. Any progeny with four markers, CyO, Sp, Ser, and Sb, suggested 
that the transgene in this line was probably located on the X chromosome. In this case, 
either a self-cross of the red-eyed progeny with all four markers was done to generate 
stable homozygous lines, or a cross with an X chromosome balancer strain Finley lab # 
270 (FM7i/Rok2). All transgenic lines generated for this work are listed in Appendix C. 
 
2.2.4 Generation and molecular characterization of a CycY mutant allele  
I used P-element imprecise excision to generate CycY mutant alleles. The 
starting P element in d03228 is inserted 1,958 bp downstream of the CycY stop codon 
and 5,723 bp upstream of the crol start codon (Figure 2-1). The genetic crossing 
scheme is shown in Figure 2-2. d03228 virgin females were mated with w*; CyO/Sp; ∆2-
3, Sb/TM6 males, which provided P-transposase. F1 females (w*; d03228/CyO; ∆2-3, 
Sb/+) were then mated to w*; CyO/Sp; TM3, Ser/Sb males, and F2 progeny were 
screened for P-element excision by the reversion of eye color to white
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Figure 2-1. The genomic region of CycY and the flanking genes crol and Pde1c. 
Exons of the CycY, crol, and Pde1c transcripts are indicated by boxes. Black boxes 
represent coding regions and grey boxes represent untranslated regions. Direction of 
transcription and approximate start sites are shown with arrows. Pde1c has five 
predicted transcripts that all start from the same position. CycY has one predicted 
transcript, and crol has three predicted transcripts (RA, RB, RC) that start from the 
same position and one (RD) that starts further upstream as shown. The P-element in 
strain d03228 is inserted just upstream of exon 1 of crol transcripts RA-RC, and within 
exon 1 (offset box) of crol transcript RD. The two deleted regions in the CycYE8 allele, 
which was isolated by imprecise excision of the P-element in strain d03228, are 
indicated as ( ∆ ). The deletion removes the entire CycY gene, the first non-coding exon 
of crol, and a non-coding portion of the last exon of Pde1c. The genomic fragment used 
to create a transgene P{CycY} that complements CycYE8 is also depicted (black bar). 
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Figure 2-2. The genetic crossing scheme for performing P-element imprecise 
excision to generate CycY null alleles. Red triangles represent the P-element in 
strain d03228. “+” represents a wild-type chromosome. ♀, virgin females; ♂, males; (  ), 
a deletion; X, cross. 
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(Carney et al., 2004). 100 white-eyed flies were collected and further balanced 
individually with Finley lab # 41 to make stocks. For each stock, genomic DNA was 
extracted from homozygous single adult flies and analyzed by PCR for the presence of 
CycY gene regions close to the d03228 insertion site. For those stocks that are 
homozygous lethal, I rebalanced each line with CyO, Act5C-GFP balancer strain, which 
allows the collection of homozygous larvae (non-GFP) for genomic DNA extraction and 
PCR. The primer pairs used to characterize the deletion are listed in Appendix D and 
the positions of these primers are schematically showed in Figure 2-3. The sequences 
of all primers used in this study are listed in Appendix E. 
The excision that removes all CycY coding sequences was named E8 and was 
shown here (Figure 2-1) to be a null allele of CycY (CycYE8). To make sure there is not 
a second site mutation on the same chromosome as CycYE8, the CycYE8 chromosome 
was cleaned up by homologous recombination with d03228 for 7 generations. Since 
homozygous d03228 is fully viable and normal, I assume the P-element insertion in this 
line did not interfere significantly with gene expression. This makes it a good choice to 
be used as a wild type chromosome for homologous recombination to remove any 
potential second site mutations generated during mutagenesis and to avoid loss of the 
initial deletion while screening recombinants. The initial balanced deletion strain 
(E8/CyO) was crossed with the homozygous d03228 strain (red-eyed). I collected non-
balanced orange-eyed female progeny (E8/d03228) and crossed again with the 
homozygous d03228 males. I repeated this cross for six more generations. The 
E8/d03228 flies from the final cross were collected and balanced with Finley lab # 41 to 
make a stock. To determine the precise endpoint of the E8 deletion, genomic DNA was
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Figure 2-3. The positions of all available primers around the genomic region 
containing crol, CycY, and Pde1c. Exons of the CycY, crol, and Pde1c transcripts are 
indicated by boxes. Black boxes represent coding regions and grey boxes represent 
untranslated regions. Direction of transcription, approximate start sites, primer position 
and orientation are shown with arrows. The length of the genome is proportionate 
except for the region labeled with “/    /”. Primer sequences are listed in Appendix E. 
 
  
35
extracted from heterozygous CycYE8 adults and the region was amplified by PCR using 
primers 5’-GGGCCAAGCACAAATACAAACG-3’ (DL94) and 5’-TGGTGAACGGCGAAC 
AGAGC-3’ (DL98). The PCR product, which is about 1 kb, was gel purified and 
sequenced from both ends. The deletion end points were determined by sequence 
alignment with wild type genomic sequence. CycYE8 is missing 6,119 bp of DNA from 
734 bp downstream of the Pde1c stop codon to 1,411 bp downstream of the CycY stop 
codon, and a second small region of 988 bp from 1,955 bp downstream of the CycY 
stop codon to the first non-coding exon of crol transcripts RA-RC or the first intron of 
crol transcript RD. This removes the entire CycY transcript along with non-coding 
portions of the last exon of Pde1c and the first non-coding exon of crol (Figure 2-1). 
 
2.2.5 Extraction of genomic DNA from single flies  
I followed the well established protocol by Ashburner with minor modifications 
(Ashburner, 1989). Freeze a single fly in an eppendorf tube at -20°C for a few minutes. 
Homogenize in the eppendorf tube with a pellet pestle attached to a pellet pestle 
cordless motor from VWR (VWR KT749521-1590 and KT749540-0000) in 50µl of 
homogenization buffer (10mM Tris-HCl pH7.5, 60mM NaCl, 10mM EDTA, 0.15mM 
Spermine, 0.15mM Spermidine, 5% Sucrose). Add 50µl of lysis buffer (300mM Tris-HCl 
pH 9.0, 100mM EDTA, 0.63% SDS, 5% Sucrose) and incubate the tube at 70°C heat 
blocker for 15 minutes. After cooling the mixture to room temperature, add 15μl of 8M 
KOAc and incubate on ice for 30 minutes. Centrifuge at 13500 rpm at 4°C for 5 minutes. 
Transfer the supernatant to a new tube and add two volumes of ethanol to precipitate 
DNA. After 5 minutes incubation at room temperature, centrifuge at 13500 rpm for 10 
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minutes at room temperature. Discard the supernatant. Air-dry the pellet for about 10 
minutes and add 100μl of H2O to dissolve the DNA. Use 1μl of the genomic DNA for 
PCR. 
 
2.2.6 Lethal phase analysis  
Eggs were collected from w*; CycYE8/CyO, Act5C-GFP flies for 12 hours on apple 
juice plates with fresh yeast paste. After another 30 hours, the numbers of unhatched 
embryos and hatched first instar larvae were counted. Since homozygous CyO balancer 
is lethal during embryogenesis, a roughly 75% hatching rate suggests no embryonic 
lethality. 180 w*; CycYE8/CyO, Act5C-GFP and 180 w*; CycYE8 (lacking GFP) first instar 
larvae were picked under a fluorescence dissection microscope and transferred into 
regular vials. The numbers of wandering third instar larvae, pupae, and adults were 
counted once a day for 15 days to score for a delay in puparium formation, progression 
through metamorphosis, and adult eclosion. To estimate the delay of puparium 
formation more accurately, I followed 180 first instar larvae for each genotype and 
calculated the average time to form pupa by counting the number of pupa newly formed 
after each 24 hour period and averaging over all individuals and days. Similarly, I 
analyzed the following animals: (1) w*; CycYE8/CyO, Act5C-GFP; P{CycY}, (2) w*; 
CycYE8; P{CycY}, (3) w*; CycYE8/CyO, Act5C-GFP and Df(2L)Exel6030/CyO, Act5C-
GFP, (4) w*; CycYE8/Df(2L)Exel6030, (5) w*; CycYE8/CyO, Act5C-GFP; P{CycY} and w*; 
Df(2L)Exel6030/CyO, Act5C-GFP; P{CycY}, (6) w*; CycYE8/Df(2L)Exel6030; P{CycY}, 
(7) w*; Eip63E81/TM3, Ser Act5C-GFP and w*; Eip63EGN50/TM3, Ser Act5C-GFP, (8) w*; 
Eip63E81/Eip63EGN50. All flies were incubated at 25ºC except were noted. 
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2.2.7 Phenotypic characterization  
200 w*; CycYE8/CyO, Act5C-GFP and 200 w*; CycYE8 first instar larvae were 
collected (see above), transferred into individual fresh vials and allowed to develop for 9 
days. For each genotype, pupae at all developmental stages were collected, weighed, 
and imaged. The relative pupal length was measured based on the image size. The 
average pupa weight and length were then calculated. To document the pupal 
phenotype, pupae at all developmental stages were carefully removed from the wall. 
For pharate adults, the pupal case was gently dissected. Images were taken with the 
Leica MZ 16FA Stereomicroscope and Leica DFC 490 camera (kindly provided by Dr. 
Markus Friedrich). Similarly, I analyzed the following animals: (1) w*; CycYE8/CyO, 
Act5C-GFP; P{CycY}, (2) w*; CycYE8; P{CycY}, (3) w*; CycYE8/CyO, Act5C-GFP and 
Df(2L)Exel6030/CyO, Act5C-GFP, (4) w*; CycYE8/Df(2L)Exel6030, (5) w*; CycYE8/CyO, 
Act5C-GFP; P{CycY} and w*; Df(2L)Exel6030/CyO, Act5C-GFP; P{CycY}, (6) w*; 
CycYE8/Df(2L)Exel6030; P{CycY}, (7) w*; Eip63E81/TM3, Ser Act5C-GFP and w*; 
Eip63EGN50/TM3, Ser Act5C-GFP, (8) w*; Eip63E81/Eip63EGN50. 
 
2.2.8 Heat shock induction and rescue efficiency 
Eggs from a self cross of CycYE8/CyO; hs-CycY/TM3, Ser flies (Finley lab fly 
stock # 700) were collected in glass vials with standard cornmeal Drosophila medium 
for 24 hours and then heat shocked on each day as indicated in Figure 2-12. For each 
heat shock induction, glass vials were incubated in a 37ºC water bath for one hour. 
Vials were kept at 25ºC otherwise. The numbers of flies with or without curly wings were 
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counted separately. If CycYE8/CyO and CycYE8 flies have equal viability (full rescue), the 
number of CycYE8 flies should be half of that of CycYE8/CyO flies. The rescue efficiency 
was then determined by the number of CycYE8 adult flies divided by half of the number 
of CycYE8/CyO adult flies. The genotype of representative flies was confirmed by single-
fly PCR. The primers used to confirm the genotypes were listed in Table 2-1. 
 
2.2.9 Generation of mosaic germline clones with homozygous CycYE8  
CycYE8 was recombined with FRT40A as previously described (Xu and Rubin, 
1993). The genetic crossing scheme is shown in Figure 2-4. CycYE8 males or virgin 
females (Finley lab stock # 692) were crossed with FRT40A flies with opposite sex 
(Finley lab stock # 355). Virgin females with straight wings and red eyes from the above 
cross were then mated with balancer strain males (Finley lab stock # 41). Individual red-
eyed males with curly wings from the above cross were mated with CycYE8 virgin 
females (Finley lab stock # 692). If none of the progeny had straight wings from the 
above cross, it suggested that CycYE8 successfully recombined with FRT40A since 
homozygous CycYE8 is lethal (see Results and Discussion). I collected red-eyed adults 
with curly wings to make a stock (Finley lab stock # 702).  
Germline clones with homozygous CycYE8 were generated based on the well-
established approach of Chou et al. with minor modification (Chou and Perrimon, 1996). 
w*; CycYE8 FRT40A/CyO females were crossed with hs-FLP/Y; ovoD1 FRT40A/CyO 
males for 3 days. Eggs were collected for 3 days and aged for 2 more days. Larvae, 
which were at either second or third instar stages, were heat shocked at 37ºC in a water 
bath for two hours. Females with straight wings (hs-FLP/w*; CycYE8 FRT40A/ovoD1
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Table 2-1. Primers used to confirm the genotypes. 
Genotypes Primer pairs Product length  
CycYE8/CyO; hs-CycY/TM3, Ser DL94/DL98 1 kb 
 DL93/DL101 1.15 kb 
CycYE8; hs-CycY/TM3, Ser DL94/DL98 1 kb 
 DL93/DL101 negative 
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Figure 2-4. The crossing scheme for recombining CycYE8 with FRT40A. Red 
triangles represent a P-element with the miniwhite gene (38D4) closely linked to the 
FRT40A insertion used as a selection marker for FRT40A; Black triangles represent the 
FRT40A site; ♀, virgin females; ♂, males; ( Δ ), a deletion; X, cross. Bigger X, 
recombination; Oval, centromere. 
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FRT40A) from the above cross were then mated to CycYE8/CyO, Act5C-GFP males to 
test for a maternal requirement for CycY. GFP positive (CycYE8 FRT40A/CyO, Act5C-
GFP) and GFP negative (CycYE8 FRT40A/CycYE8) first instar larvae were picked and 
development was followed as described above. 
 
2.2.10 Gene expression  
Gene expression was assayed by reverse-transcription PCR (RT-PCR) (Figure 
2-7) or quantitative real-time PCR (RT-qPCR) (Figure 2-13). Flies at the indicated 
developmental stages were collected and total RNA was extracted using the RiboPure® 
Kit (Ambion). The RNA samples were then treated with DNase from a DNA-free Kit 
(Ambion) to remove contaminating genomic DNA. cDNAs were synthesized with a 
Transcriptor First Strand cDNA Synthesis Kit (Roche) according to the manufacturer's 
protocol. qPCR reactions were performed using Brilliant® SYBR® Green QPCR Master 
Mix (Stratagene) in a 96-well plate. qPCR reactions were carried out in triplicate for 
each RNA sample. The primers used in this work are listed in Table 2-2. rp49 was used 
as the internal control gene and the mRNA level of CycY was normalized to rp49 levels.  
 
2.2.11 Co-affinity purification (co-AP) assays  
Co-AP assays were conducted by expressing pairs of N-terminally myc-tagged 
and NTAP-tagged proteins in Drosophila S2R+ cells, purification of the NTAP-tagged 
protein, and detection of associated myc-tagged proteins by immunoblotting. Myc-
tagged proteins were expressed from pAS1. NTAP-tagged proteins were expressed 
from pDL4, a derivative of pUAST-NTAP (Veraksa et al., 2005) containing the NTAP tag
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Table 2-2. Primers used for RT-PCR and qPCR. 
Genes Primers Finley lab # (alias) Sequence Position
a Product length (bp) 
CycY 722 (DL108) 5’-AGGAGAATGGCACCCAAC 765-782 414 
 469 (DL17) 5’-TACTCCCGGTGGCAATAG 1161-1178  
crol 723 (DL109) 5’-AGCTCGGTGCCATCAGTAG 1440-1458 332 
 724 (DL110) 5’-GCGGCATTATTCGTGGACG 1753-1771  
Pde1c 728 (DL114) 5’-GTGTGATCGCAACAATACGC 1622-1641 465 
 729 (DL115) 5’-TTGCTTTCCTCCGCTTCC 2069-2086  
β-Tubulin 642 (DL12) 5’-GACCATGTCCGGCGTAAC 881-898 438 
 643 (DL13) 5’-AGCTCCTGGATGGCAGTG 1301-1318  
rp49 732 (DL118) 5’-GATATGCTAAGCTGTCGCACAAATGGC 95-121 118 
 733 (DL119) 5’-GTGCGCTTGTTCGATCCGTAACCG 189-212  
 
a Inclusive nucleotide positions in predicted transcript RA for each gene. 
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followed by the same 5’ and 3’ RTs found in pAS1. Note that pDL4 was validated for 
Gal4-dependent expression of NTAP-tagged proteins in transiently-transfected 
Drosophila S2R+ cells, but it cannot be used to make transgenic flies, possibly due to 
mutations in the P-element. Coding regions from the ATG to the stop codon of various 
Cdks or cyclins were amplified from yeast two-hybrid clones (Stanyon et al., 2004) with 
primers that added the 5’ and 3’ RTs and the products were subcloned into pAS1 or 
pDL4 by gap repair in E.coli. I used the following protocols adapted from Effectene 
user’s manual and Veraksa’s protein purification protocol for transfection, cell lysis, and 
co-AP assays (Veraksa et al., 2005). 
2.2.11.1 Transfection of cultured Drosophila cells  
Day 1 afternoon: Resuspend S2R+ cells in a T75 flask by pipetting and count the 
cell numbers. Dilute the cell suspension to 1x106 cells/ml with fresh Schneider’s 
Drosophila culture media (Invitrogen) supplemented with 10% FBS and 0.1mg/ml 
Gentamicin. Seed 2ml of the above diluted cells in each well of a 6-well plate. Incubate 
in the 25°C fly incubator overnight. Day 2 afternoon about the same time: Replace the 
old media in the 6-well plate with fresh media and put it back into the incubator until 
transfection. For each transfection, mix 10µl of 50ng/µl pAS1-X, 10µl of 50ng/µl pDL4-Y, 
and 10µl of 50ng/µl pMT-Gal4 (Klueg et al., 2002). Add 70 µl of buffer EC to make a 
total of 100 µl. Add 12µl of enhancer, vortex at the highest speed for 1 second, and 
incubate at room temperature for 5 minutes. Add 30 µl of effectene, vortex at the 
highest speed for 15 seconds, and incubate at room temperature for 10 minutes. Mix 
with 600µl of culture media and add to the top of the cells in a drop-wise way. Put the 
plate back into the fly incubator. The reagents mentioned above, including buffer EC, 
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enhancer, and effectene, are from the effectene transfection kit (Qiagen). Day 3 
morning: Add 220µl of 10mM CuSO4 to each well to induce the expression of Gal4. Day 
4 morning: Replace with 1.5ml of fresh media supplemented with 1mM CuSO4 in each 
well. Day 6: Resuspend the transfected cells by pipetting up and down several times. 
Transfer the cells to a 1.5ml of eppendorf tube and centrifuge at 13500 rpm for 2 
minutes at 4°C to spin down the cells. Wash the cell pellet two times with cold PBS. 
2.2.11.2 Cell lysis  
Add 300 µl of fresh-made lysis buffer [50mM Tris-HCl pH7.4, 180mM NaCl, 5mM 
EDTA, 1% NP-40, 10% glycerol, 50mM NaF, 1mM Na3VO4, 1mM PMSF, 1x Protease 
inhibitor cocktail (Roche)] to the cell pellet from one well of the 6-well plate. Homogenize 
by pipetting up and down several times. Incubate on ice for 45 minutes. Vortex once 
every 5 minutes. Centrifuge at 13500 rpm at 4°C for 40 minutes to clarify the cell lysate. 
Transfer the supernatant to a new tube. 
2.2.11.3 Protein quantification  
Quantify the protein concentration using the BioRad protein assay reagent. 
Generate a standard curve using a series of BSA dilutions ranging from 0 to 10µg/ml. 
Take 4µl of protein lysate and add 796µl of H2O to make a total of 800µl. Mix with 200µl 
of BioRad protein assay dye reagent. Incubate at room temperature for 5 minutes and 
then measure OD595 to determine the absorbance and convert it to the protein 
concentration on the basis of the standard curve. Usually, the protein concentration is 
about 1.5-2.5µg/µl. 
  
45
2.2.11.4 Western blot to examine the protein expression  
Mix the cell lysate with LDS sample loading buffer (Invitrogen) and incubate at 
70°C for 10 minutes. Load 15µg of total protein for myc western blot or 2µg for protein A 
western blot. Run the SDS-PAGE gel with Invitrogen electrophoresis system at 200V for 
30-40 minutes. Transfer the protein to PVDF membrane (Bio-Rad) at 40V for 90 
minutes. Block with 1XPBS, 5% milk at room temperature for one hour or 4°C overnight. 
Incubate with primary antibody (anti-myc 1:500, Santa Cruz) at room temperature for 
one hour or 4°C overnight. Wash with 1XPBS 2 times. Incubate with secondary 
antibody [goat anti-mouse HRP conjugated secondary antibody (1:10000, BioRad) or 
goat anti-Protein A peroxidase-conjugated antibody (1:15000, Rockland 
Immunochemicals)] at room temperature for one hour. Wash with 1XPBS, 0.05% 
Tween-20 5 times for 10 minutes each time. Detect proteins with ECL plus reagents 
(GE Healthcare Life Sciences). 
2.2.11.5 Co-AP  
Transfer 40µl of rabbit IgG-conjugated agarose beads (Sigma) slurry (20µl of 
settled beads) into an eppendorf tube using big orifice pipet tips. Wash 3 times with lysis 
buffer. Mix with 500µg of cell lysate in a total of 1ml of lysis buffer. Incubate at 4°C for 
two hours. Wash with lysis buffer 5 times. Add 1XLDS sample buffer to the beads and 
heat at 70°C for 10 minutes. Resolve co-purified proteins by SDS-PAGE and detect by 
western blotting. 
 
2.2.12 Sequence alignments  
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We determined the reciprocal best-match BLAST hits between Drosophila and 
human cyclins (Table 2-3). BLAST searches were conducted with each of the 
Drosophila cyclins listed below to identify the top matching human cyclins. In cases 
where a gene had multiple protein isoforms, the longest isoform that had a cyclin 
domain was used. The top matching human proteins were then used in BLAST 
searches against the Drosophila melanogaster annotated proteins and the top matching 
protein was identified. Reciprocal best-match BLAST hits are listed in Table 2-3. An 
example of how reciprocal best-match hits are interpreted is as follows: Human CCND1, 
CCND2, and CCND3 are the human proteins most similar to Drosophila CycD, and 
Drosophila CycD is the Drosophila protein most similar to human CCND1, CCND2, or 
CCND3, according to BLAST. Multiple sequence alignment was performed using 
ClustalX version 2 (Larkin et al., 2007; Thompson et al., 2002). Pair-wise percent 
identity was determined by dividing the number of identical sites in the alignment by the 
length of the alignment, including gaps and unaligned ends. The dendrogram shown in 
Figure 2-5 A was constructed using ClustalX with the neighbor-joining algorithm. For 
Figure 2-5 B, the reciprocal best-match BLAST hits between Drosophila CycY and 
proteins from several divergent species were aligned using ClustalW followed by 
manual corrections to improve identities. Only the top matching CycY-like protein from 
each species is shown. The proteins aligned were as follows, where Genbank 
accession numbers are in parentheses: Aedes aegypti hypothetical protein 
AaeL_AAEL010543 (XP_001660900.1); Caenorhabditis elegans hypothetical protein 
ZK353.1a (NP_498858.2); Danio rerio hypothetical protein LOC767752 
(NP_001070188.1); Drosophila melanogaster CG14939-PA (NP_609519.1); Gallus
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Table 2-3. Drosophila-Human reciprocal best-match proteins. 
Drosophila protein Genbank ID Human Gene Human protein Genbank ID 
CG14939-PA (CycY) NP_609519 CCNY Cyclin Y NP_659449.3 
CG14939-PA (CycY) NP_609519 CCNYL1 Cyclin Y-like 1 NP_689736.1 
CycA-PA NP_524030 CCNA1 Cyclin A1 NP_001104516 
CycA-PA NP_524030 CCNA2 Cyclin A2 NP_001228.1 
CycB-PB NP_726246 CCNB1 Cyclin B1 NP_114172.1 
CycB-PB NP_726246 CCNB1 Cyclin B2 NP_004692.1 
CycB3-PA NP_651303 CCNB3 Cyclin B3 NP_149020.2 
CycC-PA NP_476848 CCNC Cyclin C NP_005181.2 
CycD-PF (PC) NP_727913.1 CCND2 Cyclin D2 NP_001750.1 
CycD-PF (PC) NP_727913.1 CCND3 Cyclin D3 NP_001751.1 
CycD-PF (PC) NP_727913.1 CCND1 Cyclin D1 NP_444284.1 
CycE-PD NP_723925 CCNE1 Cyclin E1 NP_001229.1 
CycE-PD NP_723925 CCNE2 Cyclin E2 NP_477097.1 
CycG-PC AAF57169.2 CCNG1 Cyclin G1 NP_004051.1 
CycG-PC AAF57169.2 CCNG2 Cyclin G2 NP_004345.1 
CycH-PA NP_524207 CCNH Cyclin H NP_001230.1 
CycJ-PA NP_523903 CCNJ Cyclin J NP_001127847.1 
CG16903-PA NP_569980 CCNL2 Cyclin L2 NP_112199.2 
CG16903-PB NP_569980 CCNL1 Cyclin L1 NP_064703.1 
CycK-PB NP_788083 CCNK Cyclin K NP_001092872.1 
CycT-PB NP_524127 CCNT2 Cyclin T2 NP_001232.1 
CycT-PB NP_524127 CCNT1 Cyclin T1 NP_001231.2 
Koko-PA NP_650721 FAM58A Family 58A NP_689487.2 
Koko-PA NP_650721 FAM58B Family 58B NP_001098987.1 
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Figure 2-5. CG14939 encodes a highly conserved Y-type cyclin. (A) Phylogenetic 
tree resulting from alignment of all Drosophila cyclins and cyclin-like proteins and their 
corresponding human orthologs. Blue dots at branch points indicate that the attached 
nodes (proteins) are reciprocal best-match BLAST hits between Drosophila and human 
(see Materials and Methods). Lengths of the horizontal lines between nodes and branch 
points indicate relative sequence similarity; e.g., the human and Drosophila Y-type 
cyclins (red line) are more similar to each other than are any other human and 
Drosophila cyclins except for CycC.  
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Figure 2-5. CG14939 encodes a highly conserved Y-type cyclin. (B) Alignment of Drosophila CycY 
and the most similar proteins from several other species. The sequences available for Nematostella and 
Trichoplax may be truncated because the genome sequences were still in draft form. Yellow or grey 
shaded amino acids are identical or similar, respectively, in at least 8 out of the 11 species shown, or 7 of 
9 species where the N- and C-terminal sequences of Nematostella and Trichoplax appear to be missing. 
Blue-shaded amino acids in the D. melanogaster sequence are known to be phosphorylated in embryos 
(Zhai et al., 2008). Red-shaded serines, corresponding to S389 in D. melanogaster, are highly conserved 
and phosphorylated in both Drosophila and human CycY (Beausoleil et al., 2004; Olsen et al., 2006; Zhai 
et al., 2008). The N-terminal region of H. sapiens CycY contains a putative myristoylation signal (green 
lettering), previously noted by Jiang et al., (Jiang et al., 2009), which appears to be conserved in many 
other species. All of the sequences contain the conserved cyclin domain (underlined), corresponding to 
amino acids 205 to 328 of Drosophila CycY; this domain is annotated in these sequences by the 
Conserved Domain Database (Marchler-Bauer et al., 2009) and corresponds to pfam (Finn et al., 2009), 
domain pfam:00134, “Cyclin_N”, the N-terminal cyclin fold found in the cyclin superfamily. Dashes 
indicate gaps in the alignment. Asterisks in the D. melanogaster sequence indicate unaligned residues 
that were removed and are shown below the alignment; one sequence is histidine-rich and the other is 
glycine-rich, and neither appears to be conserved. The unaligned N-terminal region of the Monsiga 
brevicollis sequence is also shown below. Numbers above the lines indicate residue numbers for the 
Drosophila protein. Gene names are listed in Materials and Methods.  
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gallus CCNYL1 cyclin Y-like 1 (XP_425973.2); Homo sapiens cyclin fold protein 1 
variant b (AAL78999.1); Mus musculus cyclin fold protein 1 (NP_080760.2); Xenopus 
laevis hypothetical protein LOC431857 (NP_001084816.1); Nematostella vectensis 
predicted protein (XP_001641126); Trichoplax adhaerens hypothetical protein 
(XP_002116466); Monosiga brevicollis hypothetical protein (XP_001750168). 
To identify proteins with similarity to CycY in more distant species, reciprocal 
best-match BLAST hits between Drosophila CycY and proteins in the species listed 
below were determined. The identified proteins were also determined to be reciprocal 
best-match BLAST hits with the human CCNY protein. For all of the identified proteins 
the sequence similarity with the human or Drosophila CycY proteins was restricted to 
the annotated cyclin domain (Marchler-Bauer et al., 2009) and immediate flanking 
regions, referred to as the “cyclin+” region in Figure 2-6. The cyclin+ regions were 
aligned using ClustalW and a consensus sequence was determined by identifying 
residues that were found in >50% of the sequences (Figure 2-6A). The dendrogram 
shown in Figure 2-6B was obtained by aligning the cyclin+ region of the proteins most 
similar to CycY, and the annotated cyclin domains of reciprocal best-match hits of 
Drosophila CycA and CycB for the species shown. Only the top matching CycY-like 
protein from each species is shown; gene or genome duplications in some lineages 
have resulted in several parologous CycY-like proteins (not shown). The following 
proteins from non-metazoan species were reciprocal best-match hits of Drosophila 
CycY or the human CCNY protein, where Genbank accession numbers are in 
parentheses: Arabidopsis thaliana CYCP4;3 (NP_196362.1); Coprinopsis cinerea 
predicted protein (XP_001832875); Cryptococcus neoformans cyclin (XP_566770);
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Figure 2-6. The cyclin domain of Y-type cyclins is novel and conserved 
throughout the eukaryotic kingdom. (A) Alignment of the cyclin domains from the 
proteins that are reciprocal best-match BLAST hits of Drosophila CycY in many non-
metazoan species. These proteins are also reciprocal best-match BLAST hits of human 
CycY. Alignments include the cyclin domains (arrows) as annotated by the Conserved 
Domain Database (Marchler-Bauer et al., 2009) along with the indicated flanking region 
of each protein. A consensus sequence was obtained as 31 residues that are identical 
in at least 50% of the proteins (colored); the Drosophila and human proteins each share 
27 of these consensus residues. Only the top related protein from each species is 
shown. 
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Figure 2-6. The cyclin domain of Y-type cyclins is novel and conserved 
throughout the eukaryotic kingdom. (B) Dendrogram showing sequence similarity 
among the cyclin domains from several distant species. Cyclin domains from Drosophila 
melanogaster (Dm) CycA, CycB, and CycY and their reciprocal best-match BLAST hits 
in human (Hs), Monosiga brevicollis (Mb), Arabidopsis thaliana (At), and 
Saccharomyces cerevisiae (Sc) were aligned. The cyclin domains from the Y-type 
cyclins included the annotated cyclin domain and small flanking regions as shown in 
Figure 2-6A (cyclin+). Only the top related protein from each species is shown. The 
length of the lines is proportional to sequence similarity. The lower cluster of Y-type 
cyclin domains and the upper cluster of A and B-type cyclin domains are separated by a 
relative distance of 9 (see scale bar for relative distances).  
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Dictyostelium discoideum cyclin domain-containing protein (XP_642568); Giardia 
intestinalis Cyclin fold protein 1 (EET00183.1); Laccaria bicolor predicted protein 
(XP_001886042); Medicago truncatula unknown (ACJ84314); Paramecium tetraurelia 
hypothetical protein (XP_001460214); Perkinsus marinus hypothetical protein 
(EER16009); Phaeodactylum tricornutum CYCP1 (XP_002182703.1); Phytophthora 
infestans cyclin-Y-like (EEY67633.1); Populus trichocarpa predicted protein 
(XP_002302113); Ricinus communis cyclin (XP_002520742.1); Saccharomyces 
cerevisiae PCL1 (NP_014110.1); Tetrahymena thermophila Cyclin, N-terminal domain 
containing protein (EAS05969); Toxoplasma gondii cyclin, N-terminal domain-containing 
protein (EEE19730); Trypanosoma cruzi cyclin 6 (AAG44389.1); Yarrowia lipolytica 
hypothetical protein (XP_505742). 
 
2.2.13 Yeast two-hybrid assays  
Yeast two-hybrid assays (Fields and Song, 1989) were performed using the LexA 
system (Gyuris et al., 1993) and interaction mating assays (Finley and Brent, 1994). 
Yeast strains and vectors, the protocol for one-on-one mating assays, and the reporter 
scoring methods were previously described (Zhong et al., 2003). All of the cyclins tested 
were expressed as activation domain (AD) fusions, whereas all of the Cdks were 
expressed as DNA-binding domain (BD) fusions. AD and BD strains were obtained from 
the arrays of LexA-based yeast two-hybrid clones previously described (Stanyon et al., 
2004). 
 
2.2.14 Tandem affinity purification (TAP)  
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Tandem affinity purification was performed as previously described (Puig et al., 
2001; Veraksa et al., 2005). Drosophila S2R+ cells were cotransfected with pDL4-CycY 
and pMT-Gal4 in a 100mm dish. Cells were induced with CuSO4, harvested, and lysed 
as described above. About 10-15mg clarified cell lysate was incubated with 100μl of 
settled IgG agarose beads (Sigma A2909) at cold room for 2 hours on a nutator. The 
lysate/beads mixture was loaded to a poly-prep column (0.8 x 4 cm, BioRad 731-1550), 
which was then washed 3 times with 10ml of lysis buffer and once with 10ml of TEV 
cleavage buffer (10mM Tris.HCl pH8.0, 150mM NaCl, 0.1% NP-40, 0.5mM EDTA, 1mM 
DTT). 100 units of AcTEV protease (Invitrogen 12575-023) in 1ml of TEV cleavage 
buffer was added to the beads and the mixture was incubated at 16°C for two hours. 
Three volumes of calmodulin binding buffer (10mM β-mercaptoethanol, 10mM Tris.HCl 
pH8.0, 150mM NaCl, 1mM Mg-acetate, 1mM imidazole, 2mM CaCl2, 0.1% NP40) and 
3/1000 volume of 1M CaCl2 were added to the elute from TEV cleavage to promote the 
binding with calmodulin beads and titrate the EDTA coming from the TEV cleavage 
buffer. 100μl of settled calmodulin beads were incubated with the above elute at 4°C for 
2 hours. Beads were then washed with 4ml of calmodulin binding buffer and finally, 
purified proteins were eluted from the beads with 400μl of calmodulin elution buffer 
(10mM β-mercaptoethanol, 10mM Tris.HCl pH8.0, 150mM NaCl, 1mM Mg-acetate, 
1mM imidazole, 2mM EGTA, 0.1% NP40). Concentrated elute was sent to the 
University of Michigan, Michigan Proteome Consortium, for MALDI/MS-MS. 
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2.3 RESULTS AND DISCUSSION 
 
2.3.1 CycY is a conserved uncharacterized cyclin  
Drosophila CG14939 has a single predicted transcript that encodes a protein with 
406 residues (Figure 2-1, 2-5B). Between amino acids 205 and 328 lies a cyclin 
domain, a conserved region that defines the cyclin family of proteins. The closest 
human homolog of CG14939 is a poorly characterized gene called Cyclin Y (CCNY). 
Genes in a number of other species have also been named Cyclin Y based on their 
sequence similarity to human CCNY. CG14939 is more similar to the Y cyclins from 
other species than it is to any other Drosophila melanogaster gene (Figure 2-5) 
indicating that it belongs to this orthologous family of proteins. We therefore renamed 
CG14939 Cyclin Y (CycY). Outside of the cyclin domain the protein has virtually no 
sequence similarity to other cyclins. However, CycY has been highly conserved through 
evolution. Clear CycY orthologs are found in all metazoans with fully sequenced 
genomes, including bilaterians (e.g., insects, nematodes, vertebrates), cnidarians (e.g., 
the sea anenome, Nematostella vectensis), and the placozoan, Trichoplax adhaerens. 
Cyclin Y is also found in the choanoflagellate, Monosiga brevicollis, the closest known 
unicellular relative of metazoans, suggesting that the Y-type cyclins originated prior to 
the first multicellular species. Cyclin Y proteins from all of these species share 
substantial sequence similarity over most their length, including regions outside of the 
cyclin domain (Figure 2-5B). In contrast, plants, fungi, and other non-metazoan species 
do not have proteins with extensive sequence similarity to CycY, though they do contain 
the CycY-specific cyclin domain; this cyclin domain is distinct from other cyclin domains 
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and appears to be conserved throughout the eukaryotic kingdom (Figure 2-6). In 
metazoan species the level of CycY conservation is particularly high. For example, the 
Drosophila protein shares 52% identity with the human CCNY protein. This level of 
conservation is much higher than that observed for the cell cycle cyclins (e.g., Cyclins 
A, B, D, and E), which share between 20 and 41% identity between human and 
Drosophila (Finley et al., 1996). This suggests that CycY has an important and 
potentially conserved function. Surprisingly, the function of Cyclin Y has not been 
studied and CycY mutants have not been reported for any model organism.  
 
2.3.2 Generation of a CycY mutant  
To determine the function of Drosophila CycY, I set out to generate a loss-of-
function mutant allele. I took advantage of the availability of a strain, d03228, bearing a 
P-element inserted 1,958 bp downstream of the CycY stop codon and 5,723 bp 
upstream of the start codon of the neighboring gene, crol (Figure 2-1). This insertion 
itself has no visible effect on the function of any genes in this region since the 
homozygous d03228 adults are completely viable and normal. I used imprecise excision 
to generate a small deletion around the original P-element. The deletion, E8, completely 
removed the CycY coding region while leaving the coding regions of the neighboring 
genes intact (Figure 2-1), as determined by PCR and sequencing (Materials and 
Methods). Expression of the neighboring genes, crol and Pde1c, was confirmed using 
RNA extracted from homozygous and heterozygous E8 second instar larvae (Figure 2-
7). In contrast, CycY transcription was undetectable in homozygous E8 larvae. 
Hereafter we refer to the E8 deletion as CycYE8. 
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Figure 2-7. Reverse-transcription PCR detecting expression of CycY, crol, Pde1c, 
or β-tubulin in homozygous CycYE8 or heterozygous CycYE8 (CycYE8/+) second 
instar larvae. The “+” chromosome is a CyO balancer with Act5C-GFP. A band of the 
expected size is detected for all genes in both genotypes. The band is missing in the 
homozygous CycYE8 larvae as expected. 
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Two additional lines of evidence indicate that CycY is the only gene affected in 
strain CycYE8. First, CycYE8 fully complemented crol04418, a lethal null allele of the 
neighboring gene (D'Avino and Thummel, 1998); crol04418 also complemented the 
mutant phenotype of CycYE8 (see below). Thus, although CycYE8 lacks the first non-
coding exon of crol, a crol transcript is expressed and appears to be fully functional. 
Second, as described in detail below, all of the abnormalities that I observed in 
homozygous CycYE8 mutants can be rescued either by a CycY genomic transgene 
(Figure 2-1) or by ubiquitous expression of a CycY cDNA using heat shock induction 
(see below). Combined these results indicate that the CycYE8 mutant strain is a null 
mutant for CycY. 
 
2.3.3 CycY null mutants show delayed entry into pupariation and are pupal lethal 
Homozygous CycYE8 mutants or CycYE8 over a deficiency that removes CycY 
(Df(2L)Exel6030) produce no viable adults indicating that CycY is an essential gene. To 
analyze the lethal phase, eggs from a self cross of CycYE8/CyO flies were collected for 
12 hours and aged for another 30 hours. Of 366 embryos examined, 89 (24.3%) 
remained unhatched while 277 (75.7%) hatched to first instar larvae. Since roughly 25% 
of the embryos from this cross should be homozygous CyO, which is lethal during 
embryogenesis, a third of the embryos that hatched should be homozygous CycYE8, 
indicating that zygotic expression of CycY is not essential for embryogenesis. 
To evaluate whether CycY is required during larval and pupal development, I 
picked 180-200 first instar larvae of CycY null mutants (homozygous CycYE8 or CycYE8/ 
Df(2L)Exel6030) or their siblings and followed their morphology and development for 15 
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days, after which no additional adults eclosed. CycY null mutants did not show obvious 
larval lethality since the majority (90% or 93%) of first instar larvae developed into 
pupae, which is a rate similar to their heterozygous siblings (84% or 94%, respectively) 
(Table 2-4). However, I did observe delayed growth during larval development. By the 
time third instar larvae in the heterozygous group reached the wandering stage, CycY 
null mutant larvae were still at the feeding stage and exhibited dramatically smaller body 
sizes (Figure 2-8 A, B, G, H; Figure 2-9 A, B). The CycYE8 homozygotes eventually 
grew to sizes that were 80-90% of the heterozygotes before pupariation (Figure 2-8 G, 
J). The delay in larval growth could be rescued with a genomic CycY transgene (Figure 
2-8 C, D, I; Figure 2-9 C, D). The delay was also evident in the timing of pupariation. As 
shown in Figure 2-8 A and B, the first pupa of CycYE8 heterozygotes was observed at 6 
days after egg deposition (AED), while the first pupa of CycYE8 homozygotes was 
observed at 7 days AED. Based on the number of pupae that formed each day in the 
two strains I estimated that puparium formation of CycYE8 homozygous mutants was 
delayed for about 13 hours relative to that of the heterozygous controls (Materials and 
Methods). The genomic CycY transgene shortened this delay to about 5 hours. Similar 
results were obtained with the CycYE8/Df(2L)Exel6030 mutants (Figure 2-9). 
CycY null mutants were arrested predominately during pupal stages, but with 
variable expressivity. I scored the final developmental stages of animals from each 
genotype based on the presence of defined morphological markers (Bainbridge and 
Bownes, 1981). Two major lethal phases were observed. The early lethal phase was 
between pupal stages P3 and P5; for example, all 162 CycYE8 mutants that pupated 
developed to stage P3 but only 61% reached stage P5 (Table 2-4). In contrast, all of the
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Table 2-4. CycY and Eip63E mutants display variable expressivitya 
Genotypeb  L1 w. L3 P1 P3 P4 P5 P14 P15 A
CycYE8/+ n 180 152 152 152 152 152 151 150 150
 % 100 84 84 84 84 84 84 83 83
CycYE8 n 180 162 162 162 158 110 74 23 15c
 % 100 90 90 90 88 61 41 13 8
CycYE8/+; P{CycY} n 200 180 180 180 180 180 180 180 180d
 % 100 90 90 90 90 90 90 90 90
CycYE8; P{CycY} n 200 185 185 185 185 185 185 177 177e
 % 100 93 93 93 93 93 93 89 89
CycYE8/+ and  n 200 187 187 187 187 187 187 174 174f
Df(2L)Exel6030/+ % 100 94 94 94 94 94 94 87 87
CycYE8/Df(2L)Exel6030 n 200 186 186 186 182 144 88 31 19g
 % 100 93 93 93 91 72 44 16 10
CycYE8/+; P{CycY} and  n 200 178 178 178 178 178 178 177 177h
Df(2L)Exel6030/+; P{CycY} % 100 89 89 89 89 89 89 89 89
CycYE8/Df(2L)Exel6030  n 200 179 179 179 179 179 179 176 176i
; P{CycY} % 100 90 90 90 90 90 90 88 88
Eip63EGN50/+ and  n 180 164 164 164 164 164 164 162 162
Eip63E81/+ % 100 91 91 91 91 91 91 90 90
Eip63EGN50/Eip63E81 n 180 135 129 129 76 59 0 0 0
 % 100 75 72 72 42 33 0 0 0
a 180 or 200 newly eclosed first instar larvae (L1) from each genotype were followed and the number that 
reached each stage, including wandering third instar larvae (w. L3), pupal stages (P1-P5, P14, and P15), 
and adults (A), was recorded. 
b P{CycY} represents a genomic CycY transgene (Figure 1). In CycYE8/+ and Df(2L)Exel6030/+, “+” 
stands for an Act5C-GFP-marked CyO balancer chromosome presumed to be wild type for CycY. In 
Eip63E81/+ and Eip63EGN50/+, “+” stands for an Act5C-GFP-marked TM3, Ser balancer chromosome 
presumed to be wild type for Eip63E. 
c 13 out of the 15 CycYE8 adults that eclosed had leg and wing defects and died quickly, while the 
remaining two were much smaller than their heterozygous siblings and died within two days.  
d 3 out of the 180 CycYE8/+; P{CycY} adults were found dead on the food surface with the wing still folded 
and without other obvious morphological defects. 
e 18 out of the 177 CycYE8; P{CycY} adults were found dead on the food surface with the wing still folded 
and without other obvious morphological defects. 
f One out of the 174 CycYE8/+ and Df(2L)Exel6030/+ adults was found dead on the food surface with the 
wing still folded and without other obvious morphological defects. 
g All of the 19 CycYE8/Df(2L)Exel6030 adults that eclosed had leg and wing defects and died quickly. 
h 6 out of the 177 CycYE8/+; P{CycY} and Df(2L)Exel6030/+; P{CycY} adults were found dead on the food 
surface with the wing still folded and without other obvious morphological defects. 
i 13 out of the 176 CycYE8/Df(2L)Exel6030; P{CycY} adults were found dead on the food surface with the 
wing still folded and without other obvious morphological defects. 
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Figure 2-8. Developmental timing of CycY and Eip63E mutants. (A-F) The 
development of 180 first instar larvae (L1) of each genotype were followed for 15 days. 
Genotypes include heterozygous CycYE8 (A and C) or homozygous CycYE8 (B and D). 
Larvae in C and D harbored a genomic CycY transgene on the third chromosome 
(P{CycY}). Larvae heterozygous for the Eip63E mutants, Eip63EGN50 or Eip63E81 (E), or 
transheterozygous Eip63EGN50/Eip63E81 (F) were also analyzed. The percentage of first 
instar larvae that developed into wandering third instar larvae (w L3), pupae (P), and 
adults (A) on each day after egg deposition (AED) is shown. (G-J) Typical third instar 
larvae of CycYE8/+ (G), CycYE8 (H), CycYE8; P{CycY} (I) at the same time point, and 
CycYE8 after an additional day (J). In A, C, and G, “+” stands for an Act5C-GFP-marked 
CyO balancer chromosome; in E, “+” stands for an Act5C-GFP-marked TM3, Ser 
balancer chromosome. 
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Figure 2-9. Developmental timing of CycY null mutants with and without a CycY 
genomic transgene. The development of 200 first instar larvae of each genotype was 
followed for 15 days. Genotypes shown include CycYE8/+ and Df(2L)Exel6030/+ 
combined (A), CycYE8/Df(2L)Exel6030 (B), CycYE8/+; P{CycY} and Df(2L)Exel6030/+; 
P{CycY} combined (C), CycYE8/Df(2L)Exel6030; P{CycY} (D). The percentage of first 
instar larvae (L1) that developed into wandering third instar larvae (w L3), pupae (P), 
and adults (A) on each day after egg deposition (AED) is shown. “+” stands for an 
Act5C-GFP-marked CyO balancer chromosome presumed to be wild type for CycY. 
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152 heterozygotes that pupated reached stage P5, and all but two eventually emerged 
as adults. The CycY null pupae that were arrested at stage P3 or P4 showed a variety 
of developmental defects, including defects in gas bubble translocation, head eversion, 
leg elongation, and adult tissue growth (Figure 2-10 and Table 2-5). Many mutant 
individuals stopped further development with the newly formed gas bubble still in the 
middle of the abdomen (Figure 2-10 E). In others the gas bubble translocated to the 
posterior portion of the puparium as in wild-type, but then failed to completely relocate 
to the anterior (Figure 2-10 H), which may hinder head eversion (Chadfield and 
Sparrow, 1985). Many of the mutant pupae showed different amounts of empty space 
inside the pupal case (Figure 2-10 D-I), which was probably due either to the failure of 
gas bubble translocation, or to insufficient adult tissue growth. A defect in leg elongation 
was also prevalent. Some mutant individuals had partially elongated legs that were 
either shorter than normal and did not reach the bottom of the abdomen, or were bent 
(e.g., Figure 2-10 G). More severe cases showed no sign of leg elongation (Figure 2-10 
D). Wings also did not achieve full extension. The CycYE8/Df(2L)Exel6030 mutant had 
the same range of phenotypes as homozygous CycYE8 (Table 2-5 and Figure 2-11). 
The late lethal phase of the CycY null was between stages P14 and P15, almost 
at the end of pupal development. For example, while 41% of the CycYE8 homozygous 
pupae reached stage P14, only 13% reached stage P15 (Table 2-4). The P14-arrested 
mutants exhibited the prominent malformed leg phenotype that was also observed 
during earlier pupal stages (Figure 2-10 Q). In addition to the morphological defects, 
CycY null pupae were generally shorter and much lighter than wild type pupae (Table 2-
6, Appendix F). 
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Figure 2-10. Metamorphosis defects in CycY and Eip63E mutants. (A-O) Representative early pupae 
from ventral, dorsal, and lateral views (left, middle and right columns, respectively). Genotypes include 
CycYE8/+ (A-C), homozygous CycYE8 (D-I), homozygous CycYE8 with the P{CycY} transgene (J-L), and 
Eip63E81/Eip63EGN50 (M-O). Defects are indicated by colored arrows. The CycYE8 homozygous mutant 
early pupae (second and third rows) and Eip63E null mutant early pupae (fifth row) show defects of leg 
elongation (red), head eversion (blue), gas bubble translocation (green), and adult tissue growth (purple). 
Early pupae of CycYE8 homozygotes with a genomic CycY transgene have no defects (fourth row). (P-R) 
Representative pharate adults of CycYE8/+ (P), homozygous CycYE8 (Q), and homozygous CycYE8 with 
the P{CycY} transgene (R). Homozygous CycYE8 mutant pharate adults have an obvious bent leg 
phenotype (yellow arrow in (Q). CycYE8 homozygous mutant adult escapers either die soon after eclosion 
or survive for less than two days and have a much smaller body size (W) than heterozygous control 
adults (V), or CycYE8 mutants complemented with the P{CycY} transgene (X). Many of the adult escapers 
had malformed legs (T, yellow arrow), whereas legs were normal in heterozygous control adults (S), or 
CycYE8 mutants complemented with the P{CycY} transgene (U). In CycYE8 mutants arrested during 
eclosion (Y and Z), when the pupal case was manually removed (Z) a layer of white tissue (arrowhead) 
was evident. “+” stands for a CyO balancer chromosome with Act5C-GFP. 
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Figure 2-11. Metamorphosis defects in CycY transheterozygous null mutants. 
Genotypes shown include CycYE8/Df(2L)Exel6030; P{CycY} (A-F) and 
CycYE8/Df(2L)Exel6030 (G-L). Representative early pupae (A-C, G-I), pharate adults (D, 
J), dissected legs (E, K), or adults (F, L) are shown. For early pupae, the first, second, 
and third columns present the ventral, dorsal, and lateral views, respectively. Defects 
are indicated by colored arrows. The CycYE8/Df(2L)Exel6030 transheterozygous mutant 
early pupae (G-I) show defects of leg elongation (red), head eversion (blue), gas bubble 
translocation (green), and adult tissue growth (purple). CycYE8/Df(2L)Exel6030 
transheterozygous mutant pharate adults have an obvious bent leg phenotype (J, yellow 
arrow), but the dorsal view is indistinguishable from the control (data not shown). 
CycYE8/Df(2L)Exel6030 transheterozygous mutant adult escapers die soon after 
eclosion, some of which also have malformed legs (K, yellow arrow). Some were 
arrested during eclosion (L). 
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Table 2-5. Metamorphosis defects in CycY and Eip63E mutantsa 
Arrested between P1 and P14 (%) 
Genotypes Total pupae 
Eclosed 
(%) Defects - + ++ +++ 
CycYE8 162 14 Leg elongation 18 9 22 37 
   Empty space inside pupal case 17 16 40 13 
   Head eversion 44 18 10 14 
CycYE8; P{CycY} 185 96 Leg elongation 4 0 0 0 
   Empty space inside pupal case 4 0 0 0 
   Head eversion 4 0 0 0 
CycYE8/Df(2L)Exel6030 186 17 Leg elongation  20 24 16 23 
   Empty space inside pupal case 19 24 28 12 
   Head eversion 27 35 11 10 
CycYE8/Df(2L)Exel6030  179 98 Leg elongation  2 0 0 0 
;P{CycY} 
  Empty space inside pupal case 2 0 0 0 
   Head eversion 2 0 0 0 
Eip63EGN50/Eip63E81 129 0 Leg elongation 2 17 17 64 
   Empty space inside pupal case 32 26 23 20 
   Head eversion 33 23 4 40 
     
 
a Mutants terminally arrested between pupal stages P1 and P14 (Table 2-4) were 
scored for metamorphosis defects (leg elongation, head eversion, or empty space 
inside the pupal case). - no defect; + mild defect; ++ moderate defect; +++ severe 
defect. 
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Table 2-6. CycY and Eip63E mutant pupae are smaller than wild type pupae 
 Average weighta Average lengthb 
Genotypec mg (%) n % ± SD n 
CycYE8/+ 1.12 (100) 161 100 ± 4.0 31 
CycYE8/+ and Df(2L)Exel6030/+ 1.18 (100) 239 100 ± 4.8 44 
CycYE8 0.65 (58) 137 90 ± 8.6 36 
CycYE8/Df(2L)Exel6030 0.75 (64) 230 92 ± 6.4 44 
CycYE8/+; P{CycY} 1.19 (100) 265 100 ± 4.9 72 
CycYE8; P{CycY} 1.13 (95) 239 102 ± 5.0 72 
CycYE8/+; P{CycY} and Df(2L)Exel6030/+; P{CycY} 1.21 (100) 246 100 ± 4.4 47 
CycYE8/Df(2L)Exel6030; P{CycY} 1.14 (94) 279 101 ± 4.2 48 
Eip63EGN50/+ and Eip63E81/+ 1.25 (100) 104 100 ± 3.7 30 
Eip63EGN50/Eip63E81 0.75 (60) 142 90 ± 5.3 40 
 
a Percent of average weight is calculated relative to heterozygous siblings (100%). 
b Percent of average length is calculated relative to heterozygous siblings (100%). 
c The plus symbol (+) stands for an Act5C-GFP-marked balancer chromosome; either CyO with CycYE8 and 
Df(2L)Exel6030, or TM3, Ser with Eip63EGN50 and Eip63E81. 
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Among the small fraction of CycYE8 pupae that reached stage P15, 8 out of 23 
(35%) arrested during the process of eclosion. The remainder eclosed into adults, but 
the majority (13 out of 15) died very quickly with their wings still folded. Most of these 
adults displayed short bent legs (Figure 2-10 T). Only two animals successfully eclosed 
into adults that looked normal, though they were smaller than newly emerged 
heterozygous control adults (Figure 2-10 V, W) and they survived for less than two 
days. When the mutants that were arrested during eclosion were manually dissected 
from the pupal case, a layer of white tissue could be seen, which seemed to adhere 
adult structures to the inside wall of the pupal case (Figure 2-10 Y, Z). All of the CycY 
null mutant defects described above could be rescued by introduction of a CycY 
genomic transgene (Figure 2-10 and 2-11, Table 2-4, 2-5, and 2-6).  
 
2.3.4 The expression of CycY is essential during the transition from third instar 
larvae to prepupae 
The null mutant phenotype of CycY suggested an important function during 
metamorphosis. To determine the developmental time point at which CycY expression 
is required, I generated transgenic flies that expressed myc-tagged CycY from a heat 
shock promoter. A series of different heat shock regimes were performed to compare 
their ability to rescue the lethality of homozygous CycYE8 (Figure 2-12). Heat shock on 
the first 3 days after egg laying failed to rescue the viability of homozygous CycYE8 
mutants. However, when heat shock was extended for one or two more days, which 
included late third instar larvae, the rescue ability was dramatically increased to 30%-
35%. If CycY was also provided during early pupal stages, the rescue ability increased
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Figure 2-12. Temporal requirements for the expression of CycY. Embryos from a 
CycYE8/CyO; hs-CycY/TM3, Ser self cross were collected for 24 hours and heat 
shocked for different regimes. Each row indicates a different heat shock schedule. On 
the left side, each bar represents a single 1h heat shock at 37ºC on that particular day. 
The efficiencies of rescue to adulthood are shown on the right. The genotype of each 
adult was determined by the presence or absence of CyO and Ser balancer 
chromosomes (Materials and Methods). Representative adult genotypes were 
confirmed by single-fly PCR. For each condition, the total number of adults analyzed 
was between 200 and 300. 
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further to 50-60%. If CycY expression was withheld until 4 days after egg-laying, a 50% 
rescue rate could still be achieved. However, if heat shock was delayed for one more 
day, the rescue ability decreased to only 13% (Figure 2-12). Combined, these data 
suggest that the most important period for zygotic CycY expression is from the late 
larvae to the early stages of pupal development, consistent with the first major lethal 
phase of the CycYE8 mutant. 
To see whether CycY is expressed at the developmental times when it appears 
to be needed, I used quantitative real-time PCR to determine the CycY mRNA levels. I 
found that the relative abundance of CycY mRNA fluctuated over a narrow range during 
development (Figure 2-13). The highest mRNA level was observed in 0-1h embryos, 
most likely due to maternal deposition. CycY message levels then decreased from later 
embryogenesis through the first and second instar larval stages but increased again in 
third instar larvae and peaked at pupal stages. The transcription variation of CycY is 
thus consistent with its essential requirement for pupariation. 
 
2.3.5 CycY shows a maternal effect that can be partially rescued by zygotic 
expression  
The mutant phenotypes described above were based on zygotic null mutants, 
which showed normal embryogenesis and slow but otherwise normal larval 
development. To test whether maternally expressed CycY contributes to early 
development I generated maternal null mutants using the ovoD1 dominant female sterile 
technique (Chou et al., 1993). Hs-FLP/w*; CycYE8 FRT40A/ovoD1 FRT40A females were 
heat shocked for 2 hours during larval development to express FLP recombinase and
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Figure 2-13. Developmental expression pattern of CycY. Total RNA was extracted 
from Drosophila tissues at the indicated developmental time points and mRNA levels of 
CycY were determined by quantitative real-time PCR (qPCR) as described in Materials 
and Methods. Expression was normalized to the mRNA levels of the internal control 
rp49. 
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promote homologous recombination between the CycYE8 FRT40A and ovoD1 FRT40A 
chromosomes. Since ovoD1 is dominant female sterile, mothers will only lay eggs if 
homozygous CycYE8 FRT40A germline cells are generated and CycY is not essential for 
oogenesis. Mothers that received heat shock treatment during larval development were 
crossed with w1118 males and the number and development of the eggs laid were 
monitored. I observed that heat shock treated CycYE8 FRT40A/ovoD1 FRT40A females 
could lay similar numbers of eggs as heat shock treated FRT40A/ovoD1 FRT40A 
females, indicating that CycY is not essential for at least some of the major processes of 
oogenesis. However, nearly 40% of the eggs from CycYE8 mothers had fused dorsal 
appendages or translucent body or both (Figure 2-14). These two morphological defects 
in some cases are common phenotypes in mutants of genes involved in axis 
specification (Cook et al., 2004) (G. Atikukke and R. Finley, unpublished), suggesting 
that CycY may play a role in axis specification. 
To test for a maternal contribution to embryogenesis, females with homozygous 
CycYE8 germline cells were generated using the ovoD1 dominant female sterile 
technique (Chou et al., 1993), and were crossed with CycYE8/CyO, Act5C-GFP males. 
Zygotic null progeny were identified by absence of the GFP balancer. Interestingly, the 
majority (99.6%) of zygotic null embryos from null mothers failed to hatch, suggesting 
that maternal expression of CycY is essential for embryogenesis. Surprisingly, when 
females with homozygous CycYE8 germline cells were crossed with w1118 males, 7.3% 
of the embryos hatched into first instar larvae and 73% of these larvae developed into 
normal adults. Taken together, these data suggest that maternally provided CycY plays
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Figure 2-14. Eggs developed from homozygous CycYE8 germline cells show fused 
dorsal appendages or translucent body defects. A. FRT40A, a wild type egg 
showing the normal two dorsal appendages. B. CycYE8 FRT40A, egg with fused dorsal 
appendages. C. CycYE8 FRT40A, egg with translucent body. 
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an important role during embryogenesis, but that this role can be accomplished at least 
to a limited extent by zygotic expression. 
 
2.3.6 Eip63E is a potential binding partner of CycY 
Cyclin proteins generally serve as regulatory subunits for Cdks. In a previous 
high throughput yeast two-hybrid screen (Stanyon et al., 2004) we identified an 
interaction between CycY and Eip63E, a Cdk with no known cyclin partner (Rascle et al., 
2003; Stowers et al., 2000). To test specificity, I conducted additional two-hybrid assays 
using additional Cdks and cyclins (Table 2-7). I found that CycY interacted only weakly 
or not at all with other Cdks, including Cdk1, Cdk2, Cdk4, Cdk5, Cdk7, Cdc2rk, and 
CG7597. Likewise, Eip63E interacted with CycY and CycC, a protein known to be 
promiscuous in two-hybrid assays, but only weakly or not at all with CycA, CycB, 
CycB3, CycD, CycE, CycG, CycH, CycJ, CycK, CycT, koko, and CG16903.  
As another approach to try to identify CycY partners, I set out to do tandem 
affinity purification (TAP) followed by mass spectrometry (MALDI/MS-MS). I transiently 
expressed NTAP-CycY, which has an N-terminal protein A binding site and calmodulin 
binding domain, in Drosophila S2R+ cells and did a sequential protein purification by 
using IgG beads and calmodulin beads. Co-purified proteins were identified by 
MALDI/MS-MS (Materials and Methods). I did not identify a Cdk or any of the interactors 
that were found by yeast two-hybrid. In addition to the bait protein, NTAP-CycY, I only 
identified three putative CycY-associated proteins, Hsc70, Act5C, and αTub84D. All of 
these are abundant proteins that are among the most common nonspecific proteins 
often identified in co-AP/MS experiments. This result may be due to the transient 
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Table 2-7. CycY/Eip63E interaction specificity by yeast two-hybrid assay 
 
Eip63E  
 Leu2 LacZ 
CycY 3 1 
CycA 0 0 
CycB 0 0 
CycB3 0 1 
CycC 3 2 
CycD 0 0 
CycE 0 0 
CycG 0 0 
CycH 0 0 
CycJ 0 0 
CycK 0 0 
CycT 0 0 
Koko 0 0 
CG16903 0 0 
 
 
 
 
CycY 
 
Leu2 LacZ 
Eip63E 3 1 
Cdk1 1 0 
Cdk2 1 0 
Cdk4 0.5 0 
Cdk5 0.5 0 
Cdk7 0 0 
Cdc2rk 0.5 0 
CG7597 0 0 
 
 
 
 
 
 
 
 
 
Interactions between LexA DNA-binding domain (BD)-tagged Eip63E and activation 
domain (AD)-tagged cyclins (left), or AD-tagged CycY and BD-tagged Cdks (right) were 
tested by yeast two-hybrid mating assays. Activity for the two reporter genes, LEU2 and 
lacZ, was scored by the growth on plates lacking leucine (scale 0-3, where 0=no growth, 
3=heavy growth) and blue color on X-gal plates (scale 0-5, where 0=white, 5=dark 
blue). 
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transfection approach I used to express the bait protein. Due to the low transfection 
efficiency, the abundance of the bait proteins may be very high in some cells but low or 
absent in others. This could lead to the relatively high contamination rate observed. The 
establishment of stably expressing cell lines should circumvent this problem and 
therefore is strongly recommended for future studies. Although Hsc70, Act5C, and 
αTub84D are common contaminants in co-AP/MS experiments, it is of course possible 
that any of these proteins actually interacts with CycY. It is interesting to consider actin, 
which is an abundant component of the cytoskeleton. Actin has also been identified as 
one of the subunits of the Brahma (Brm) chromatin-remodeling complex. Its initial 
identification as a member of this complex was also under suspicion due to its high 
abundance in the cytoplasma and the lack of evidence of its nuclear localization. 
Several convincing experiments, however, demonstrated the existence of nuclear actin; 
for example, the careful isolation of nuclei from Xenopus oocytes to avoid contamination 
with cytoplasmic proteins and the development of antibody that specifically recognizes 
nuclear actin (G-actin instead of F-actin, which can be recognized by phalloidin) 
demonstrated that actin is indeed in the nucleus (Olave et al., 2002). The existence of 
stoichiometric amounts of actin and actin related proteins in chromatin-remodeling 
complexes has now been well established (Olave et al., 2002). It has been proposed 
that actin promotes the assembly and stability of the complex, modulates the binding of 
the remodeling complex to chromatin, and enhances the ATPase activity (Mohrmann 
and Verrijzer, 2005). Interestingly, I identified both physical and genetic interactions 
between CycY and the Brm chromatin-remodeling complex (discussed in Chapter 3), 
raising the possibility that the CycY-actin interaction is genuine.  
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As an alternative approach to confirm and test the specificity of the Eip63E-CycY 
interaction identified by yeast two-hybrid, I expressed tagged versions of Cdks and 
cyclins in cultured Drosophila cells and tested interaction by co-affinity purification (co-
AP) followed by immunoblotting (Materials and Methods). In the co-AP assay, CycY 
interacted strongly with Eip63E but only weakly or not at all with Cdk2, Cdk4, or Cdc2rk 
(Figure 2-15 A, B). Eip63E, on the other hand, interacted much more strongly with CycY 
than with other cyclins tested, including CycK, CycD, and CG31232 (Koko) (Figure 2-15 
C). As expected, Glycine 243 (G243) of Eip63E, which is essential for its function in vivo 
(Stowers et al., 2000), is required for binding to CycY (Figure 2-15 D). In further support 
of the interaction between these proteins, a recent study demonstrated an interaction 
between the human homolog of Eip63E, PFTK1, and human CycY using yeast two-
hybrid and co-AP assays from human cells (Jiang et al., 2009). Taken together, our 
data and the studies with the human orthologs support the notion that CycY and Eip63E 
constitute a conserved cyclin-Cdk pair.  
A recent large-scale phosphoproteome study in Drosophila embryos identified 
several phosphorylated peptides from the CycY protein (Zhai et al., 2008). A number of 
the phosphorylation sites are in highly conserved serine residues, suggesting that they 
may affect CycY function (Figure 2-5 B). One of these residues, S389, has also been 
found to be phosphorylated in human CycY, both in nuclear and cytoplasmic fractions 
(Beausoleil et al., 2004; Olsen et al., 2006). Position Ser389 in the Drosophila protein is 
conserved in every species that we examined (Figure 2-5 B). Moreover in one of the 
two preceding positions of every CycY there is another serine (S388 in Drosophila), 
which was also identified as a phosphorylated residue in the human protein. As a first 
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Figure 2-15. CycY preferentially interacts with Eip63E in Drosophila S2R+ cells. 
Cells were cotransfected with the indicated constructs and lysed for co-affinity 
purification (co-AP) using IgG beads. Co-purified proteins were further detected by 
western blot using anti-Myc or anti-protein A (PrA) antibody. (A) CycY interacts with 
Eip63E. (B) CycY interacts much more strongly with Eip63E than with Cdk2, Cdk4, or 
Cdc2rk. (C) Eip63E interacts much more strongly with CycY than with CycD, CycK, or 
CG31232 (Koko). (D) Eip63E G243A mutant interacts poorly with CycY. (E) CycY 
S389A mutants display decreased affinity for Eip63E.  
  
79
test of the potential importance of these residues I generated a Drosophila CycY S389A 
mutant and S388A/S389A double mutant and tested their Cdk-binding ability. The 
Ser389A mutant had a dramatically decreased ability to bind Eip63E (Figure 2-15E). 
The double mutant did not further diminish Cdk binding indicating that S388 does not 
contribute to the interaction. While these results point to a role for S389 in Cdk 
interaction, I was unable to show that phosphorylation is important, since a S389E 
mutant also failed to interact with the Cdk (data not shown).  
 
2.3.7 CycY and Eip63E have similar mutant phenotypes 
If Eip63E and CycY form a functional Cdk/cyclin complex in vivo, we might 
expect their mutant phenotypes to be similar. Previous studies have shown that Eip63E 
is important for embryogenesis, larval development, and morphogenesis (Stowers et al., 
2000). Those studies demonstrated that the majority of Eip63E null mutants die during 
larval development, while a small percentage survive to pupal stages with an occasional 
adult escaper. Stowers et al., also showed that puparium formation in Eip63E mutants is 
delayed by 2-3 days, pupae are small, and the rare adult escapers have a bent-leg 
phenotype and short life spans (Stowers et al., 2000). All of these phenotypes are 
similar to those I observed for CycYE8. To further compare the Eip63E and CycY loss-of-
function phenotypes, I performed a detailed side-by-side phenotypic characterization. I 
used a transheterozygous null mutant, Eip63E81/Eip63EGN50 (Stowers et al., 2000) and 
compared its phenotype with that of CycYE8. I found that CycY and Eip63E null mutants 
showed similar developmental defects, though the Eip63E null mutant phenotype was 
generally more severe. Both mutants displayed a major lethal phase during 
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metamorphosis (Figure 2-8 A, B, E, F). While CycY mutants showed lethality during 
early or late pupal stages, the majority of Eip63E mutants died at earlier pupal stages 
(Table 2-4). Both mutants also showed similar metamorphosis defects, including gas 
bubble translocation defects, failed head eversion, and leg elongation defects (Figure 2-
10; Table 2-5). In addition, pupae of both mutants were similarly small in weight and 
length (Table 2-6). Finally, both mutants exhibited delayed puparium formation, for 13 
hours in the case of CycY, and 37 hours for Eip63E (Figure 2-8). I also note that 
Stowers et al. (Stowers et al., 2000) showed that Eip63E has a zygotically rescuable 
maternal contribution to embryogenesis, similar to my observation for CycY. The striking 
similarity between the mutant phenotypes of Eip63E and CycY, combined with the 
specific physical interaction between the proteins in yeast two-hybrid and co-AP assays, 
supports the idea that CycY and Eip63E may function together in vivo. We cannot 
exclude the possibility, however, that one or both proteins have additional partners. For 
example, one potential explanation for the earlier lethality and more severe phenotype 
of Eip63E mutants relative to the CycY null is that Eip63E may have functions 
independent of CycY and these may involve other cyclin partners. Alternatively, the 
subtle differences in CycY and Eip63E mutant phenotypes may be due to differences in 
the levels of perdurance of their maternal components. Further in vivo analysis of the 
interaction will be needed to distinguish these possibilities. 
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2.4 CONCLUSIONS 
Cyclin Y is a highly conserved protein that has not been characterized in any 
model organism. Only minimal information is available for the human ortholog, CCNY. 
The gene is broadly expressed in human tissues, with particularly high levels in testis 
(Jiang et al., 2009; Li et al., 2009). Localization studies with GFP fusions in cell lines 
have shown that one isoform of human CycY, which has also been called CycX, is 
nuclear while another isoform may be anchored to the cell membrane via a conserved 
myristoylation signal (Jiang et al., 2009). Recently, CCNY was identified as a potential 
susceptibility factor for inflammatory bowel disease (IBD), a complicated genetic 
disorder affecting the intestinal mucosa. A single nucleotide polymorphism (SNP) 
located in an intron of CCNY was found to be strongly associated with the two IBD 
subphenotypes, Crohn’s disease and ulcerative colitis (Franke et al., 2008; Weersma et 
al., 2009), though it is not yet clear whether CCNY plays a direct role in these diseases. 
Another study found that human CycY is among a number of proteins that are 
significantly upregulated in metastatic colorectal cancer cells (Ying-Tao et al., 2005), 
though again it is not clear whether this cyclin contributes to the phenotype of these 
cells. The establishment of a CycY-deficient animal model could provide a system for 
studying conserved functions of Cyclin Y and for understanding its potential role in 
human diseases.  
Here I described the first mutant allele for a Y-type cyclin, a null for Drosophila 
CycY. I showed that CycY is an essential gene that is required for a broad range of 
developmental processes, including normal oogenesis, embryogenesis, larval and pupal 
development. The most obvious defects in the null were visualized during pupal 
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development, and included defects in gas bubble translocation, head eversion, leg 
elongation, and adult tissue growth. Similar phenotypes have been described for a 
number of genes involved in the response to the steroid hormone ecdysone, including 
E74, EcR, BR-C, and crol (Bender et al., 1997; D'Avino and Thummel, 1998; Fletcher 
and Thummel, 1995b; Kiss et al., 1988). CycY may also be involved in the ecdysone 
response. Consistent with this possibility, I provide several lines of evidence suggesting 
that at least one of the Cdk partners for CycY is the ecdysone-inducible protein, Eip63E. 
CycY and Eip63E preferentially interact in yeast two-hybrid assays and in co-AP assays 
from cultured Drosophila cells. The human orthologs of these proteins have also been 
shown to interact and to colocalize in human cell lines (Jiang et al., 2009). Finally, the 
mutations in Eip63E and CycY show a similar range of phenotypes. Our findings in 
Drosophila should provide a model system for further biochemical and genetic studies 
on the function of this conserved Cdk/cyclin pair. 
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CHAPTER 3 
 
CYCLIN Y GENETICALLY INTERACTS WITH BRM COMPLEX COMPONENTS  
IN DROSOPHILA 
 
3.1 INTRODUCTION 
CycY is a highly conserved protein found in all metazoans. I previously showed 
that CycY is an essential gene that is required for many developmental processes (Liu 
and Finley Jr, 2010). A null mutant of CycY is lethal and exhibits delayed larval growth 
and major developmental defects during metamorphosis. Analysis of germline mutant 
clones also revealed a role of CycY during oogenesis and embryogenesis. CycY 
interacts specifically with the Cdk, Eip63E, both in yeast two-hybrid assays and in co-AP 
assays in cultured Drosophila cells (Liu and Finley Jr, 2010; Stanyon et al., 2004). The 
striking phenotypic similarity between CycY and Eip63E null mutants and the physical 
interaction between CycY and Eip63E supports the notion that CycY and Eip63E 
constitute a conserved cyclin-Cdk pair. This conclusion was further supported by 
several recent studies with human cell lines, in which the orthologs of CycY and Eip63E, 
which is generically known as Cdk14, were shown to interact and co-localize to the 
plasma membrane (Davidson et al., 2009; Jiang et al., 2009). While the Drosophila null 
phenotypes of CycY and Eip63E indicate that they are essential for development, they 
have not provided clues about potential tissue-specific or cell-specific functions of the 
CycY/Eip63E complex. A recent study found that both CycY and Eip63E are required 
for maximal phosphorylation of the Wnt co-receptor, LRP6, and for maximal Wnt 
signaling in cultured cells (Davidson et al., 2009). This led to a model in which 
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membrane-associated CycY recruits Cdk14 to the membrane where it phosphorylates 
LRP6 to help prime LRP6 for activation by Wnt. However, it is not clear whether or not 
CycY plays a role in Wnt signaling in vivo in Drosophila. The null phenotypes of CycY 
and Eip63E are not typical of wingless pathway mutants. This suggests that CycY may 
belong to other important pathways instead of or in addition to the Wnt signaling 
pathway. Here I set out to find pathways to which CycY may belong by testing for 
tissue- or cell-specific requirements for CycY and screening for genetic interactions with 
candidate pathway members. 
The early pupal lethality of the CycY null makes it difficult to study the gene’s 
potential role in later stages or in particular tissues. This difficulty can be overcome by 
conditionally knocking down gene expression in a spatially and temporally controlled 
manner by regulated synthesis of double-stranded RNAs (dsRNAs). dsRNA induces 
gene-specific silencing, a highly conserved phenomenon known as RNA interference 
(RNAi) (Fire, 1999; Fire et al., 1998). In Drosophila, long dsRNAs can be used as a tool 
to knock down expression of specific genes because Drosophila lacks the interferon-
mediated immune response, which shuts down global protein synthesis and promotes 
general mRNA degradation in mammalian cells (Echeverri and Perrimon, 2006). Long 
dsRNAs expressed in or introduced into Drosophila cells are cleaved by the enzyme 
Dicer into short interfering RNAs (siRNAs), which are then incorporated into the RNA-
induced silencing complex (RISC) to induce target mRNA degradation. Tissue-specific 
gene knockdown can be achieved by expressing the dsRNA using the Gal4/UAS 
system (Brand and Perrimon, 1993). In this system, dsRNA expression is put under 
control of the Upstream Activating Sequence (UAS) form yeast, which harbors binding 
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sites for the Gal4 transcription factor. Transgenic flies containing the UAS-dsRNA gene 
can be crossed with any of a variety of available lines that express Gal4 in specific 
tissues. In the progeny, dsRNAs will be generated only in the tissues where Gal4 is 
expressed. Here I used the Gal4/UAS system and dsRNA directed at CycY to knock 
down CycY expression in specific tissues to reveal a role for the gene in wing 
development. 
CycY has been identified to physically interact with Snr1 in a high throughput 
yeast two-hybrid screen (Giot et al., 2003). This prompted us to investigate the 
relationship between CycY and Snr1, and to test whether Snr1 is a downstream target 
of CycY/Eip63E. Snr1 is a core subunit of the Brm chromatin-remodeling complex in 
Drosophila, which is involved in regulation of transcription. There are two subclasses of 
Brm complex, BAP and PBAP, which differ in their subunit structure and function 
(Moshkin et al., 2007). Snr1 is a member of both complexes, as are Brm, Mor, actin, 
BAP55 (actin related protein), BAP60, BAP111, and possibly BAP74 (Hsc70-4) (Kal et 
al., 2000; Mollaaghababa et al., 2001; Papoulas et al., 1998). BAP and PBAP 
complexes also have distinct accessory components called signature components 
(Chalkley et al., 2008; Collins et al., 1999; Kaeser et al., 2008; Mohrmann et al., 2004). 
The core subunits provide the basic structure and enzymatic activity of the complex, 
while the signature components provide distinct functional specificity (Moshkin et al., 
2007). BAP and PBAP function coordinately, independently, or antagonistically on 
target gene transcription and modulate distinct biological processes. For example, the 
well-known functional requirement of the Brm complex for entry into mitosis is believed 
to be executed by BAP, but not PBAP (Moshkin et al., 2007). An important cell cycle 
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regulator, stg (cdc25 phosphatase), which triggers mitosis, was down regulated in 
cultured Drosophila cells in which BAP components were knocked down by RNAi, and 
in Snr1 temperature-sensitive mutants (Moshkin et al., 2007; Zraly et al., 2004). A direct 
interaction between BAP and the stg promoter region has also been demonstrated by 
chromatin immunoprecipitation (ChIP) (Moshkin et al., 2007).  
By modulating chromatin structures, the Brm complex is involved in both gene 
activation and suppression. Several interesting groups of genes have been identified to 
be the direct targets of Brm complex regulation. These include the Hox genes, a group 
of related genes that specify the anterior-posterior axis and determine the segment 
identity during early embryonic development. Hox genes include the Antennapedia 
complex (ANT-C) and the bithorax complex (BX-C), which encode homeodomain 
transcription factors (Duncan, 1987; Kaufman et al., 1990). The transcription of Hox 
genes is ultimately sustained in the off or on state in late embryogenesis by the action of 
the Polycomb group (PcG) of repressors and the trithorax group (trxG) of activators, 
respectively (Harding and Levine, 1988; Ingham, 1988; Orlando and Paro, 1995). Brm 
was initially identified as a member of the trithorax group that dominantly suppressed 
Polycomb (Pc) mutations (Kennison and Tamkun, 1988). BAP, the osa-containing Brm 
complex, represses transcription of Wg target genes, such as nub and dpp (Collins and 
Treisman, 2000). BAP is also required for activation of several targets of EGFR 
signaling involved in wing vein development, such as Delta, rhomboid, and argos 
(Marenda et al., 2004; Terriente-Felix and de Celis, 2009), though it is still unclear if the 
complex regulates these genes directly. Finally, a cluster of Ecdysone-induced genes 
(Eig) were found to be strongly misregulated in Brm and Snr1 mutants and these genes 
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were further shown to be the direct targets regulated by the Brm complex in cultured 
cells (Zraly et al., 2006). This established a direct connection between chromatin 
structure modification and ecdysone signaling.  
The core subunit of the Brm complex, Brm ATPase, is expressed at all 
developmental stages with a relatively high level throughout embryogenesis and in 
pupae (Elfring et al., 1998). In addition to the ATPase domain, Brm proteins possess a 
Bromodomain, which is ~ 110 amino acids and specifically recognizes acetylated lysine 
in the histone tail (Mohrmann and Verrijzer, 2005). Surprisingly, deletion of the 
Bromodomain does not affect chromatin binding and appears to be dispensable for Brm 
function. On the other hand, domain II, which is located N-terminal to the ATPase 
domain, contributes essential functions to the assembly or stability of the Brm complex 
(Elfring et al., 1998). Lysine (K) 804 is a conserved amino acid in the ATP-binding site. 
Mutation of this lysine to arginine (R) eliminates enzymatic activity but conserves the 
protein’s ability to assemble into the 2 megadalton (MD) Brm complex. This mutant is 
used widely as a dominant negative antimorphic allele of Brm for functional studies. By 
analyzing animals ectopically expressing BrmK804R, or mosaic animals created with a 
Brm null allele, Brm has been shown to be important for the development of the 
peripheral nervous system, preventing homeotic transformations, and cell viability 
(Elfring et al., 1998).  
Snr1 has been suggested to function as a regulatory subunit by recruiting other 
transcription factors to constrain Brm complex activity in particular tissues (Marenda et 
al., 2004). The spatial and temporal expression pattern of Snr1 is similar to that of Brm 
(Dingwall et al., 1995), except for a few differences (Zraly et al., 2003). One striking 
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example is that Snr1 is barely detected in leg imaginal discs where Brm is highly 
expressed, suggesting that Snr1 only functions in a subset of Brm complexes (Zraly et 
al., 2003). Snr1 homozygous zygotic null mutants die before entering the third instar 
larval stage (Dingwall et al., 1995), while germline clone analysis revealed its essential 
function during oogenesis (Zraly et al., 2003). Mosaic animals with somatic null clones 
showed similar phenotypes to Brm mutants, such as reduced cell viability and 
peripheral nervous system defects. However, consistent with the expression differences 
between Snr1 and Brm, clones of a Snr1 null revealed no function during leg 
development (Zraly et al., 2003). Surprisingly, Snr1 is required for adult viability, which 
has not yet been linked with Brm in Drosophila (Marenda et al., 2003; Zraly et al., 2003). 
However, in human adrenal cortex carcinoma derived cell line SW13, Brg1 could induce 
a senescent-like morphology (Shanahan et al., 1999). In addition, Brm1 levels increase 
in the liver of old mice (Iakova et al., 2003). Not only ATP-dependent chromatin 
remodeling, but other chromatin modifications, such as histone acetylation, 
deacetylation, DNA methylation, have also been suggested in organismal aging 
(Bandyopadhyay and Medrano, 2003). 
Drosophila Snr1 and its orthologs in yeast (SNF5) and human (hSNF5/INI1) 
share a highly conserved domain, including two direct repeats and a coiled-coil (CC) 
region. The repeat domain in Snr1 and INI1 has been shown to mediate protein-protein 
interactions to direct the metazoan SWI/SNF complex to target loci (Cheng et al., 1999; 
Kalpana et al., 1994; Rozenblatt-Rosen et al., 1998). Contrary to the nuclear localization 
of wild type, a truncated Snr1 mutant, Snr1-2, which lacks the CC domain and part of 
repeat 2, is predominately localized in the cytoplasm, probably due to the exposure of 
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the nuclear export signal (NES, 248-261) immediately N-terminal to the truncation site 
(Brumby et al., 2002; Zraly et al., 2003). A small fraction of Snr1-2 mutant protein still 
localizes to the nucleus and assembles into the Brm complex (Zraly et al., 2003). Since 
Snr1-2 phenotypes are sensitive to Snr1 dosage, Snr1-2 has been used as a dominant 
negative allele of Snr1. Ectopic expression of Snr1-2 led to several striking 
developmental defects including extra wing vein along L2, incomplete abdominal tergite 
fusion along the dorsal midline, and decreased adult viability (Zraly et al., 2003).  
In this chapter, I describe the consequences of conditionally knocking down 
CycY expression in specific tissues. I show that CycY is required for wing growth and 
sustained adult viability. I also show that CycY genetically interacts with Snr1 and Brm, 
two components of the Brm ATP-dependent chromatin-remodeling complexes, and that 
the CycY protein can physically interact with Snr1. Furthermore, I show that the 
downstream targets of Brm complexes, Eig71Eh and Eig71Ei, are misregulated in CycY 
mutants. Taken together, these data suggest that CycY may be involved in gene 
regulation by modulating Brm complex activity. 
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3.2 MATERIALS AND METHODS 
 
3.2.1 Fly stocks 
All fly stocks were maintained in vials containing standard cornmeal molasses 
medium. GMR-Gal4, en-Gal4, 69B-Gal4, e22c-Gal4, and Act5C-Gal4 were obtained 
from the Bloomington stock center (stock numbers 1104, 6356, 1774, 1973 and 4414 
respectively). UAS-Snr1-2, Snr1R3 (Zraly et al., 2003) was kindly provided by Dr. 
Andrew K. Dingwall. UAS-BrmK804R (Elfring et al., 1998) was kindly provided by Dr. 
Jessica E.Treisman. y1w* hs-FLP; Ubi-GFP FRT40A was kindly provided by Dr. 
Dongbin Xu. The UAS-RNAi lines, UAS-dicer2, UAS-Snr1i, and UAS-Brmi, were 
obtained from the Vienna Drosophila Resource Center (transformant IDs 60008, 12644, 
and 37720 respectively). CycYE8, CycYE8 FRT40A, UAS-CycY, and hs-CycY have been 
described previously (Liu and Finley Jr, 2010). All fly strains used in this study are listed 
in Appendix G. 
 
3.2.2 Plasmid cloning for P-element transformation  
pWIZ-CycYiN was constructed by first subcloning an XbaI/XbaI fragment which 
included the 5’ 605bp of the CycY cDNA, beginning with the ATG, into the NheI site of 
pWIZ (Lee and Carthew, 2003) in the sense orientation to make pWIZ-CycYiN-sense. 
This XbaI/XbaI fragment was generated by PCR from pAS1-CycY (Finley lab # 897) 
using oligonucleotides [forward: 5’ ATGCTCTAGAATGGGCAACAAGAACTCG (Finley 
lab # 679); reverse: 5’ ATGTCCTCTAGACGATCCGATTGCCGATTC (Finley lab # 
680)], which provided XbaI digestion site at both ends. Next, an XbaI/EcoRI fragment 
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containing the same 5’ 605bp of the CycY cDNA, beginning with the ATG, was 
subcloned into the AvrII/EcoRI site of pWIZ-CycYiN-sense in the anti-sense orientation 
to make pWIZ-CycYiN. This XbaI/EcoRI fragment was generated by PCR from pAS1-
CycY (Finley lab # 897) using oligonucleotides [forward: 5’ ATGCTCTAGAATGGGCAA 
CAAGAACTCG (Finley lab # 679); reverse: 5’ ATGTCCGAATTCCGATCCGATTGCCG 
ATTC (Finley lab # 681)], which provided XbaI and EcoRI digestion site at each end 
respectively. pWIZ-CycYiC was constructed similarly, by subcloning the 3’ 616bp of the 
CycY cDNA ending with the stop codon in both orientations into pWIZ. In this case, the 
XbaI/XbaI fragment was generated by PCR from pAS1-CycY (Finley lab # 897) using 
oligonucleotides [forward: 5’ GCAATCTCTAGACCGGCTGGACATCTTCGACG (Finley 
lab # 682); reverse: 5’ GCTTGGTCTAGATCACGATAGTATGGCCACG (Finley lab # 
683)], which provided XbaI digestion site at both ends. The XbaI/EcoRI fragment was 
generated by PCR from pAS1-CycY (Finley lab # 897) using oligonucleotides [forward: 
5’ GCAATCTCTAGACCGGCTGGACATCTTCGACG (Finley lab # 682); reverse: 5’ 
GCTTGGGAATTCTCACGATAGTATGGCCACG (Finley lab # 684)], which provided 
XbaI and EcoRI digestion site at each end respectively. P-element mediated 
transformation was performed as previously described (Rubin and Spradling, 1982). 
Plasmids used or constructed for this study are listed in Appendix H. All transgenic lines 
generated for this study are listed in Appendix I. 
 
3.2.3 Analysis of the wing phenotype  
Wings were dissected from adult flies and mounted for microscopic examination 
in mineral oil. Pictures were taken with Leitz fluorescence microscope and SPOT RT3 
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camera. The entire wing was photographed with 100x magnification and a close-up of 
defined area of the wing was photographed with 630x magnification. The sizes of the 
posterior and anterior areas of the wing were independently measured using Image J 
software (Collins, 2007) and the ratio of the posterior to anterior areas (P/A) was 
calculated. For each genotype analyzed, twenty wings were scored. To count cell 
numbers, defined areas of the posterior and anterior compartments of the wing, as 
indicated in Figure 3-2A, were photographed and the number of bristles in the picture 
was counted; the number of bristles was taken as the number of cells in each area 
since each wing cell secret only one bristle during development (Meyer et al., 2000). 
Error bars indicate standard deviation of 20 individual measures. The ratio of posterior 
cell size to anterior cell size is equal to the number of cells in the defined area in the 
anterior region divided by that in the posterior region. The ratio of the posterior cell 
number to anterior cell number is equal to the ratio of the posterior to anterior areas 
divided by the ratio of the posterior to anterior cell sizes. 
 
3.2.4 Immunostaining 
Wing imaginal discs from third instar larvae were dissected in 1 x PBS and put 
quickly on ice. Discs were fixed in freshly made 4% paraformaldehyde in 1 x PBS at 
room temperature for 30 minutes and washed with PBS 3 times. Discs were then 
incubated with primary antibody at 4°C overnight followed by 2-3 hours incubation at 
room temperature with secondary antibody. The following antibodies were used: rabbit 
anti-GFP (1:50; Invitrogen); rabbit polyclonal anti-Histone H3 phospho-Ser10 (1:50; 
Upstate Biotechnology); FITC-conjugated goat anti-rabbit IgG (1:200; Jackson 
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Immunoresearch); Texas Red goat anti-rabbit IgG (1:200; Invitrogen); Alexa Fluor® 488 
goat anti-rabbit (1:200; Invitrogen). DAPI (1μg/ml; Sigma) was used to counterstain the 
DNA. TUNEL staining was performed as previously described with minor modification 
(Wang et al., 1999). Briefly, after secondary antibody incubation, discs were blocked in 
block buffer (50mM Tris.HCl pH6.8, 150mM NaCl, 0.5% NP-40, 5mg/ml BSA) at 4°C 
overnight and then incubated in 100mM Na-Citrate, 0.1% TritonX-100 at 65°C in a water 
bath for 30 minutes. After three quick washes in wash buffer (50mM Tris.HCl pH6.8, 
150mM NaCl, 0.5% NP-40, 1mg/ml BSA), discs were incubated in TUNEL dilution 
buffer (Roche) twice for 5 minutes each time at room temperature. After 30 minutes 
incubation in 50μl of labeling solution (in situ cell death detection TMR Red kit, Roche) 
at 37°C in a water bath, 5μl of Terminal deoxynucleotidyl transferase (TdT) enzyme 
solution was added and discs were incubated for 2 more hours. Discs were washed in 
wash buffer and mounted in Vectashield (Vector laboratories) for imaging. 
 
3.2.5 Analysis of adult lifespan 
For each genotype analyzed, males and females were collected within 24 hours 
of eclosion and were maintained in vials with fresh cornmeal molasses medium at the 
indicated temperature. Each vial contained either 30 males or 30 females. A total of 150 
adults were analyzed for each genotype and sex. Adults were transferred to fresh vials 
every 1-2 days for 25 to 50 days and the number of dead adults was counted after each 
transfer. For analyzing the adult lifespan of the CycYE8 homozygous mutant, since it is 
lethal during metamorphosis, I rescued mutant animals to adults by expressing a CycY 
cDNA under control of a heat-shock promoter (Liu and Finley Jr, 2010). Heat shock was 
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applied once every day at 37°C in a water bath from one day after egg laying until adult 
eclosion, and then the adults were kept at 25°C. CycYE8 heterozygous control animals 
were similarly treated with heat shock although the exogenous CycY is not required for 
these animals to reach the adult stage. To test whether the adult requirement of CycY 
can be rescued by providing exogenous CycY, in a separate experiment, these animals 
were continuously applied heat shock treatment once everyday from one day after egg 
laying until 35 days after adult eclosion. 
 
3.2.6 Gene expression 
Gene expression was assayed by reverse-transcription and quantitative real-time 
PCR (RT-qPCR) as previously described (Liu and Finley Jr, 2010). First instar larvae 
with the desired genotypes were collected and transferred to standard fly medium. 
Newly formed white prepupae (0 hour prepupae) were collected and transferred to a 
petri dish with a piece of wet filter paper and allowed to age at 25°C for the times 
indicated in Figure 3-9 (Fletcher and Thummel, 1995a). About 30 pupae were collected 
at each time point for RNA isolation. qPCR reactions were carried out in triplicate for 
each RNA sample. The primers used in this work are listed in Table 3-1. rp49 was used 
as the internal control gene and the mRNA level of each analyzed gene was normalized 
to rp49 levels.  
 
3.2.7 Co-affinity purification (co-AP) assays  
Co-AP assays were conducted as previously described (Liu and Finley Jr, 2010).
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Table 3-1. Primers used for qPCR in this study 
Gene Primers Sequence Positiona Product length (bp) 
Eig71Eh DL147 5’- GTTGACTGTCTGCTTCCTGGTGAT 41-64 230 
 DL165 5’- TTGCTCGATTCGGAGAAGCTATCG 247-270  
Eig71Ei DL149 5’- CTGCCATTAGCTATTGTGTGCCTG 51-74 202 
 DL150 5’- ATCGGCTAACATCTGACCATCCAG 229-252  
Eig71Eg DL172 5’- TTGATGTGCCAGGTCCTAACTCAG 77-100 261 
 DL173 5’- TTATTAAGACCGCAGGCTATCGGC 314-337  
Eig71Ef DL174 5’- CTGCCGAAAGTTAAGGGACACTTG 116-139 235 
 DL175 5’- GGCATTCTTCTAAGTTCGCCTTGG 327-350  
EcR DL176 5’- TCAGGCGTATAATGAGTCAACCCG 1624-1647 345 
 DL177 5’- CCACCTTCATCGAGAACATTTGGC 1945-1968  
Eip93F DL155 5’- CAACCATCGGAACAATGACTACGC 3398-3421 396 
 DL156 5’- GATTCGCACTTGATGTGACTGCTG 3770-3793  
ImpE2 DL170 5’- GGCCACTGAAATCAAAGAGGAACC 531-554 234 
 DL171 5’- CCAATTGGCGAGTTCTGGATCAAC 741-764  
Eip63E DL168 5’- GTCGCAATACATGGAGAAGCATCC 1007-1030 367 
 DL169 5’- GTAGGTATCACGTATGCCCGGAAA 1350-1373  
rp49 DL118 5’-GATATGCTAAGCTGTCGCACAAATGGC 95-121 118 
 DL119 5’-GTGCGCTTGTTCGATCCGTAACCG 189-212  
 
a Inclusive nucleotide positions in predicted transcript RA for each gene. 
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3.3 RESULTS 
 
3.3.1 Generation of CycY conditional knockdown transgenic flies  
I set out to generate transgenic Drosophila that express long double-stranded 
RNA (dsRNA) to knock down the expression of CycY in a temporally and spatially 
controlled manner using the UAS/Gal4 system (Brand and Perrimon, 1993; Lee and 
Carthew, 2003). To avoid misinterpreting gene knockdown phenotypes that may arise 
from off-target effects (Dietzl et al., 2007; Kulkarni et al., 2006; Ma et al., 2006; Ni et al., 
2009), I generated two nonoverlapping CycY RNAi constructs. One (UAS-CycYiN) 
targeted the N-terminal coding region and the other (UAS-CycYiC) targeted the C-
terminal coding region (Figure 3-1A). To test the knockdown efficiency, Drosophila 
S2R+ cells were cotransfected with each RNAi construct along with a construct that 
expresses NTAP-tagged CycY. Both the N-terminal and C-terminal RNAi constructs 
efficiently knocked down the ectopically expressed CycY, while the control RNAi 
(targeting Koko) had no effect (Figure 3-1B). I generated multiple transgenic fly strains 
containing each CycYi construct and tested the gene knockdown effect in different 
tissues using different Gal4 driver lines. Ubiquitous expression of both CycYi constructs 
using Act5C-Gal4 induced lethality. CycYiN knockdown flies did not survive beyond 
second instar larval stage, which is an earlier lethal phase than CycYE8 null mutants, 
most of which survive to pupal stages (Liu and Finley Jr, 2010). Ubiquitous knockdown 
with CycYiC showed a lethal phase and morphological defects similar to CycYE8 null 
mutants (Liu and Finley Jr, 2010). Both RNAi constructs result in similar levels of 
transcript knockdown in second instar larvae (Figure 3-1C). 
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Figure 3-1. Generation of CycY conditional knockdown transgenic flies. (A) CycY 
transcript. The cDNA corresponding to the single CycY transcript is indicated by the 
box. The ATG is shown with a back line while the stop codon is indicated with a red line. 
The coding regions used to generate CycYiN and CycYiC RNAi constructs are indicated. 
(B) Western blot to detect the in vitro knock down efficiency of exogenously expressed 
NTAP-CycY by CycYiN, CycYiC, Kokoi (unrelated control), or vector only (pWIZ) in 
Drosophila S2R+ cells. The immunoblot was probed with antibody to NTAP or β-tubulin. 
(C) RT-qPCR to detect the in vivo knock down efficiency of endogenous CycY in 
second instar larvae by CycYiN and CycYiC RNAi constructs driven by the ubiquitous 
driver, Act-Gal4. Two independent insertion lines (N1 and N2 or C1 and C2) were tested 
for each construct. (D-G) Adult fly eyes harboring the indicated CycY RNAi constructs 
and the GMR-Gal4 driver. 
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Expression of CycYiC and CycYiN in the posterior region of the eye imaginal disc 
using the GMR-Gal4 driver (Freeman, 1996) resulted in dramatically different effects. 
Whereas CycYiC did not induce eye defects (Figure 3-1 F-G), CycYiN resulted in rough 
eyes with variable levels of dark pigmentation. Some eyes were yellow to orange with 
random black spots, while others were totally black (Figure 3-1 D-E and data not 
shown). The severity of the eye defects induced by different CycYiN insertion lines 
correlated with the level of CycY knockdown (Figure 3-1 C-E). The eye phenotype 
induced by CycYiN is unexpected based on the CycYE8 null mutant, which displayed no 
eye defects in adult escapers or pharate adults (Liu and Finley Jr, 2010). Thus, I 
surmise that CycYiN may knock down expression of a gene(s) in addition to CycY, a 
possibility that could also explain why ubiquitous CycYiN expression leads to earlier 
lethality than the CycYE8 mutant. The similarities between the CycYiC and CycYE8 
phenotypes on the other hand, suggest that CycYiC specifically knocks down CycY, 
which I further confirmed in cDNA rescue experiments described below. 
 
3.3.2 CycY is required for wing growth 
To test whether CycY is required for normal cell proliferation or differentiation I 
expressed CycYiC in cells of the posterior compartment of wing imaginal discs using the 
en-Gal4 driver (Brand and Perrimon, 1993; Sigrist and Lehner, 1997). Two independent 
CycYiC insertion lines (CycYiC1 and CycYiC2) were crossed with the en-Gal4 driver line 
to knock down expression of CycY in the posterior wing. To quantitatively evaluate the 
effect on wing tissue growth, I measured the size of the wing in the posterior 
compartment relative to the anterior compartment (P/A). CycY knockdown resulted in 
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smaller posterior wing compartments compared to wild type (Figure 3-2 A-C, I). Two 
copies of UAS-CycYi enhanced the wing size phenotype, as did coexpression of Dicer2, 
an enzyme that enhances RNAi by cleaving dsRNA into siRNA (Figure 3-2 D-E, I) (Lee 
et al., 2004). The decreased compartment size could be partially rescued by 
overexpressing CycY with one copy of UAS-CycY whereas two copies rescued even 
better (Figure 3-2 F-G, I), but failed to be rescued by UAS-GFP (Figure 3-2 H-I), 
indicating that the observed phenotype was due to the decreased expression of CycY 
rather than any potential off-target effect.  
To determine whether the decreased wing size was the result of decreased cell 
number, cell size, or both, I measured the relative cell numbers and sizes in defined 
areas of the anterior and posterior compartments (see Materials and Methods for 
details). Cell numbers were determined by counting the number of bristles since each 
wing cell secrets only one bristle during development (Meyer et al., 2000), whereas cell 
sizes were estimated by the density of cells in a particular area. Decreasing CycY 
expression did not significantly change cell size. The reduced wing size resulting from 
CycY knockdown was primarily due to decreased cell numbers (Figure 3-2J).  
To address whether a decrease in cell number caused by loss of CycY might be 
caused by decreased cell proliferation or increased cell death, I also made mitotic 
clones with the CycY deletion mutant, CycYE8 (see Chapter 4, section 4.2.10 for details). 
I stained the wing imaginal discs with CycYE8 null clones for phosphorylated histone H3 
(PH3) to detect cells undergoing mitosis, or stained the wing imaginal discs with CycY 
knocked down in the posterior compartment by TUNEL approach to detect cells 
undergoing apoptosis. However, I did not observe any abnormal proportion of mitotic
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Figure 3-2. CycY is required for wing growth. (A-H) Adult fly wings harboring the en-
Gal4 driver and indicated UAS constructs. The number in the upper right corner is the 
ratio of the posterior to anterior wing sizes (P/A). The red boxes in (A) indicate the 
defined area for counting the cell numbers in the posterior and anterior region 
respectively. (I) The P/A area ratio for each indicated genotype. (J) The P/A ratio of 
wing area, cell size, and cell number for control and CycY knock down fly wings. 
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wing imaginal disc cells in clones lacking CycY (Figure 4-5 S-U) or apoptotic wing 
imaginal disc cells upon knockdown of CycY (Appendix J). It is possible that these 
assays are not sufficiently sensitive to detect changes that lead to only a 20% reduction 
in cell number.  
 
3.3.3 CycY is required for sustained adult viability 
I previously showed that CycY is required for embryogenesis, larval growth, and 
metamorphosis, and that it plays a role in oogenesis (Liu and Finley Jr, 2010). To test 
whether CycY is also required during adult life, I rescued CycYE8 null mutants into 
adults by expressing a CycY cDNA under control of a heat-shock promoter. Heat shock-
induced expression was ceased after eclosion and adult viability was followed for 50 
days. CycYE8 adults showed reduced lifespan compared with their heterozygous 
siblings and this effect was more severe for males than for females (Figure 3-3A). This 
phenotype can be partially rescued by continuously providing CycY in adults by heat-
shock treatment of the adults once every day (Figure 3-3B). This finding is consistent 
with the expression data showing that CycY is expressed in both male and female 
adults and is relatively higher in males (Liu and Finley Jr, 2010). In summary, CycY 
appears to be important throughout the Drosophila life cycle. Using the adult viability 
phenotype and tissue-specific knockdown should enable exploration of the genetic 
pathways to which CycY may belong. 
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Figure 3-3. CycY is required for adult viability. (A) CycYE8 null mutants that harbor a 
CycY transgene under heat-shock promoter control (hs-CycY) were rescued to adult 
stage by continuous heat shock treatment once every day after egg laying until adult 
eclosion to provide exogenously expressed CycY. These CycYE8 null mutants displayed 
significantly decreased lifespan relative to their heterozygous siblings. The decrease in 
life span was more dramatic in males than in females. (B) Continuous heat-shock 
treatment of adult homozygous CycYE8 mutants that harbor the hs-CycY transgene 
partially rescued the reduced longevity phenotype. While continuous heat shock 
reduced viability relative to no heat shock, the difference between homozygous and 
heterozygous CycYE8 mutants was minimal. 
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3.3.4 Snr1 interacts with CycY and is a potential downstream target 
To gain insight into the cellular functions of CycY and to identify the signaling 
pathways to which CycY belongs, I began by examining the available protein interaction 
data for CycY (Figure 3-4A). Previously, I showed that CycY physically interacts with 
Eip63E/Cdk14 in Drosophila, which has been supported by studies with human cells 
(Davidson et al., 2009; Jiang et al., 2009; Liu and Finley Jr, 2010). To focus on potential 
downstream targets of the CycY/Eip63E complex I excluded physical interactors that 
are more likely to be upstream regulators. These included other cyclins, the Cdk 
inhibitor protein Dacapo, and 14-3-3, a scaffold protein that binds to and modulates the 
function of a variety of signaling proteins, especially their phosphorylated forms (Fu et 
al., 2000). I searched among the remaining interactors for proteins that may be required 
at similar developmental times as Eip63E and CycY. Two of the interactors are encoded 
by novel genes, CG5783 and CG8997, which have not been studied. Another two, PIF-
1B, and PIF-2, are cysteine-rich proteins. Both were identified to interact with the non-
conserved N-terminal histidine-rich domain of Eip63E. It has been proposed that the 
function of PIF binding is to counter the inhibitory effect of the long N-terminal extension 
of Eip63E, which may inhibit the protein’s kinase activity (Rascle et al., 2003). Mri is a 
poorly characterized glycerol kinase. Interestingly, it has been identified in a genome-
wide study to be involved in autophagic cell death in salivary glands (Gorski et al., 
2003), which is one of the dramatic developmental changes that happen during 
metamorphosis. The essential requirement of CycY and Eip63E during metamorphosis 
makes this interaction a good candidate for future studies. Another Eip63E interactor is 
Trx-2 (thioredoxin-2), one of the three classical thioredoxins that function to reduce
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Figure 3-4. CycY physically interacts with Snr1. (A) Protein interactions centered on 
Cdk14 and CycY in Drosophila. Protein-protein interactions initially detected in yeast 
two-hybrid screens using Drosophila proteins (black lines), human orthologous proteins 
(blue lines) or orthologous proteins from both species (red lines) (Davidson et al., 2009; 
Gao et al., 2006a; Giot et al., 2003; Jiang et al., 2009; Liu and Finley Jr, 2010; Rascle et 
al., 2003; Shu et al., 2007; Stanyon et al., 2004). The interactions indicated by blue lines 
are predicted interactions between Drosophila proteins based on the interactions 
identified with human orthologs. Interactions that have been verified by some other 
assay such as co-affinity purification are indicated by solid lines. Dashed lines indicate 
two-hybrid interactions not yet validated by another assay. (B) CycY interacts with Snr1 
in Drosophila S2R+ cells. Cells were cotransfected with the indicated constructs and 
lysed for co-affinity purification (co-AP) using IgG beads.  
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disulfide bonds in other proteins. Trx-2 has been reported to play a role in adult 
longevity and tolerance to oxidative stress; homozygous null mutants, however, are 
viable and fertile (Svensson and Larsson, 2007). The final CycY interactor is Snr1, the 
Drosophila counterpart of yeast SNF5, a core subunit of SWI/SNF ATP-dependent 
chromatin-remodeling complex. Snr1 has a number of properties consistent with a 
possible role in a common pathway with CycY and Cdk14. 
First, previous analysis of a temperature-sensitive allele, Snr1E1, revealed an 
essential role for Snr1 during the window of time one day before and after pupariation 
(Marenda et al., 2003), which is coincident with the time frame when zygotic CycY is 
critically required (Liu and Finley Jr, 2010). Second, germline clone analysis has shown 
that Snr1 is essential for oogenesis (Zraly et al., 2003) and CycY is also required for 
normal oogenesis (Liu and Finley Jr, 2010). Third, Snr1 mRNA levels oscillate during 
late larval and pupal development coincident with transient ecdysone pulses (Zraly et 
al., 2003). Similarly, I have shown that CycY mRNA levels oscillate along with ecdysone 
pulses (Liu and Finley Jr, 2010), while Stowers et al., showed that one of the transcripts 
of Cdk14/Eip63E is induced by ecdysone (Stowers et al., 2000). Based on the similar 
developmental requirements and expression profiles for Cdk14, CycY, and Snr1, I 
hypothesized that these genes belong to a common gene regulatory pathway. As a first 
step to test this hypothesis, I confirmed the physical interaction in vitro by co-affinity 
purification (co-AP) in Drosophila S2R+ cells (Figure 3-4B). I then screened for genetic 
interactions between CycY and members of the SWI/SNF complex, which in Drosophila 
is known as the Brahma (Brm) complex. 
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3.3.5 CycY genetically interacts with Snr1 and Brm, key members of the Brm 
complex 
It has been reported that Snr1 is required for sustained adult viability (Marenda et 
al., 2003; Zraly et al., 2003). Dingwall and colleagues constructed and characterized a 
number of Snr1 mutants (Dingwall et al., 1995; Marenda et al., 2003; Zraly et al., 2003). 
One mutant is Snr1-2, a putative dominant negative. It was previously shown that 
overexpression of Snr1-2 using the Act5C-Gal4 driver in animals that are heterozygous 
for a Snr1 null mutant (Snr1R3) dramatically decreases adult viability (Zraly et al., 2003). 
To test whether CycY mutants enhance or suppress the Snr1 associated viability defect, 
I combined heterozygous CycYE8 null mutants with a combination of the Snr1-2 
dominant-negative and the null allele Snr1R3. Ubiquitous expression of Snr1-2 in the 
heterozygous Snr1R3 background alone at 30°C decreased adult viability significantly in 
males (Figure 3-5), though this effect was much weaker than previously reported (Zraly 
et al., 2003). The viability of heterozygous CycYE8 mutants was not significantly different 
from wild-type (Figure 3-5 and data not shown). Strikingly, removal of one copy of CycY 
dramatically enhanced the adult viability defect of the Snr1 mutants, particularly in 
males (Figure 3-5). 
Another morphological defect induced by ubiquitous expression of the dominant 
negative Snr1-2 is incomplete abdominal tergite fusion along the dorsal midline, 
suggesting functions for Snr1 and presumably the Brm complex in developing 
histoblasts (Zraly et al., 2003). I used the dorsal midline phenotype as a second assay 
to test for genetic interaction between Snr1 and CycY. Similar to our observation with 
the longevity phenotype, when one copy of CycY was removed while expressing the
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Figure 3-5. CycY mutants genetically enhance the reduced lifespan induced by 
Snr1 mutants. (A-B) Expression of an Snr1 dominant negative (UAS-Snr1-2) 
ubiquitously using the Act5C-Gal4 driver in a heterozygous Snr1 loss-of-function mutant 
(Snr1R3/+) results in reduced adult viability. Removal of one copy of CycY enhanced the 
adult viability defect in Snr1 mutants. This effect is more pronounced in males (A) than 
in females (B). 
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Snr1-2 dominant negative (in a heterozygous Snr1R3 background) I observed a dramatic 
enhancement of the dorsal midline fusion defect (Figure 3-6, Table 3-2). Since Snr1 is a 
key subunit of the Brm complex, I wished to ask whether CycY also genetically interacts 
with Brm. However, use of the Act5C-Gal4 driver to ubiquitously knock down expression 
of Brm or CycY, or to express the Brm dominant negative, BrmK804R resulted in lethality. 
Thus, it was not possible to test for genetic interactions using the dorsal midline defect 
and the Act5C-Gal4 driver. Previously, Zraly et al. showed that expression of Snr1-2 
using the e22c-Gal4 driver, which is highly expressed in abdomen, also resulted in the 
dorsal midline fusion defect (Zraly et al., 2003). However, when I used the e22c-Gal4 
driver to express the Brm dsRNA, BrmK804R, the CycYiC, or to knock down both CycY 
and Brm together, I did not observe any dorsal midline fusion defects (Table 3-2). This 
result suggests that either CycY and Snr1 function independent of the Brm complex in 
histoblasts, or the e22c-Gal4 driver is not strong enough to induce any visible 
phenotype with CycY and Brm knockdown.  
As a further test for genetic interactions between CycY and the Brm complex I 
turned to phenotypes generated by knocking down expression in the wing imaginal disc. 
As discussed above, knocking down CycY in the posterior compartment of the wing 
using the en-Gal4 driver led to decreased cell numbers and tissue size. I tested whether 
this phenotype is modified by mutants of Snr1 or Brm. Expression of Snr1-2 or Snr1 
dsRNA using the en-Gal4 driver resulted in no change in posterior compartment size 
(Figure 3-7 A-B) and failed to modify the decreased posterior wing phenotype induced 
by CycY knockdown (Figure 3-7C and D compared with Figure 3-7H and I). Knockdown 
of Brm expression with en-Gal4 showed a very weak reduction in tissue size (Figure 3-
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Figure 3-6. CycY enhances the dorsal midline fusion defect associated with Snr1 
mutants. (A) Abdominal tergite of a wild type adult. (B-D) Expression of the Snr1-2 
dominant negative in a Snr1R3 heterozygous background resulted in incomplete 
abdominal tergite fusion along the dorsal midline. This phenotype was enhanced by 
heterozygous CycYE8 (Table 3.2). Examples of different levels of severity of the defect 
are shown; mild + (B), medium ++ (C), and severe +++ (D). 
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Table 3-2. CycY genetically enhances the dorsal midline fusion defects 
associated with Snr1 mutants. 
Dorsal midline defectsa 
Genotype n 
- + ++ +++ 
Act-Gal4/CyO; UAS-Snr1-2, Snr1R3/TM3 Ser 326 86% 9% 5% 1% 
CycYE8/CyO 120 100% 0% 0% 0% 
CycYE8/Act-Gal4; UAS-Snr1-2, Snr1R3/TM3 Ser 145 51% 26% 13% 10% 
e22c-Gal4/+; UAS-BrmK804R/+ 301 100% 0% 0% 0% 
e22c-Gal4/+; UAS-Brmi/+ 129 100% 0% 0% 0% 
e22c-Gal4/+; UAS-CycYiC1/+ 113 100% 0% 0% 0% 
e22c-Gal4/+; UAS-Brmi/UAS-CycYiC1 147 100% 0% 0% 0% 
CycYE8/ e22c-Gal4; UAS-Brmi/+ 77 100% 0% 0% 0% 
 
a The severity of the dorsal midline fusion defect was quantitatively scored as wild type 
(-), mild (+), medium (++), and severe (+++). A representative image for each level of 
severity is shown in Figure 3-6. 
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Figure 3-7. Genetic interaction between CycY and Brm mutants in the wing. (A-H) 
Adult fly wings harboring en-Gal4 and the indicated UAS constructs. The number in the 
upper right corner is the ratio of the posterior wing size to that of the anterior (P/A). (I) 
The P/A area ratio for each indicated genotype. en-Gal4/+; UAS-CycYiC1/UAS-BrmK804R 
are completely pupal lethal. 
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7E). Knockdown of both CycY and Brm together also resulted the decreased posterior 
wing size, but also produced a remarkable novel phenotype. The L4 vein structure was 
severely disrupted and the overall wing morphology was distorted or crumpled, 
especially between veins L4 and L5 (Figure 3-7G and I). The loss of vein and crumpled 
wing blade is similar to the phenotype previously described for knockdown of several 
Brm complex components, including Brm, Snr1, Osa, and Mor using Sal-Gal4 or 638-
Gal4 drivers (Terriente-Felix and de Celis, 2009). The fact that I visualized the same 
phenotype with a combined knockdown of Brm and CycY together, but not with 
knockdown of Brm alone, indicates that loss of CycY enhances the Brm knockdown 
phenotype. I also observed a synthetic lethal genetic interaction between CycY and 
Brm. Ectopic expression of BrmK804R by en-Gal4 was lethal at 25°C. At 20°C, however, I 
observed some viable adults that showed decreased posterior wing sizes, a notch along 
the posterior wing margin, and partial loss of L4 and L5 wing veins (Figure 3-7F and I). 
Knockdown of CycY in the same animals resulted in complete lethality. In summary, I 
observed that knockdown of CycY enhances the wing developmental defects induced 
by both Brm knockdown and expression of a Brm dominant negative mutant, suggesting 
that CycY and Brm function cooperatively to regulate some of the same processes in 
the wing. 
To further test for genetic interaction between CycY and Snr1 I used the 69B-
Gal4 driver line, which drives expression of Gal4 throughout most of the wing disc 
(Brand and Perrimon, 1993). Expression of the CycY dsRNA driven by 69B-Gal4 at 
25°C induced extra wing-vein tissue to the anterior side of the L2 vein in 10.9% of the 
animals and extra wing veins on both sides of L2 in a small percentage of the animals 
  
113
(Figure 3-8 B and C). The extra vein phenotypes can be suppressed by overexpressing 
CycY with a UAS-CycY transgene (Table 3-3), indicating that this phenotype is induced 
by specific knock down of CycY. As expected, increasing the temperature to 30°C, 
which leads to elevated levels of Gal4 (Brand and Perrimon, 1993), resulted in a more 
severe phenotype than observed at 25°C; for example, after increasing the temperature, 
the fraction of normal wings went from 88% to 30% while the fraction of wings with extra 
veins on both sides of L2 went from 0.8% to 29% (Table 3-3). Similarly, knockdown of 
Snr1 resulted in an extra wing vein along the anterior side of L2 (Table 3-3), similar to 
the phenotype previously observed for expression of Snr1-2 (Zraly et al., 2003) . Knock 
down of both CycY and Snr1 together significantly enhanced the wing vein phenotype 
relative to knock down of either gene alone; for example, the fraction of normal wings 
was reduced from 30 or 50% for CycY or Snr1 knockdown, respectively, to 15% in the 
double knockdown animals (Table 3-3). Removal of one copy of CycY, however, did not 
modify the Snr1 phenotype (Table 3-3). Knockdown of Brm using 69B-Gal4 was lethal 
at 30°C, but did not lead to any obvious defects at 25°C (Figure 3-8D). Strikingly, 
knockdown of Brm in combination with CycY suppressed the extra wing vein phenotype 
induced by knockdown of CycY and resulted in a highly penetrant novel phenotype. The 
whole wing blade mildly curved to the ventral side along the midline between the L3 and 
L4 longitudinal veins. When flattened with a coverslip, a deep crease was evident 
(Figure 3-8E and Table 3-3). A similar though weaker effect was observed by knocking 
down Brm in a heterozygous CycYE8 background (Figure 3-8F and Table 3-3). The fact 
that CycY knockdown and heterozygous CycYE8 showed similar but different levels of 
modification of the Brm mutant phenotypes suggests a dosage effect and supports
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Figure 3-8. Knock down of CycY enhances Snr1 knock down phenotypes and 
leads to synthetic effects with Brm mutants. Knock down of CycY or Snr1 by 
expressing dsRNA transgenes (CycYiC or Snr1i) with the 69B-Gal4 driver showed extra 
wing vein tissue along the anterior or posterior side of L2. Representative wings of wild 
type “-“ (A), extra vein (arrowhead) along one side of L2 “+” (B), and extra vein 
(arrowhead) along both sides of L2 “++” (C) are shown. (D-F) Wings from 69B-
Gal4/UAS-Brmi (D), UAS-CycYiC2/+; 69B-Gal4/UAS-Brmi (E), and CycYE8/+; 69B-
Gal4/UAS-Brmi (F) adults reared at 25°C. 
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Table 3-3. Genetic interactions revealed by double knockdown of CycY and Brm or Snr1. 
Extra wing veina Curved wing 
Temp Genotype n 
- + ++ - + 
30°C UAS-CycYiC2/+; 69B-Gal4/+ 237 30.4% 40.9% 28.7% 100% 0% 
 69B-Gal4/UAS-Snr1i 795 49.8% 50.2% 0% 100% 0% 
 UAS-CycYiC2/+; 69B-Gal4/UAS-Snr1i 127 15% 28.3% 56.7% 100% 0% 
 CycYE8/+; 69B-Gal4/UAS-Snr1i 324 52.5% 47.2% 0.3% 100% 0% 
25°C UAS-CycYiC2/+; 69B-Gal4/+ 222 88.3% 10.9% 0.8% 100% 0% 
 UAS-CycYiC2/+; 69B-Gal4/UAS-CycY 172 99.4% 0.6% 0% 100% 0% 
 69B-Gal4/UAS-Brmi 114 100% 0% 0% 100% 0% 
 UAS-CycYiC2/+; 69B-Gal4/UAS-Brmi 130 100% 0% 0% 0% 100% 
 CycYE8/+; 69B-Gal4/UAS-Brmi 147 100% 0% 0% 0% 100% 
 
a Wing vein defects were quantitatively scored as wild type (-), extra vein along one side of L2 (+), and extra vein along 
both sides of L2 (++). A representative image for each class is shown in Figure 3-8 A-C. 
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conclusion that the CycY knockdown effect was specific. The phenotype of double 
knockdown of Brm and CycY is similar to the previously described Contrabithorax (Cbx) 
phenotype, which is a curving of the wing indicating a partial transformation of wing to 
haltere due to misregulated Ubx expression (Cabrera et al., 1985; Faucheux et al., 
2003). Interestingly, BrmK804R mutants exhibit partial haltere-to-wing transformation 
(Elfring et al., 1998), which is opposite to the curved wing or wing-to-haltere 
transformation phenotype. Thus, it would seem that Brm knock down and Brm dominant 
negative mutants display opposite effects with respect to this phenotype. A possible 
explanation is that the Brm ATPase subunit may have multiple roles in the Brm complex, 
which can activate some genes but repress others. In the case of Brm knockdown 
mutants, all function of Brm should be diminished, whereas the dominant negative may 
only impair a subset of Brm function.  
In summary, I detected tissue-specific genetic interactions between CycY and 
two members of the Brm complex, Snr1 or Brm. Removal of one copy of CycY 
genetically enhanced the defects in adult viability and dorsal midline fusion induced by a 
Snr1 dominant negative. Knockdown of CycY enhanced the extra wing vein phenotype 
induced by Snr1 knockdown and enhanced the wing phenotype of Brm knockdown or a 
Brm dominant negative. These genetic interactions indicate that CycY functions with the 
Brm complex to control specific aspects of wing development.  
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3.3.6 CycY is required for maximal expression of some genes regulated by the 
Brm complex 
The functional relationship between CycY and the Brm complex genes may be 
one where they act in the same pathway to regulate gene transcription. For example, 
one possibility is that CycY may modulate Brm complex activity to regulate specific 
genes. To begin to test this possibility, I examined the transcription level of several Brm 
complex targets in CycYE8 homozygous mutants. One set of Brm complex targets 
appears to be the Eig71E genes, a cluster of 11 ecdysone-regulated genes located at 
cytological position 71E. These genes encode small, secreted, cysteine-rich peptides 
proposed to be involved in an antimicrobial defense system, based on their sequence 
similarity to vertebrate defensins (Wright et al., 1996). Both Snr1 and Brm proteins have 
been detected at the promoters of Eig71E genes in Drosophila S2 cells suggesting that 
these genes are direct targets of the Brm complex. In support of this, Zraly et al. 
showed that expression of a dominant negative Brm in early pupae results in 
downregulation of most of the Eig71E genes, whereas Snr1 mutants lead to 
upregulation, further suggesting that Brm and Snr1 have opposing roles in their 
regulation Eig71E genes in pupae (Zraly et al., 2006). To test whether CycY also 
regulates Eig71E gene expression I quantified mRNA levels in early pupae (0-14 hr 
after puparium formation) that were homozygous or heterozygous for CycYE8 (Figure 3-
9 A-D). I found that in wild-type pupae, the transcription pattern of Eig71Eh, Eig71Ei, 
Eig71Eg, and Eig71Ef was very similar, with a gradual increase in expression peaking 
at 6 hr after puparium formation followed by a decrease. In CycYE8 mutants, the overall 
transcription of each gene at most time points was significantly decreased, with the 
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most dramatic difference evident at the 6 hour peak. This phenotype is similar to Brm 
mutants but opposite to Snr1 mutants in which these genes are up regulated (Zraly et 
al., 2006). Interestingly, transcription of three other ecdysone-responsive genes (Eip93F, 
ImpE2, Eip63E) and the ecdysone receptor gene (EcR) were mildly up regulated in the 
CycY mutant (Figure 3-9 E-H). None of these genes has been shown to be markedly 
affected in either Snr1 or Brm mutants. Combined, these data suggest that CycY is 
required for maximal expression of at least some of the genes that are regulated by the 
Brm complex.  
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Figure 3-9. Gene expression in CycYE8 mutants. Total RNA was extracted from 
prepupae at the indicated developmental time points and mRNA levels of each tested 
gene were determined by RT-qPCR. Expression was normalized to the mRNA levels of 
the internal control gene, rp49. (A) Eig71Eh, (B) Eig71Ei, (C) Eig71Eg, (D) Eig71Ef, (E) 
EcR, (F) Eip93F, (G) ImpE2, (H) Eip63E. 
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3.4 DISCUSSION 
In the current study, I identified additional developmental processes that require 
CycY, including adult viability, abdominal dorsal midline fusion, and wing development. 
More importantly, I identified that CycY genetically interacts with the Brm complex 
components, Snr1 and Brm, in controlling these developmental processes. The 
maximum expression of some of the Brm complex target genes, such as Eig71E genes, 
is not achieved in CycY null mutants. I also showed that CycY can physically interact 
with Snr1 in Drosophila cells. Taken together, these results lead us to hypothesize that 
CycY may modulate the activity of Brm chromatin-remodeling complexes, possibly by 
phosphorylating Snr1 or other components of the complex, and thereby regulate the 
transcription of genes involved in a broad spectrum of developmental processes. 
 
3.4.1 CycY may modulate the Brm ATP-dependent chromatin-remodeling complex 
activity through phosphorylation 
CycY and the Brm complex are required for a similar spectrum of developmental 
processes, consistent with the possibility that they function in a common pathway. Like 
Snr1 and Brm, CycY is an essential gene that is required throughout the Drosophila life 
cycle, from oogenesis, embryogenesis, and larval growth, to metamorphosis, and adult 
viability. Mutations in CycY and Brm complex components have also revealed common 
tissue-specific requirements, including development of the integument of the adult 
abdomen and development of wing veins. The integument of the adult abdomen 
develops from nests of larval histoblast cells. After a continuous proliferation between 3 
and 15 hours after pupariation, the abdominal histoblast cells begin to migrate and 
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displace the larval epidermal cells, which are then histolyzed by apoptosis (Fristrom and 
Fristrom, 1993). Dominant negative Snr1-2 blocked abdominal tergite fusion along the 
dorsal midline and this phenotype was dramatically enhanced by removal of one copy of 
CycY (Figure 3-6, Table 3-2). A similar abdominal dorsal midline fusion defect has been 
observed for mutants of the Drosophila caspase, Ice (Muro et al., 2006). Thus, it is 
possible that CycY and Snr1 are involved in histoblast proliferation, migration, or 
differentiation, or in apoptosis of larval epidermal cells. Clonal analysis with the mutants 
described in this dissertation may help distinguish these possibilities. 
The cell fate determination of wing veins and intervein regions initiates from the 
larval wing imaginal blade, when broad “provein” and intervein regions are specified by 
the differential expression of cell signaling molecules, Hedgehog (Hh) and 
decapentaplegic (Dpp), and intervein specific transcription factors, blistered (bs), Net, 
Plexus (px), and provein specific transcription factors, Iroquois (Iro) (for veins L1, L3 
and L5), knirps (kni) and knirps-like (knrl) (vein L2), abrupt (ab) (vein L5) (De Celis, 
2003). The vein cell fate of each provein is determined by a specific combination of 
transcription factors. However, vein commitment depends on restriction by Notch 
signaling and activation by EGFR signaling pathways. Snr1 dominant negative mutants 
display extra wing vein tissue, whereas Brm mutants exhibit loss of wing vein, 
suggesting an inhibitory effect of Snr1 on Brm complex activity in this tissue. Several 
EGFR signaling targets, such as Delta, rhomboid, and agros, and other vein cell fate 
determination factors or signaling molecules, such as bs and dpp, were found to be 
misregulated in mutants of Brm complex subunits (Marenda et al., 2004; Terriente-Felix 
and de Celis, 2009). Knockdown of CycY showed a similar extra wing vein defect to 
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knockdown of Snr1. Snr1 knockdown enhanced the extra vein defect induced by CycY 
knockdown (Figure 3-8, Table 3-3). Therefore CycY is also involved in vein cell fate 
determination, and may function by modulating Brm complex regulation of vein cell fate 
genes.  
Taken together, the similar developmental requirement for CycY and Snr1/Brm, 
and the genetic interaction between them suggests that CycY may be involved in a 
common signaling pathway with the Brm complex. However, CycY is unlikely to function 
downstream of the Brm complex since direct downstream targets of the complex are 
misregulated in CycY mutants (Figure 3-9 A-D). The simplest interpretation of these 
results is that CycY acts in parallel or upstream of the Brm complex. The molecular 
function of the Brm complex is thought to be primarily transcriptional regulation (Tamkun, 
1995) whereas the molecular function of cyclins like CycY is to activate cyclin-
dependant kinases to phosphorylate downstream substrates. Our finding that Snr1 and 
CycY can physically interact (Figure 3-4B) is consistent with the possibility that 
CycY/Cdk14 phosphorylates either Snr1 or another component of the Brm complex to 
regulate its activity. Snr1 is phosphorylated at threonine 102 by dDYRK2 and MNB in 
vitro and in vivo and this phosphorylation was proposed to regulate the 
nuclear/cytoplasmic distribution of Snr1 (Kinstrie et al., 2006). In fact, phosphorylation is 
an important mechanism by which the Brm complex activity is regulated. The human 
orthologs of Brm (hBrm/Brg1) and Mor (BAF155) have been reported to be inactivated 
by phosphorylation prior to the onset of mitosis (Muchardt et al., 1996; Sif et al., 1998), 
a time when chromatin becomes condensed and transcription is inhibited. Brg1 and 
BAF155 were later shown to be associated with and phosphorylated by CycE/Cdk2 
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(Shanahan et al., 1999). Thus, it is possible that CycY/Cdk14 also regulates Brm 
complex activity by phosphorylating one or more of the Brm complex components. In 
Chapter 4, I describe efforts to detect phosphorylation of Snr1 by CycY/Cdk14.  
 
3.4.2 CycY may modulate Brm complex activity in a cell-type- and temporal-
specific manner 
Several lines of evidence indicate that the Brm complex can activate or repress 
transcription of specific genes in a cell-type specific manner. For example, Eig71E 
genes are oppositely regulated in BrmK804R mutant pupae and in Brm knockdown 
Drosophila S2 cells. In BrmK804R mutant pupae, most of the Eig71E genes are down 
regulated, whereas in Brm knockdown cells, ecdysone-induced expression of these 
genes is advanced (Zraly et al., 2006). The expression of another gene, String (Stg), is 
also differentially regulated by the Brm complex in different cells. Knockdown of Snr1 or 
Brm in S2 cells results in down regulation of Stg and arrest in G2/M phase (Moshkin et 
al., 2007). However, in pupae, down regulation of Stg was only observed in Snr1E1 
mutants, but not in BrmK804R mutants (Zraly et al., 2004). More strikingly, the human Brm 
ortholog, Brg1, is a well-known tumor suppressor. However, it is also essential for the 
viability of some types of cells (Mohrmann and Verrijzer, 2005). All of these results 
might be due to cell type specific activation or repression of specific gene by the ATP-
dependent chromatin-remodeling complexes. Snr1, a core subunit of Brm complex, 
plays the role of an activator or repressor and may be responsible for determining 
whether the complex activates or represses a gene in a specific cell type. For example, 
in the intervein cells, rhomboid expression is inhibited by Snr1, which blocks the 
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activation effect of Brm, whereas in the provein cells, rhomboid expression is activated 
by Brm due to the absence of Snr1-recruited repressors (Marenda et al., 2004). Thus, 
the different regulatory effects of Snr1 may be determined by the availability of tissue-
specific transcription factors. 
The regulation of Brm complex activity by CycY is also cell-type specific (Figure 
3-10). Most of the genetic interaction data indicate that CycY positively regulates Snr1 
function, which may either cooperate or antagonize with Brm. For example CycY 
genetically enhances the longevity and dorsal midline fusion defect induced by ectopic 
expression of truncated Snr1 (Figure 3-5 and 3-6, Table 3-2). Knockdown of Snr1 or 
CycY resulted in similar extra wing vein phenotypes, while the double knockdown 
showed a much stronger effect (Figure 3-8, Table 3-3). CycY appears to activate Snr1 
function, whether it is serving to activate or repress genes. For instance, in the intervein 
cells, Snr1 recruits gene-specific repressors to inhibit the expression of vein-specific 
genes, and therefore Snr1 knockdown wings display extra wing vein tissue (Marenda et 
al., 2004). Knockdown of Snr1 enhanced the extra wing vein phenotype induced by 
CycY knockdown, whereas Brm knockdown suppressed this phenotype (Figure 3-8, 
Table 3-3). Thus in intervein cells, CycY and Snr1 work together to antagonize Brm. On 
the other hand, in the provein cells, Snr1 functions with the Brm complex to turn on 
vein-specific gene expression and this role of Snr1 is also positively regulated by CycY 
since reducing CycY can enhance the loss-of-vein phenotypes induced by Brm 
knockdown (Figure 3-7G). The above model helps explain the tissue-specific genetic 
interaction between CycY, Snr1, and Brm. Examination of Eig71E gene expression in 
pupae, however, suggests a more complicated relationship. The Eig71E genes were
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Figure 3-10. CycY may modulate Brm complex activity in a cell-type- and 
temporal-specific manner. Snr1 may constrain Brm complex activity by recruiting 
transcriptional inhibitors to repress gene expression at some cell types (for example, 
intervein cells) or at specific developmental time points (for instance, at 0h after 
puparium formation or APF) to repress the expression of provein genes or Eig71E 
genes, respectively. Snr1 may also operate with Brm complex to activate gene 
expression in other cell types (for example, provein cells) or at other developmental time 
points (for instance, at 6h APF) to activate the expression of these same genes. Under 
any circumstance, CycY, presumably with its Cdk14 partner, positively regulates Snr1 
function to regulate gene expression. 
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upregulated in the Snr1E1 mutant, but downregulated in BrmK804R mutants, which are a 
collection of pupae between 0 and 24 hours after puparium formation. My expression 
data is consistent with previous reports that the expression of Eig71E genes is 
repressed at the beginning of puparium formation, but is induced by ecdysone signaling 
during the prepupal stage (Wright et al., 1996). Ecdysone-induced expression is 
downregulated in CycYE8 mutants, especially at the 6 hour peak. These data seem to 
conflict with our proposed model that CycY positively regulates Snr1 function. However, 
it is possible that CycY cooperates with Snr1 to either promote or repress the Brm 
complex activity in a temporal-specific manner (Figure 3-10). The gene expression 
analysis with 0-24 pupae may reflect an overall inhibitory effect of Snr1 on Brm complex 
activity, while my analysis was carried out during the stage of ecdysone-induced 
expression when presumably Snr1 has an activating role on the Brm complex. Similar 
analysis of the expression of these Eig71E genes at specific developmental time points 
in Snr1 or Brm mutants is needed to further test this model. 
 
3.4.3 Does CycY play a role in cell cycle regulation? 
Thus far it is uncertain whether or not CycY plays a direct role in regulating the 
cell cycle although I have detected genetic interactions between CycY and the Brm 
complex, which has been substantially connected with cell cycle regulation. In mammals, 
the Brm complex cooperates with Rb to inhibit expression of CycE and CycA, and 
therefore regulates the exit from G1 and S phase progression. On the other hand, 
CycE/Cdk2 has been found to bind and phosphorylate Brm subunits Brg1 and BAF155 
(orthologs of Drosophila Brm and Mor, respectively) to maintain chromatin in a 
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transcriptionally permissive state (Reisman et al., 2009). In Drosophila, it has been 
proposed that the Brm complex may exert an inhibitory effect on DNA replication origins 
by recruiting a repressor through Snr1. After Cdk2/CycE is also recruited to replication 
origins by associating with cdc6, Brm complex subunits are phosphorylated by 
Cdk2/CycE mediated by association with Snr1, and therefore the Brm complex and its 
inhibitory effect is removed from the replication origins to facilitate the DNA synthesis 
(Brumby et al., 2002). 
Some findings argue against a role for CycY in cell cycle regulation. CycY has 
not been identified in genome-wide RNAi screens for cell cycle regulators in human or 
Drosophila cells, and I have found that knockdown of CycY expression in cultured 
Drosophila cells does not produce obvious defects in the cell cycle (data not shown). I 
did not observe any functions of CycY during the development of eye, a best tissue for 
studying cell proliferation and differentiation. The eyes from CycYE8 pharate adults or 
adult escapers look normal (Liu and Finley Jr, 2010), and knockdown of CycY in the 
posterior compartment of the eye imaginal disc generated viable adults with normal 
eyes (Figure 3-1 F-G). Cdk14/Eip63E has also been shown not to be required for cell 
division in the eye (Stowers et al., 2000).  
However, several studies support a direct or at least indirect role for CycY/Cdk14 
in cell cycle regulation. The decreased wing size phenotype induced by CycY 
knockdown by en-Gal4 supports a function related with cell growth, cell proliferation, or 
cell death (Figure 3-2). Unfortunately, I failed to detect any abnormal percentage of 
mutant cells that undergo mitosis or apoptosis in third instar larval imaginal discs 
(Figure 4-5 S-U, Appendix J). The human Cdk14 ortholog, also called PFTK1, functions 
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as a Cdk to regulate cell cycle progression, cell proliferation, and activation of Wnt 
signaling (Davidson et al., 2009; Shu et al., 2007). Two cyclin binding partners for 
PFTK1 have been identified, CCND3 (human CycD3) and CCNY (human CycY) 
(Davidson et al., 2009; Jiang et al., 2009; Shu et al., 2007). PFTK1 knockdown led to 
G1 arrest, whereas ectopic expression promoted S-phase entry (Shu et al., 2007), 
suggesting a positive role during the G1 to S phase transition. However, Davidson et al. 
showed that CCNY oscillates throughout the cell cycle and peaks at G2/M phase 
(Davidson et al., 2009). Although CCNY/PFTK1 complex peaks at G2/M to activate Wnt 
signaling by phosphorylating the Wnt co-receptor LRP6, a direct cell cycle regulatory 
function during G2/M still has not been described. However, direct downstream targets 
of the Wnt pathway transcription complex β-catenin/LEF-1 include the G1/S genes 
CycD1 and c-myc (Nollet et al., 1999). It is also not clear whether the cell cycle related 
PFTK1 kinase activity during G1 to S phase is activated by CCND3, CCNY, or both. It is 
possible that both CCND3 and CCNY activate PFTK1 but with different substrate 
specificities. It is possible that CCND3 promotes the phosphorylation of Rb while CCNY 
promotes the phosphorylation of SWI/SNF complex subunits, and both phosphorylation 
events would promote the G1 to S phase transition. In Drosophila, however, there is 
only one CycD, which apparently does not have functions independent of Cdk4, and 
CycD/Cdk4 complex has been found to be required for cellular growth but not for 
progression through G1 (Datar et al., 2000; Meyer et al., 2000). Yeast two-hybrid and 
co-AP data also argue against the interaction between Drosophila CycD and Eip63E 
(Liu and Finley Jr, 2010). Whether Drosophila CycY and its related kinase are involved 
in cell cycle regulation in both human and Drosophila requires further investigation. 
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3.4.4 CycY, Brm complex, and Wg/Wnt signaling 
CycY and Cdk14 have been reported to phosphorylate the Wnt co-receptor 
LRP6/arrow in human and Drosophila cultured cells to activate Wg/Wnt signaling 
(Davidson et al., 2009). We do not know, however, whether the CycY/Cdk14 complex 
regulates Wg signaling in vivo or whether there are specific developmental processes 
where CycY/Cdk14 modulate Wg signaling. The genetic interaction between CycY and 
Wg signaling has not been explored. Interestingly, the Brm complex has been found to 
inhibit the expression of Wg targets (Collins and Treisman, 2000). Thus, it is possible 
that some or all of the genetic interactions I observed between CycY and the Brm 
complex are due to CycY’s role in Wg signaling. The null mutant phenotypes of CycY 
and Eip63E have more similarities to that of Brm complex components than to that of 
Wg components, suggesting that both CycY and Brm have functions that are 
independent of Wg signaling. The epistatic relationship between CycY, the Brm 
complex, and Wg targets should be investigated further. The CycY mutants and genetic 
tools created here should help in this endeavor.  
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CHAPTER 4 
 
SEARCHING FOR CYCLIN Y’S PATHWAYS IN DROSOPHILA 
 
4.1 INTRODUCTION 
The studies described in Chapters 2 and 3 provided an initial characterization of 
the essential roles that CycY plays in Drosophila and suggested that CycY may bind 
Cdk14 and activate its kinase activity to regulate the Brm chromatin-remodeling 
complex. This hypothesis needs to be tested further in vivo. The studies also raised 
many questions about CycY function. In this chapter I set out to answer some of these 
questions. Most of the results described in this chapter are negative and failed to 
provide evidence either in support of the hypothesis being tested, or disproving it. 
Nevertheless the results from these experiments are likely to be useful for guiding future 
studies aimed at a better understanding of the biological functions of CycY and 
identifying the signaling pathways in which it is involved.  
Data presented in Chapter 2 showed that CycY physically interacts with Eip63E 
as demonstrated by Y2H and co-AP assays. I also showed that CycY and Eip63E null 
mutants have similar phenotypes. Both are required for almost all developmental 
stages. The major developmental defects of zygotic nulls are manifested during 
metamorphosis, especially during prepupal development, a process that is mainly 
regulated by the steroid hormone, ecdysone. Interestingly, one of the Eip63E transcripts 
is also ecdysone inducible. Taken together, these data suggest that CycY and Eip63E 
are bona fide in vivo Cyclin/Cdk partners, a proposal that has been further supported by 
the identification of the CCNY/PFTK1 interaction in human cell lines. However, we still 
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lack direct in vivo evidence from Drosophila. Since I do not have antibodies to either 
CycY or Eip63E, I was unable to do in vivo immunoprecipitation. As an alternative 
approach, I decided to test whether CycY and Eip63E genetically interact with each 
other. The essential requirement of CycY and Eip63E during metamorphosis and the 
ecdysone induced expression of Eip63E prompted me to test whether CycY is required 
for some key developmental events during metamorphosis, for example the glue protein 
synthesis, secretion, or extrusion, and autophagic cell death.  
Data presented in Chapter 3 showed that CycY genetically interacts with 
components of the Brm chromatin-remodeling complex and that CycY also physically 
interacts with Snr1, a core subunit of the complex. However, the molecular mechanism 
behind these interactions is unknown. Considering that the likely molecular function of 
the CycY/Eip63E complex is to phosphorylate downstream targets, a simple hypothesis 
is that Snr1 is one of the substrates. To test this hypothesis, I expressed and purified 
MBP-tagged Snr1 and several mutant variants and used these fusion proteins as 
substrates for in vitro kinase assays.  
I show here that CycY does not genetically modify the hatching rate defect 
associated with Eip63E81 allele. I also show that CycY null mutants display normal 
starvation induced autophagy during early L3 stage. Interestingly, the process of glue 
extrusion, which is regulated by ecdysone, is misregulated in the CycY mutant. Due to 
the failure of generating high quality CycY Ab and the non-specificity of RNA in situ 
hybridization, I was unable to show the endogenous CycY protein or mRNA localization. 
Consistent with studies with human cells, I showed that CycY with an N-terminal tag is 
mainly localized in the cytoplasm. Finally, in vitro kinase assays suggest that Snr1 may 
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not be a direct phosphorylation target of CycY/Eip63E complex. This result suggests an 
alternative hypothesis for how CycY/Cdk14 may regulate the Brm complex. 
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4.2 MATERIALS AND METHODS 
 
4.2.1 Fly stocks 
All fly stocks were maintained in vials containing standard cornmeal molasses 
medium and raised at 25°C unless otherwise stated. Most of the fly strains used in this 
study have larval markers for identifying larvae with specific genotypes. A double 
balancer strain that have a [y+] transgene on the second chromosome in a y1 
background and a Tb allele on the third chromosome was kindly provided by Dr. Lei 
Zhang (University of Texas Southwestern Medical Center; Shanghai Institute of 
Biochemistry and Cell Biology) (Finley lab # 442). Fly strains used in this study are 
listed in Appendix K. 
 
4.2.2 Embryo hatching rate  
Roughly equal numbers of newly emerged virgin females (~20) of each genotype 
were mated with w1118 males (~30) or males with the indicated genotypes in a regular 
vial for 2 days. These adults were then transferred to egg chambers after 2 days of 
mating and eggs were collected on apple juice plates once every 12 hours for two days. 
After incubating the collected eggs for about another 12 hours, the number of hatched 
first instar larvae was counted. The hatched larvae were discarded after counting. The 
number of hatched first instar larvae was counted again after another 12 hours. The 
reason for counting twice is to prevent too many larvae from accumulating on the apple 
juice plates since they will crawl to the cover of the plate and dry out or dig through the 
agar when it is over crowded. The number of eggs that failed to hatch eventually after 
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aging for at least 24 hours at 25°C was also counted. Hatching rate is the total number 
of hatched first instar larvae divided by the sum of larvae and unhatched eggs. 
 
4.2.3 Assay of glue synthesis and extrusion from salivary glands during prepupal 
development  
Egg chambers were set up with Finley lab strain # 710 (y1w*; CycYE8/CyO [y+]; 
sgs3-GFP/TM6b Tb). Larvae with black mouth hooks (y1w*; CycYE8/CyO [y+]; sgs3-
GFP/TM6b Tb or y1w*; CycYE8/CyO [y+]; sgs3-GFP) and yellow mouth hooks (y1w*; 
CycYE8; sgs3-GFP/TM6b Tb or y1w*; CycYE8; sgs3-GFP) were collected separately and 
transferred to regular vials. 0h prepupae were collected and transferred to a petri dish 
with a piece of wet filter paper. The glue secretion from salivary glands was monitored 
under a dissection fluorescence microscope once every half hour for a total of 4 hours. 
All the pupae under study were classified into five different groups on the basis of the 
GFP intensity, which represents the glue protein sgs3 level, during the first four hours 
after puparium formation. Group 1 had lost almost all GFP; group 2, had only a weak 
GFP signal; group 3 had medium levels of GFP signal; group 4 had strong GFP signal 
at the time of puparium formation, but the signal went away in less than 1.5h; group 5 
had GFP signal that remained longer than all the above mentioned situations.  
 
4.2.4 LysoTracker staining  
An egg chamber was set up with Finley lab fly strain # 693 (w*; CycYE8/CyO 
Act5C-GFP). CycYE8 heterozygous (GFP positive) and homozygous (GFP negative) first 
instar larvae were transferred separately into regular vials (about 20 per vial) from apple 
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juice plates. Well-fed early third instar larvae were collected for direct dissection or were 
transferred into 5ml of 20% sucrose/PBS for 4 hours before dissection for protein 
starvation experiments (Britton and Edgar, 1998). I followed the LysoTracker staining 
protocol as described by Neufeld with minor modification (Neufeld, 2008). Early third 
instar larvae were dissected in a 6-well dissection dish containing PBS and the 
dissected salivary glands and fat body tissue that were attached to the mouth hooks 
were immediately transferred to an eppendorf tube with PBS on ice. After finishing the 
dissection of all larvae (~10), PBS was removed and replaced with 1ml of 2 μg/ml 
Hoechst 33342 (Invitrogen H1399, 1mg/ml stock solution). After 10-minute incubation, 
Hoechst 33342 was removed and the dissected tissues were washed twice with PBS (5 
minutes for each wash). The eppendorf tube was kept on the bench without shaking 
during the washing step. After washing with PBS, the tissues were incubated with 1ml of 
1μM LysoTracker Red DND-99 (Molecular Probes L-7528, 1mM stock solution) for 2 
minutes. After washing twice with PBS (5 minutes for each wash), the salivary glands 
and fat body were mounted with PBS and photographed immediately.  
 
4.2.5 Expression and purification of MBP-tagged fusion proteins from bacterial 
cells  
I followed the following protocol, which I modified based on the NEB instruction 
manual for pMAL Protein Fusion and Purification System. Transform the expression 
vector into NEB express cells (NEB C25231, fhuA2 [lon] ompT gal sulA11 R(mcr-
73::miniTn10--TetS)2 [dcm] R(zgb-210::Tn10--TetS) endA1 Δ(mcrC-mrr)114::IS10). 
Inoculate 10ml of rich media (per liter: 10g tryptone, 5g yeast extract, 5g NaCl, 2g 
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glucose, 100μg/ml ampicillin) with a single colony. Inoculate 1L of rich media with the 
10ml of overnight culture and grow to OD600 ~0.6, which usually takes about 2.5-3h. Add 
IPTG to a final concentration of 0.6mM to induce the fusion protein expression and 
incubate with shaking at 37°C for 4 hours. Spin down and measure the weight of the 
wet pellet. Resuspend 1g pellet in 10 ml of lysis buffer [1xPBS, 1mM PMSF, 
1mMEDTA, 1xProtease inhibitor cocktail (Roche)]. Add rLysozyme (Novagen) ~ 50KU/g 
cell pellet and shake at room temperature for 1h (200RPM). Store the cell lysate at -
20°C freezer over night. Thaw rapidly at 37°C in a water bath and then return to ice. 
Transfer the cell lysate to a 50ml centrifugation tube and keep the volume around 20ml, 
no more than 25ml. Sonicate on ice (8 x 15 seconds each, pulsed 15s in between, duty 
cycle 50%, setting 5, microtip max). Spin at 17,000 rpm at 4°C for 30 min. Filter the 
supernatant with a 0.4µm membrane. Quantify protein concentration with the BioRad 
protein assay reagent. Dilute the supernatant to 2.5mg protein/ml with MOPS column 
buffer (50mM MOPS pH 7.5, 200mM NaCl, 1mM EDTA, 1mM PMSF). Load to a 15ml 
amylose (NEB) column (1ml/min) equilibrated with 150ml of MOPS column buffer. Wash 
the column with 180ml of MOPS column buffer (3ml/min). Elute MBP-tagged fusion 
proteins with the MOPS column buffer supplemented with 10mM maltose. Collect 15 
fractions (1ml/min), each ~ 1.5ml. Quantify the protein concentration in each fraction 
and run an SDS-PAGE gel and stain with Coomassie to identify the purified protein 
fractions. The following MBP-fusion proteins have been expressed and purified for this 
study (Table 4-1). 
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Table 4-1. MBP-fusion proteins expressed and purified for this study 
 
Plasmids 
Finely lab # Plasmid names Expressed proteins Used for 
1030 pMalc2-nCycY MBP-nCycY CycY Ab purification 
1010 pMalc2-Snr1 MBP-Snr1 Substrate for kinase assay 
1033 pMalc2-Snr1 T102/198A MBP-Snr1 T102/198A Substrate for kinase assay 
1034 pMalc2-Snr1 T102A MBP-Snr1 T102A Substrate for kinase assay 
1035 pMalc2-Snr1 T198A MBP-Snr1 T198A Substrate for kinase assay 
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4.2.6 Generation and purification of CycY peptide antibody 
A 14 amino acid small peptide DRKSKDMPPVFEER (CycY 16-29) was 
synthesized and used for the immunization of a guinea pig by Open Biosystems. Forty 
five ml of crude serum was received and directly used for western blot (1:250) to detect 
CycY. To purify the anti-CycY serum, a small MBP-tagged N-terminal CycY (1-115, 
MBP-nCycY; expression vector pMalc2-nCycY is Finley lab plasmid # 1030) was 
expressed in E.coli, purified (see section 4.2.5 for details), and coupled to the Affi-Gel 
15 (Bio-Rad). Affinity purification of CycY antiserum is based on the manufacturer’s 
protocol (Bio-Rad).  
 
4.2.7 RNA in situ hybridization  
I followed the following protocol adapted from the protocol provided by Dr. Ye 
Tao (The University of Texas M. D. Anderson Cancer Center) and Dr. Russell Finley 
(WSU). 
4.2.7.1 Collect and fix embryos for hybridization  
Set up an egg chamber and collect eggs at room temperature (22°C) for 20-24 
hours. Wash eggs off the egg laying plate into a sieve and wash several more times to 
remove as much debris as possible. Immerse the eggs in the sieve in 50% bleach for 5 
minutes to dissolve the egg chorions. Wash several times with water and blot dry. Using 
a paint brush with soft hair, transfer the eggs immediately into a glass scintillation vial 
containing equal volumes of fixative solution (3.7% formaldehyde in PEM; PEM: 100mM 
PIPES, 1mM MgCl2, 1mM EGTA, pH 6.9) and heptane; place the glass vial on a shaker 
and shake at 400 rpm for 20 minutes at room temperature. Using a pasteur pipet, 
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remove and discard the lower phase and add an equivalent volume of methanol 
(precooled to -70°C) into the vial. Shake the vial vigorously by hand for 1 minute. 
Discard the upper phase in the vial, and any embryos that remain at the interface 
should be discarded as well. Remove the embryos from the bottom phase and transfer 
into a 1ml tube. Rehydrate the embryos through a graded methanol:PBS (130mM NaCl, 
7mM Na2HPO4, 3mM NaH2PO4, pH7.4) series (7:3, 5:5, 3:7, 0:10), 10 minutes each. Fix 
the embryos for 20 minutes with 3.7% formaldehyde. Wash in 1xPBS, then dehydrate 
through graded methanol:PBS series (3:7, 5:5, 7:3, 10:0), 10 minutes each. Store the 
embryos at -20°C for further treatment.  
4.2.7.2 Probe synthesis 
Using pAS1-CycY as template, PCR with primers 5' TGTGGGATGACCAGGCC 
GTTTGG (Finley lab # 792) and 5'-GGCCAGTGAATTGTAATACGACTCACTATAGGG 
AGGCGGCGGAATTAGCTTGGCTGCAG-3' (Finley lab # 497) to amplify a CycY cDNA 
fragment (C-terminal 359bp) with a T7 promoter at the 3’ end. Alternatively, PCR with 
primers Finlab # 497 and 5’RT-F (Finley lab # 891) to amplify full length CycY cDNA 
with a T7 promoter at the 3’ end. Set up the following RNA labeling reaction with the 
DIG RNA Labeling Kit (SP6/T7) from Roche Applied Science (11-175-025-910): 10μl of 
PCR products from above (~ 1μg DNA); 2μl of 10 x Transcription buffer; 2μl of l0x 
nucleotide mix (with digoxigenin-UTP); 1μl of RNase inhibitor; 2μl of T7 RNA 
polymerase. Add RNase-free water to give a final reaction volume of 20μl. Incubate the 
reaction mixture at 37°C for 2 hours. Clean up the in vitro synthesized labeled RNA 
probes with Megaclear RNA purification kit (Ambion). Add 2µl of RNase inhibitor (40U) 
to the purified RNA probe. Aliquot the probe and store at -70°C. 
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4.2.7.3 Preabsorb anti-Dig Ab 
Remove methanol from the fixed embryos (~50μl). Add 1ml of PTW (PBS, 0.1% 
Tween-20) and 5μl of Roche HRP conjugated anti-digoxigenin antibody. Rotate at 4°C 
overnight. Add NaN3 to the preabsorbed Ab solution to a final concentration of 0.1% to 
stabilize the Ab. Preabsorbed Ab may be stored for several months at 4°C and diluted 
further 1:10 when used. 
4.2.7.4 Pretreatment, hybridization and washing 
Rehydrate the fixed embryos through 70%, 50%, 30%, 0% methanol in PTW 
(PBS, 0.1% Tween-20). Five minutes for each step. Incubate the embryos in 50μg/ml 
proteinase K in PTW at room temperature for 4 minutes. Rinse the embryos twice for 1 
minute in PTW. Wash with PTW twice for 5 minutes. Fix the embryos in 4% 
paraformaldehyde in PBS for 20 minutes at room temperature. Rinse the embryos five 
times for 1 minute in PTW.  
Rinse the embryos in 1:1 PTW: hybridization buffer (50% deionized formamide, 
5x SSC, 100μg/ml tRNA, 50μg/ml heparin, 0.1% Tween-20; SSC: 0.15M NaCl and 
15mM tri-sodium citrate; adjust pH to 4.5 with 1M citric acid if the hybridization 
temperature is 70°C, otherwise do not adjust pH). Resuspend the embryos in 
hybridization buffer and transfer to a 0.6ml tube. Prehybridize overnight (~20h) at 70°C 
or 55°C. Heat the probe (1:25-1:100 in hybridization buffer) to 90°C for 5 minutes. Put 
the heated probe on ice immediately. Remove prehybridization buffer from the 0.6ml 
tube and add 200μl fresh hybridization buffer containing heat denatured probe. 
Hybridize overnight in 70°C or 55°C water bath. 
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Remove hybridization buffer containing the probe and rinse the embryos in fresh 
hybridization buffer once and wash once for 20 minutes at 70°C or 55°C. Wash the 
embryos in 1:1 PTW: hybridization buffer for 20 minutes at 70°C or 55°C. Wash in PTW 
five times for 20 minutes at room temperature.  
4.2.7.5 Immunodetection of the probes  
Incubate the hybridized embryos with preabsorbed anti-dig Ab (further dilute 1:10 
in PTW to make a final 1:2000) for 2 hours at room temperature. Wash four times for 20 
minutes in PTW. Rinse twice for 1 minute in fresh-made detection solution (100mM 
NaCl, 50mM MgCl2, 100mM Tris-HCl pH 9.5, 0.1% Tween-20). Resuspend the embryos 
in 1ml of detection solution and add 20μl of NBT/BCIP mixture solution (Roche). Monitor 
the reaction under the microscope. When the stain appears, stop the reaction with 
several rinses in PTW. Mount the embryos in 70% glycerol. Use small pieces of No.1 
coverslip as supports for the main coverslip to prevent the embryos from being 
squashed. 
 
4.2.8 Immunofluorescence staining of Drosophila S2R+ cells 
I followed the following protocol provided by Bridget Elsa Varughese (WSU). 
4.2.8.1 Coat coverslip with Concanavalin A (ConA) 
Immerse coverslips into nitric acid for about 2 minutes. Wash with abundant 
amounts of sterile water. Make sure the final pH of the wash is ~neutral. Dry the 
coverslips on paper towel and put one in each well of a 6-well plate. Spread 100-200µl 
ConA (250µg/ml, Sigma C5275) on each coverslip. Incubate at 37°C for 2 hours. 
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Remove the extra ConA with a pipette and rinse with sterile dH2O 3 times. Store the 
coverslips in water at 4°C for future use. 
4.2.8.2 Seed cells  
Dislodge S2R+ cells and count the cell density. Dilute the cell suspension to 
5x105 cells/ml with fresh media. Remove extra water from the 6-well plate with ConA-
coated coverslips. Plate 200µl of the cells (105 cells in total) onto each coverslip. Wait 
30min for the cells to settle down. Remove excess cell suspension form the coverslip 
with a pipette.  
4.2.8.3 Staining  
Fix the cells with 1ml of 4% paraformaldehyde (pre-warmed at 37°C) for 10 min 
at room temperature. Wash 3 times with 1xPBS (10 minutes for each wash). Block with 
1ml of 0.1% PBT (Triton), 5% BSA for 1h at room temperature or 4°C overnight or 
longer. Add 200µl of 1°Ab (mouse anti-myc Ab 1:100, Santa Cruz; rabbit anti-GST Ab 
1:100, Santa Cruz) to a piece of parafilm then put the coverslip on the top of it with the 
cells facing down. Incubate at 4°C overnight or for 1-3h at room temperature. Wash 3 
times with 1xPBS (10 minutes for each wash). Add 200µl of 2°Ab (FITC conjugate Goat 
anti-mouse IgG 1:200, Sigma; Texas Red® goat anti-rabbit IgG 1:200, Invitrogen) to a 
piece of parafilm then put the coverslip on the top of it with the cells facing down. 
Incubate at room temperature for 1h. Wash 3 times with 1xPBS (10 minutes for each 
wash). Mount with vectashield mounting media with DAPI. Seal the edge with nail 
polish. Keep slides at room temperature in the dark overnight to fully dry. Stained slides 
can be stored at 4°C in the dark for months. Images were taken with a Zeiss Axio 
imager upright microscope and Zeiss AxioCam MRm camera. 
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4.2.9 Immunoprecipitation and kinase assay 
I followed the following protocol provided by Dr. Stephen Guest (WSU) with 
minor modification. Transfect S2R+ cells with plasmids and prepare cell lysate as 
described in Chapter 2 (section 2.2.11). Quantify protein concentration in the cell lysate 
and aliquot 500μg of total protein to an epppendorf tube. Add fresh-made lysis buffer 
(20mM Tris.HCl pH 7.4, 150mM NaCl, 1mM EDTA, 1mM EGTA, 1mM NaF, 1mM 
Na3VO4, 1mM β-Glycerophosphate, 1 x protease inhibitor cocktail, 1mM PMSF) to make 
it a total of 1ml. Add 10μl of anti-myc Ab (Santa Cruz) to the above cell lysate and rotate 
at 4°C for an hour. Add 20μl of protein A agarose beads (Santa Cruz sc-2001) and 
continue to incubate on a nutator at 4°C overnight. Centrifuge immunoprecipitation 
reactions at 2500rpm at 4°C for 5 minutes. Remove supernatant and wash the beads 3 
times with kinase assay buffer (50mM Hepes pH7.5, 10mM MgCl2, 1mM DTT). After the 
final wash, add 20μl of kinase reaction mix to each immunoprecipitate (1 x kinase assay 
buffer, 50μM cold ATP, 4.5μCi [γ32P] ATP, and 2μg of potential kinase substrate). 
Incubate at 30°C for 30 minutes. Stop the reaction by adding 20μl of 2 x Laemmli 
sample buffer and analyze by SDS-PAGE.  
 
4.2.10 Mosaic analysis 
y1w* hs-FLP; Ubi-GFP FRT40A (Finley lab # 434) virgin females were crossed 
with y1w*; CycYE8 FRT40A/CyO [y+]; TM6B Tb/Sb (Finley lab # 705) males or y1w*; 
FRT40A/CyO [y+]; TM6B Tb/Sb (Finley lab # 704) males as control in glass vials. Eggs 
were collected for 24 hours. Twenty-four and 48 hours after egg laying, the glass vials 
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were heat-shocked in a 37°C water bath for 2 hours to initiate FRT-mediated mitotic 
recombination (Xu and Rubin, 1993). These vials were kept at 25°C otherwise. Third 
instar larvae with yellow mouth hooks (y1w* hs-FLP; CycYE8 FRT40A/Ubi-GFP FRT40A 
or y1w* hs-FLP; FRT40A/Ubi-GFP FRT40A) were collected and dissected. Dissected 
imaginal discs were fixed in 4% paraformaldehyde in PBS for 30 minutes at room 
temperature. After washing 3 times with PBST, staining 10 minutes in 1μg/ml 
DAPI/PBST (Sigma), and a final 10-minute wash in PBST, imaginal discs were 
incubated with antifade solution (0.5% p-Phenylenediamine and 40% glycerol in PBS) 
for 20 minutes and mounted on a slide. Similarly, y1w* ey-FLP; Ubi-GFP FRT40A (Finley 
lab # 435) virgin females were crossed with y1w*; CycYE8 FRT40A/CyO [y+]; TM6B 
Tb/Sb (Finley lab # 705) or y1w*; FRT40A/CyO [y+]; TM6B Tb/Sb (Finley lab # 704) 
males to create mosaic clones specifically in the eye.  
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4.3 RESULTS AND DISCUSSION 
 
4.3.1 CycY does not genetically modify the hatching rate defect associated with 
the Eip63E81 allele 
I have shown that CycY physically interacts with Eip63E and that null mutants of 
the two genes have strikingly similar phenotypes, suggesting that CycY and Eip63E 
function together in vivo. To further test this possibility I set out to screen for a genetic 
interaction between the two genes. Since there is a maternal requirement for both CycY 
and Eip63E during embryogenesis, I compared the hatching rate of embryos from 
female heterozygous for Eip63E or CycY mutants with that of double mutants when 
mated with w1118 males (Table 4-2). However, I only identified a decreased hatching 
rate associated with the Eip63E81 allele, but not with any allele of CycY or the other two 
Eip63E deficiency alleles. Embryos from double heterozygous mutants (CycYE8/+; 
Eip63E81/+) had similar hatching rate as those from the heterozygous Eip63E81 mutant. 
The same was true when the father was heterozygous for a CycY allele, an Eip63E 
allele, or both. These data suggested that the decreased hatching rate is an allele-
specific phenotype of Eip63E81 that is not modified by decreasing the dosage of CycY. 
There are several possibilities to explain the differences between the Eip63E81 allele 
and the two Eip63E deficiency lines. Eip63E81 has an in frame deletion of the DNA 
sequences that encode amino acids 226-241 within a region conserved among Cdks, 
including the highly conserved lysine 234, which is essential for ATP binding. Stowers et 
al. proposed that Eip63E81 is a null (Stowers et al., 2000). However, it is more likely to 
be a dominant negative since this truncated Eip63E may maintain its ability to interact
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Table 4-2. Embryo hatching rates of CycY and Eip63E mutants. 
Maternal genotype Paternal genotype Embryos collected Hatching rate (%) 
CycYE8/+ w1118 906 98 
CycYDf6030/+ w1118 721 99 
Eip63E81/+ w1118 2273 73 
Eip63EDf6096/+ w1118 771 98 
CycYE8/+; Eip63E81/+ w1118 2519 74 
CycYDf6030/+; Eip63EDf6096/+ w1118 1184 98 
CycYDf6030/+; Eip63EDf6095/+ w1118 1030 99 
CycYDf6030/+ CycYE8/+ 772 98 
Eip63E81/+ Eip63EDf6096/+ 1178 75 
CycYE8/+; Eip63E81/+ CycYDf6030/+; Eip63EDf6095/+ 3127 78 
CycYE8/+; Eip63E81/+ CycYDf6030/+; Eip63EDf6096/+ 1888 78 
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with the cyclin binding partner, even though it has lost its kinase activity. This may 
cause the different behaviors of Eip63E81 and the deficiency. It is also possible that 
there is a second site mutation on the Eip63E81 chromosome that contributes to or 
causes the hatching defect. Although these results did not provide further evidence to 
support the idea that CycY and Eip63E function together, the failure to detect a genetic 
interaction does not weaken the hypothesis. For interaction partners, lowering the 
dosage of the two proteins simultaneously may not enhance the phenotype associated 
with either single mutant. It is also possible that CycY and Eip63E function together only 
in specific tissues or at specific developmental times, one of which may not be 
embryogenesis. Thus, other phenotypic assays, perhaps using other alleles, may yet 
reveal genetic interactions between CycY and Eip63E. 
 
4.3.2 CycYE8 mutants show delayed glue extrusion from salivary glands  
Homozygous CycY mutants are lethal and have major developmental defects 
during metamorphosis, a process tightly regulated by ecdysone. This combined with the 
fact that at least one of the Eip63E transcripts is induced by ecdysone led me to 
hypothesize that CycY/Eip63E are involved in the ecdysone signaling or response 
pathways. To search for processes that CycY may regulate I considered ecdysone-
regulated processes that are required for normal metamorphosis. One such process is 
synthesis of glue mixture. Glue mixture is a substance secreted by salivary glands prior 
to pupariation and serves to help attach the pupae to a dry surface. It is composed of 
several glycoproteins, one of which is sgs3. Sgs3 is expressed during the second half of 
third instar larval development only in the salivary glands. A few hours before 
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pupariation, sgs3 starts to be secreted to the salivary ducts and lumen and at puparium 
formation it is expelled from the salivary gland. This series of responses is under the 
regulation of ecdysone. A convenient tool for monitoring glue synthesis, secretion, and 
extrusion is a transgene, sgs3-GFP, which has an identical expression pattern as the 
endogenous sgs3 (Biyasheva et al., 2001). I examined sgs3-GFP activity in CycY 
mutants. Homozygous CycYE8 mutants showed normal glue synthesis and secretion 
compared to the heterozygous control (Figure 4-1 C-D compared to A-B). However, it 
took the mutants longer to expel the glue proteins to the outside of the salivary gland as 
visualized by the longer time to keep the GFP signal inside the pupae (Figure 4-1 J-M, 
Table 4-3). The failure to expel the secreted glue proteins to the ventral side of the body 
surface may be due to neural signal transduction or muscle contraction defects. The 
mechanism of how the loss of CycY may lead to delayed glue extrusion still requires 
further investigation. However, the identification of a specific biological process in which 
CycY is involved, should be useful for further delineation of CycY signaling pathways. 
This phenotype can be used to ask specific questions about potential upstream 
regulators or downstream targets. For example, from the list of potential genes that 
might be responsible for glue extrusion, which genes are misregulated in CycY 
mutants? Are they misregulated in Brm mutants too and are they direct targets of Brm 
complex?  
 
4.3.3 CycY loss-of-function mutants show normal starvation-induced autophagic 
effects during the early L3 stage 
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Figure 4-1. CycYE8 mutants show normal glue synthesis and secretion but 
delayed glue extrusion from salivary glands. (A-D) Salivary glands from late third 
instar larvae were dissected from heterozygous CycYE8 (A and B) or homozygous 
CycYE8 (C and D), which also harbored a sgs3-GFP transgene on the third 
chromosome. Glue protein was synthesized in the cytoplasm and absent from the nuclei 
(A and C) and then secreted to the ducts and lumen in the late third instar larvae (B and 
D). The glue protein-free layer of cells surrounding the lumen filled with green glue 
proteins is weakly visible. (E-N) Glue protein was directly visualized from synchronized 
prepupae at 0h (E, J), 0.5h (F, K), 1h (G, L), 1.5h (H, M), and 2h (I, N) in heterozygous 
CycYE8/CyO [y+] (E-I) or homozygous CycYE8 (J-N), which also harbored a sgs3-GFP 
transgene on the third chromosome. 
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Table 4-3. Glue protein extrusion is delayed in CycYE8 mutants 
Groupsa (%) 
Genotypes Total pupae 1 2 3 4 5 
y1w*; CyO [y+]/Sp; sgs3-GFP 25 64 16 4 8 8 
y1w*; CycYE8/CyO [y+]; sgs3-GFP 46 77 9 5 0 9 
y1w*; CycYE8; sgs3-GFP 42 0 0 3 3 94 
 
a Group 1, GFP signal almost lost at the time of puparium formation; group 2, only weak 
GFP signal at the time of puparium formation; group 3, medium levels of GFP signal at 
the time of puparium formation; group 4, strong GFP signal at the time of puparium 
formation, but the signal disappeared in less than 1.5h; group 5, GFP signal persisted 
longer than all the above mentioned situations.  
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Autophagy is a lysosome-mediated process of bulk cytoplasmic degradation 
through which long-lived proteins, organelles, and other components of the cytoplasm 
are engulfed within autophagosomes, the hallmark of autophagic cell death. In contrast 
to apoptotic cell death, cells that die with an autophagic cell death digest their own 
contents without the aid of engulfing phagocytes. Under starvation conditions, 
eukaryotic cells recover nutrients via autophagy. In addition to survival of starvation, 
autophagy has been implicated in many aspects of health and development, such as 
pathogen infection, cancer, and cell growth (Scott et al., 2007). Several lines of 
evidence prompted me to hypothesize that CycY is involved in an autophagy signaling 
pathway. First, CycY and several autophagy genes have been associated with human 
Crohn’s disease, a complex inflammatory disease involving the small intestine affected 
by over 30 genetic loci (Barrett et al., 2008). Human CycY (CCNY) and the autophagy 
gene, ATG16L1 and IRGM, were identified as susceptibility factors for Crohn’s disease 
(Franke et al., 2008; Mizushima et al., 2003; Parkes et al., 2007; Weersma et al., 2009), 
suggesting that they may be involved in a common pathway. Second, autophagy is an 
important mechanism for eliminating obsolete larval tissues during Drosophila 
metamorphosis, a period when CycY is essential. Third, Snr1, a potential target of CycY 
(see Chapter 3), promotes the expression of autophagy genes (Zraly et al., 2006). To 
test whether CycY is involved in the autophagic response, I dissected well-fed and 
starved early L3 larvae of CycYE8 heterozygous and homozygous mutants and stained 
the fat body tissue with LysoTracker Red, a lysosome-specific fluorescent dye, to detect 
the presence of the autophagic response. As shown in Figure 4-2, in CycYE8 
heterozygotes mutants, this response is induced by starvation in the fat body, as
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Figure 4-2. CycY loss-of-function mutants show normal starvation induced 
autophagic effects during early L3 stage. Fat bodies from well-fed (A and C) or 
starved (B and D) early L3 of CycYE8 heterozygotes (A-B) or homozygotes (C-D) were 
stained with LysoTracker (Red) and Hoechst 33342 (Blue). Fat bodies from starved 
larvae in both samples show induced autophagy as indicated by the appearance of 
lysosome staining. 
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expected (Figure 4-2B). Homozygous CycYE8 mutants showed a similar strong 
autophagic response under starvation conditions, indicating that CycY is not required for 
autophagy, at least not during the early L3 developmental stage (Figure 4-2D). Whether 
CycY is required for autophagic response during other developmental stages requires 
further investigation. 
Autophagy is known to be inhibited by TOR (target of rapamycin) signaling and 
Atg5 and TOR double mutants show a strong genetic enhancement of larval growth 
defects (Scott et al., 2004). To test whether CycY is involved in the autophagic 
response using an independent approach, I generated CycY/Atg1 and CycY/TOR 
double mutants to look for genetic interactions. However, I was unable to detect any 
genetic interactions between CycY and Atg1 or CycY and TOR. The larval size of 
CycY/Atg1 double mutants (CycYE8; Atg1Δ3D) is similar to that of Atg1Δ3D single mutants. 
The same is true when comparing the larval size of CycY/TOR double mutants (TORΔ6B; 
Tub-Gal4/CycYiC1) to that of TORΔ6B single mutants (see Chapter 3 for details about 
CycYiC1, a CycY knockdown transgene). Taken together, I did not detect any genetic 
interaction between CycY and Atg1 or TOR as far as the phenotypes I checked. 
 
4.3.4 The CycY expression pattern  
Revealing the tissue expression pattern and subcellular localization of the CycY 
protein in vivo may provide clues about its biological functions. To this end, I first 
generated antibodies directed at a CycY peptide (see Materials and Methods) and 
tested the crude serum by western blot and immunostaining. However, the crude serum 
turned out to have high background and low sensitivity. Only high levels of exogenous 
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expression from a transgene could be detected, but endogenous expression could not 
be detected. I then tried affinity purification, but the affinity purified CycY antibody did 
not perform better than the crude serum. In short, the CycY antibody generated from 
guinea pig with a small peptide as antigen was not useful for this study. A better way to 
generate CycY antibodies in the future may be to immunize rabbits with purified MBP-
nCycY and purify the rabbit serum, which will be available in larger quantities than 
serum from a guinea pig, with MBP-nCycY-coupled to beads (e.g., Affi-Gel 15).  
To determine the CycY mRNA expression pattern, I tried RNA in situ 
hybridization. I synthesized two CycY probes and used them for RNA in situ 
hybridization (see Materials and Methods) of wild type and CycYE8 mutant embryos and 
imaginal discs. Unfortunately, I did not detect any difference between the staining 
patterns in wild type and CycYE8 mutants in either embryos or imaginal discs. This 
suggested that the probes do not specifically recognize CycY. Use of additional 
nonoverlapping probes in the future may overcome this problem. 
An alternative approach to using antibodies to determine protein expression 
patterns is to use transgenes that express tagged proteins. Such an approach should 
be feasible for CycY. I have generated a CycY genomic transgene that can fully rescue 
the CycYE8 null mutant to the adult stage (Chapter 2, section 2.3.3), suggesting that it 
may mimic the endogenous CycY function and expression pattern. This CycY genomic 
transgene includes the entire CycY gene and putative regulatory regions flanking the 
transcript, including sequences 4,032 bp upstream of the CycY start codon, and 1,970 
bp downstream of the stop codon, and none of the coding regions of crol or Pde1c 
(Chapter 2, section 2.2.2). On the basis of this vector (pCaSpeR2-CycY, Finley lab # 
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977), a C-terminal GFP-tagged CycY genomic vector could be generated by regular 
molecular cloning approaches. For example, there are two unique restriction enzyme 
digestion sites upstream and downstream of the CycY TGA stop codon, AvrII and MfeI 
respectively. By regular PCR, three fragments can be amplified, from AvrII to the last 
codon of CycY, ORF of GFP tag, and from CycY stop codon TGA to MfeI genomic 
region. By including suitable restriction enzyme digestion sites at each end of the PCR 
products, these three fragments could be sequentially cloned into a cloning vector. PCR 
of the three ligated fragments would generate a fragment that could replace the original 
AvrII/MfeI fragment in pCaSpeR2-CycY by gap repair or by restriction digestion and 
ligation. In this modified vector, a C-terminal GFP tag would be added just in front of the 
CycY TGA stop codon. Transgenic flies could then be generated and used to determine 
the spatial, temporal expression pattern, and subcellular localization of CycY by 
following GFP fluorescence signal. 
 
4.3.5 Subcellular localization of a complementing myc-CycY fusion protein 
Two recent publications about human CycY (CCNY) in cultured cells 
independently concluded that the N-terminus of CycY has a myristoylation signal, which 
anchors the protein to the cell membrane. Mutation of the putative myristoylation site, 
glycine 2, to an alanine abolished membrane localization in cultured cells, as did fusion 
to N-terminal tags such as GFP or HA. Forced expression of CycY resulted in 
relocalization of GFP-PFTK1 from the cytoplasm to the plasma membrane, indicating 
that this cyclin is capable of recruiting the Cdk to the membrane (Davidson et al., 2009; 
Jiang et al., 2009). The presence of a myristoylation signal and the localization of CycY 
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to the plasma membrane make it likely that CycY functions at least in part by localizing 
Cdk activity to the plasma membrane to direct phosphorylation of membrane-associated 
substrates. One such substrate identified by Davidson et al is LRP6, a Wnt co-receptor 
(Davidson et al., 2009). Their data suggest that phosphorylation of LRP6 by 
CycY/PFTK1 primes the subsequent Wnt-dependant phosphorylation and hence 
activates the Wnt signaling pathway. They showed that mutation of the myristoylation 
signal of CycY decreased the PFTK1-dependent phosphorylation of LRP6. The 
potential importance of the membrane localization and myristoylation of CycY function 
in human cells raises the question of whether it is also important in Drosophila. Due to 
the lack of a good anti-CycY antibody, I tested the subcellular localization of an N-
terminally myc-tagged CycY expressed in Drosophila S2R+ cells. Consistent with the 
data with human cells, in Drosophila cells CycY with an N-terminal myc tag is mainly 
localized in the cytoplasm, as is myc-Eip63E (Figure 4-3). I surmise that the N-terminal 
myc tag is blocking membrane localization; however, I have not tried a C-terminally 
tagged CycY to verify that the lack of an N-terminal tag would result in membrane 
localization. This experiment should be done to see where native CycY localizes. In the 
meantime, results with the myc-tagged CycY suggest that membrane localization may 
not be very important for in vivo function. Evidence for this comes from 
complementation studies I conducted with myc-CycY. I generated transgenic flies 
expressing myc-tagged CycY from a cDNA, under control of either UAS or the heat 
shock promoter. Myc-CycY expressed from the heat shock promoter or using a 
ubiquitous Gal4 driver line rescued CycYE8 null mutants to the adult stage, suggesting 
that myc-CycY has no obvious functional defects, at least in Drosophila. Combined with
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Figure 4-3. The subcellular localization of N-terminal myc-tagged CycY and 
Eip63E. Drosophila S2R+ cells expressing myc-CycY (A-C) or myc-Eip63E (D-F) were 
stained with myc Ab (green, A and D) and DAPI (blue, B and E). 
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the fact that N-terminal tags can disrupt membrane localization and we observed no 
membrane localization for myc-CycY, these data suggests that membrane anchoring is 
not important for CycY function in Drosophila. Alternatively, overexpression of myc-
CycY in vivo may bypass the requirement for membrane localization. Further analysis of 
the requirement for a myristoylation signal in vivo will be required to resolve this 
question. 
 The cytoplasmic localization and full rescue ability of myc-CycY bring up more 
interesting questions. Does CycY/Eip63E complex also have an active role in Wg 
signaling transduction in Drosophila as in human and Drosophila cells? Is the 
membrane localization of CycY essential to fulfill this function in Drosophila? How does 
loss of CycY in vivo influence Wg signaling? If the membrane-anchored CycY is 
essential for Wg signaling transduction, then can we explain the full rescue ability of 
myc-CycY? One possibility is that a small amount of myc-CycY is anchored to the 
membrane and this is sufficient for LRP6 phosphorylation and Wg pathway function in 
vivo. Another possibility is that there are other redundant cyclins to replace CycY at 
least for phosphorylation of arrow/LRP6 or that this phosphorylation can be fulfilled by 
other known arrow/LRP6 kinase, sgg/GSK3, in vivo. Finally, it is possible that 
arrow/LRP6 phosphorylation by a CycY kinase is only one of several CycY functions 
and that it is not essential for viability. To distinguish these possibilities and to gain a 
better understanding of the importance of membrane localization for in vivo CycY 
function, the generation of CycYM2A mutant transgenic flies seems necessary. 
It is interesting to note that the N-terminally truncated isoform of human CycY, 
which lacks the myristoylation signal, has been shown to be predominantly localized in 
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the nucleus. It has also been shown to activate the transcriptional activities of c-Myc (Li 
et al., 2009), which is one of the downstream regulatory targets of Wnt/β-catenin 
signaling (He et al., 1998). Does this suggest that the short isoform of CycY, which is 
not a membrane anchored protein, also regulates Wnt signaling by phosphorylating 
LRP6? Alternatively, it is possible that the short isoform of CycY functions in the nucleus 
to modulate the transcriptional activities of myc.  
 
4.3.6 The CycY/Eip63E complexes expressed in Drosophila cells is unable to 
phosphorylate Snr1 in vitro 
Since Snr1 physically interacts with CycY in vitro and the molecular function of 
the cyclin/Cdk complexes is to phosphorylate downstream targets, a simple hypothesis 
to explain the genetic interaction between CycY and the Brm complex is that Snr1 is the 
substrate of CycY/Eip63E. To test this hypothesis, I expressed and purified MBP-Snr1, 
MBP-Snr1 T102A, MBP-Snr1 T198A, and MBP-Snr1 T102/198A fusion proteins from 
E.coli and used them as substrates for in vitro kinase assays using CycY/Eip63E 
expressed in Drosophila S2R+ cells. I expressed myc-tagged CycY, Eip63E, or both 
and various controls, then affinity purified the tagged fusion proteins and used them for 
in vitro kinase assays as previously described (Kolonin and Finley, 2000) (Guest et al. in 
prep.). The results provided no evidence for specific phosphorylation of Snr1 by 
CycY/Eip63E (Figure 4-4). Although MBP-Snr1 appeared to be more strongly 
phosphorylated by purified myc-Eip63E than by the control (lane 2 vs. lane 9), the signal 
was the same with the myc-Eip63E kinase-dead mutant (lane 2 vs. lane 4). Moreover, 
Snr1 phosphorylation was not strengthened in the presence of CycY (lane 2 vs. lane 6). 
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Figure 4-4. The CycY/Eip63E complex is unable to phosphorylate Snr1 in vitro. 
Drosophila S2R+ cells were cotransfected with the indicated constructs and lysed for 
pull down with myc antibody. γ32P [ATP] was added along with maltose binding protein 
(MBP) fusion proteins purified from E.coli expression as indicated to each 
immunoprecipitate as in vitro substrates. Both lane 8 and 9 are negative controls. Lane 
8 had no immunoprecipitate, while lane 9 had anti-myc immunoprecipitate from 
untransfected cells. 
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These results indicate that MBP-Snr1 is weakly phosphorylated by a kinase that co-
immunoprecipitates with myc-Eip63E. The relatively weak phosphorylation signal from 
MBP-Snr1 T102/198A suggests that threonine 102 or 198 are among the 
phosphorylation sites (lane 6 vs. lane 7).  
One possible explanation for our failure to detect Snr1 phosphorylation by 
CycY/Eip63E is that some coactivators of the Eip63E kinase may be missing from the 
cultured cells or the immunoprecipitates. For example PIF-1B is an Eip63E-interacting 
protein that has been proposed to counter the inhibitory effect of the long N-terminal 
extension of Eip63E (Rascle et al., 2003). We do not know whether PIF-1B is expressed 
in the S2R+ cells. Another possible explanation for the kinase assay results is that Snr1 
may not be a direct substrate of CycY/Eip63E and may function as a bridge to bring 
CycY/Eip63E to the vicinity of the Brm multi-protein complex to phosphorylate other 
components. The possible CycY-dependent phosphorylation of other components in the 
Brm complex should be tested in the future. 
 
4.3.7 CycYE8 null mutant clones do not show defective cell growth or proliferation 
in third instar larvae imaginal discs and fat bodies compared to wild type sister 
clones 
Genetic mosaic techniques provide a way to examine a lethal homozygous 
mutation in just a subset of cells in vivo. To look for developmental defects associated 
with loss of CycY from sets of cells, I generated CycYE8 null clones either specifically in 
the eye with ey-FLP or in all developing tissues with hs-FLP by FRT-mediated mitotic 
recombination (Xu and Rubin, 1993). Consistent with the normal eye of CycYE8 adult 
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escapers or pharate adults (Liu and Finley Jr, 2010), the eye of the adults with CycYE8 
null clones also look normal (data not shown). To check the CycYE8 null clones induced 
by ubiquitous FLP, third instar larvae with yellow mouth hooks (y1w* hs-FLP; CycYE8 
FRT40A/Ubi-GFP FRT40A) were dissected. The GFP+ cells (CycYE8/Ubi-GFP or Ubi-
GFP/Ubi-GFP) and the GFP- cells (CycYE8) from the imaginal discs and fat bodies were 
compared. Surprisingly, I did not find any defective cell growth or proliferation when 
comparing the size of CycYE8 null clones with sister twin clones or the individual cell 
size of CycYE8 null and wild type (Figure 4-5 A-R). In addition, after staining for 
phosphorylated histone H3 (PH3) to visualize cells undergoing mitosis, I observed no 
obvious difference between wild type and CycYE8 null clones (Figure 4-5 S-U). I also did 
not detect any adult morphological defects. These results are unexpected and hard to 
explain considering that zygotic CycYE8 null mutants had delayed larval growth (delayed 
13 hours compared with the heterozygous control animals), small sized pupae (90% 
compared with the heterozygous control), and pupal lethality (Chapter 2, section 2.3.3). 
One possible explanation is that both the delayed larval growth and the decreased 
pupal size phenotypes are not very strong, therefore the mild difference between 
CycYE8 null clones and wild-type sister twin clones is not easily appreciated. Another 
possibility is that these CycYE8 null clones were formed during larval development and 
the CycY proteins synthesized before the null clone formation lasted long enough 
beyond the identification of any visible effect. 
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Figure 4-5. CycYE8 null mutant clones do not show defective cell growth or proliferation in third 
instar larvae imaginal discs and fat bodies. Third instar larvae with yellow mouth hooks (y1w* hs-FLP; 
CycYE8 FRT40A/Ubi-GFP FRT40A) were dissected and stained with DAPI (blue). CycYE8 null clones are 
GFP negative. Representative wing imaginal discs (A-I, S-U), eye imaginal disc (J-L), and fat bodies (M-
R) are shown. White dotted line circles the CycYE8 null clones in the wing imaginal disc (S-U). The 
existence of CycYE8 null clones suggests that absence of CycY is not cell lethal. 
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4.4 Conclusions 
In this chapter, I showed that CycY does not genetically modify the hatching rate 
defect associated with Eip63E81 allele, which neither supports nor weakens my 
hypothesis that CycY and Eip63E form an in vivo cyclin Cdk pair. I also showed that 
CycY null mutants display normal starvation induced autophagic effects during the early 
third instar larval stage. Mosaic analysis of CycY null clones did not reveal any defective 
cell growth or proliferation in third instar larvae imaginal discs and fat bodies compared 
to wild type sister clones. Interestingly the process of glue extrusion, which is regulated 
by ecdysone, is misregulated in the CycY mutant. This developmental process could be 
used in the future to help elucidate the signaling pathways to which CycY belongs. Due 
our failure to generate high-quality CycY antibodies and to the non-specific RNA in situ 
hybridization, I was unable to determine the endogenous CycY protein or mRNA 
localization. However, consistent with studies with human cells, I showed that CycY with 
an N-terminal myc tag is mainly localized in the cytoplasm. Intriguingly, this version of 
CycY successfully rescued the CycYE8 null mutant to the adult stage, raising the 
questions of the importance of the membrane localization of CycY and of its role in Wg 
signaling in vivo. Finally, in vitro kinase assays suggest that Snr1 may not be a direct 
phosphorylation target of the CycY/Eip63E complex. This result suggests that Snr1 may 
function as a bridge to bring CycY/Eip63E to the vicinity of the Brm complex to 
phosphorylate other components and therefore regulate the Brm complex activity. 
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CHAPTER 5 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
5.1 CONCLUSIONS 
In this dissertation, I described the characterization of a novel conserved cyclin 
CG14939 (CycY) in Drosophila. I generated the first mutant animal model for this gene 
as well as transgenic RNAi strains that can be used to specifically knock down the 
expression of CycY in a temporally and spatially controlled manner. I provided multiple 
lines of evidence showing that the Cdk partner of CycY is Eip63E (Cdk14). I also 
showed that CycY is an essential gene that is required from oogenesis to adult viability. 
Finally, I demonstrated the physical and genetic interaction between CycY and 
components of Brm complexes from several different aspects. Here I summarize some 
of the major findings and implications. 
 
5.1.1 CycYE8 is a null mutant allele of CycY 
Using P-element imprecise excision, I created a CycY null mutant allele, CycYE8, 
which lacks all CycY coding sequences. Multiple lines of evidence indicate that CycY is 
the only gene affected in strain CycYE8. First, the two neighboring genes, crol and 
Pde1c, are expressed in homozygous CycYE8 larvae, in contrast to CycY. Second, 
CycYE8 and crol04418, a lethal null allele of the neighboring gene, mutually 
complemented the mutant phenotypes of each other, suggesting that crol is fully 
functional in CycYE8. Third, transheterozygous mutants of CycYE8 over a deficiency 
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strain that lacks CycY (Df(2L)Exel6030), display similar developmental defects to the 
homozygous CycYE8 mutants. Fourth and definitively, a CycY genomic transgene or 
ubiquitous expression of a CycY cDNA can substantially rescue most of the 
abnormalities that I observed in homozygous CycYE8 mutants, including the delayed 
larval growth, defects during metamorphosis, and adult viability. However, I have not yet 
tested whether the CycYE8 oogenesis defect and embryonic lethality can be rescued 
with CycY transgene, so it is formally possible that a second site mutation may partially 
or fully contribute to these. A rescue experiment using the maternal and zygotic CycYE8 
null mutants will be necessary for any future study of the early developmental 
requirement of CycY. The CycYE8 mutant strain provides a powerful tool for further 
functional characterization of CycY in Drosophila.  
 
5.1.2 CycYiC can be used to specifically knock down the expression of CycY 
In this project, I generated multiple transgenic fly strains for each of two non-
overlapping RNAi constructs, CycYiN and CycYiC. Multiple lines of evidence suggest 
that CycYiC can be used to specifically knock down the expression of CycY. Expression 
of CycYiC with the en-Gal4 driver led to decreased wing size in the posterior 
compartment where CycY expression is reduced compared with the anterior region with 
wild-type CycY expression. This decreased wing size phenotype can be partially 
rescued by expression of a CycY cDNA, suggesting that the observed phenotype was 
due to decreased expression of CycY and not an off-target effect. Expression of CycYiC 
with the 69B-Gal4 driver induced extra wing vein tissue, which can be fully rescued by 
expression of a CycY cDNA, again indicating a CycY-specific knockdown effect. A final 
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piece of evidence for the specific knockdown ability of CycYiC comes from the genetic 
interaction data. Using the 69B-Gal4 driver to knock down Brm resulted in no obvious 
defects. However, combining Brm knockdown with either CycYiC or the removal of one 
copy of wild-type CycY led to a novel wing phenotype, suggesting not only a genetic 
interaction between Brm and CycY, but also the specificity of the CycY knockdown. 
Combined, these results suggest that CycYiC specifically knocks down the expression of 
CycY. The fly strains harboring the CycYiC transgene will be very useful in future studies 
to test for tissue specific requirements of CycY and to help identify the signaling 
pathways to which CycY may belong. For each new phenotype detected with CycYiC, a 
test for specificity should be conducted. For example, the CycYiC phenotype should be 
tested to see if it is enhanced by CycYE8 or suppressed by a CycY cDNA. 
 
5.1.3 The Cdk partner of CycY is Eip63E/PFTK1/Cdk14 
A potential Cdk partner for CycY was first identified in a large-scale yeast two-
hybrid screen with Drosophila proteins (Stanyon et al., 2004). The identified kinase was 
Eip63E, which previously had no known cyclin partner (Rascle et al., 2003; Stowers et 
al., 2000). I demonstrated that CycY and Eip63E specifically interact when expressed 
with N-terminal affinity tags in Drosophila S2R+ cells. However, due to the lack of 
antibodies to either CycY or Eip63E, I was unable to perform in vivo pull-down assays to 
test whether they are bona fide in vivo partners. Nevertheless, several additional lines of 
evidence support this conclusion. If Eip63E and CycY form a functional Cdk/cyclin 
complex in vivo, we might expect their mutant phenotypes to be similar. Therefore I 
performed a detailed side-by-side phenotypic characterization of CycY and Eip63E null 
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mutants and showed that they are strikingly similar. Further supporting evidence that 
CycY regulates Eip63E comes from studies in human cells. The human ortholog of 
Eip63E is PFTK1. Two recent publications about human CycY (CCNY) in cultured cells 
independently demonstrated the PFTK1/CycY interaction by co-AP assays and showed 
that membrane-anchored CycY recruits cytoplasmic PFTK1 to the membrane (Davidson 
et al., 2009; Jiang et al., 2009). Davidson et al further showed that Wnt co-receptor 
LRP6 is a membrane-associated phosphorylation target of the CycY/PFTK1 complex 
(Davidson et al., 2009). 
An additional argument for the Cdk14/CycY partnership comes from examination 
of sequence conservation. Cyclin proteins are present in non-metazoans but they do not 
share any extensive sequence similarity to CycY. Some of the non-metazoan cyclin 
proteins, however, do possess a CycY-specific cyclin box (Liu and Finley Jr, 2010). This 
domain is similar to the CDK-binding domain in other cyclins but it appears to have 
emerged in a common ancestor of plants and animals. The Y–type cyclin box in yeast 
or plant cyclins, for example, is more similar to the same domain in human and 
Drosophila CycY than to the other yeast or plant cyclin boxes, suggesting that this 
domain is ancient and has been conserved independently of the other cyclins over 500 
million years of evolution. A specific example of this conservation can be seen in the 
yeast cyclin PCL1. This protein is the reciprocal best-matched protein for both human 
and Drosophila CycY; this means that PCL1 is the yeast protein most similar to human 
or Drosophila CycY, which are in turn the human and Drosophila proteins most similar 
to PCL1. Essentially all of this sequence similarity resides in the CycY-specific cyclin 
box. The Cdk partner for PCL1 is Pho85, which has a number of cyclin regulators and 
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plays diverse roles in yeast (Huang et al., 2007). In the context of establishing the Cdk 
partner for CycY, it is interesting to note that the reciprocal best-matched protein for 
Pho85 in human and Drosophila is PFTK1 and Eip63E, respectively. This raises the 
intriguing possibility that this particular cyclin-Cdk interaction is ancient and may have 
novel properties that distinguish it from other cyclin-Cdk pairs. Taken together, these 
data suggest that CycY and Cdk14 constitute a conserved cyclin-Cdk pair. 
 
5.1.4 CycY is required from oogenesis to adult life 
A thorough characterization of CycYE8 null mutant phenotypes revealed that 
CycY plays an essential role during almost all developmental stages. The CycYE8 
zygotic null mutant is lethal with most mutant animals arresting during pupal 
development. The mutant exhibited delayed larval growth and major developmental 
defects during metamorphosis, including impaired gas bubble translocation, head 
eversion, leg elongation, and adult tissue growth. Heat-shock-induced expression of 
CycY at different times during development resulted in variable levels of rescue, the 
timing of which suggests a key function for zygotic CycY during the transition from third 
instar larvae to prepupae. I further took advantage of the availability of the heat-shock 
rescued CycYE8 mutant adults and found that CycY is required for adult longevity, 
especially in males. Using the ovoD1 dominant female sterile technique, I revealed that 
maternal CycY also plays a role during oogenesis and is required for embryogenesis; 
interestingly, this role can be accomplished at least to a limited extent by zygotic 
expression.  
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By testing the tissue specific knockdown of CycY and genetic interaction 
between CycY and Brm complex components, I was able to show a few tissue specific 
requirements of CycY. Knockdown of CycY with en-Gal4 and 69B-Gal4 drivers revealed 
that CycY is involved in wing growth and wing vein development. Removal of one copy 
of CycY enhanced the abdominal dorsal midline fusion defect associated with Snr1 
mutants, suggesting a role of CycY in the development of the integument of the adult 
abdomen. The identification of the tissue- and developmental stage-specific 
requirements of CycY provides a platform through which the biological functions of 
CycY can be further elucidated. 
 
5.1.5 CycY genetically and physically interacts with components of the Brm 
complex and is involved in regulation of Brm complex target genes 
To gain insight into the cellular functions of CycY and to identify the signaling 
pathways to which CycY belongs, I began by examining the available protein interaction 
data for CycY and Cdk14. Among all the identified and predicted physical interactors, 
Snr1 shares similar developmental requirements and expression profiles with CycY. To 
test whether CycY and Snr1 belong to a common signaling pathway, I first confirmed 
the physical interaction between CycY and Snr1 by co-AP assay from cultured cells. I 
further showed that CycY and two Brm complex components, Snr1 and Brm, genetically 
interact during multiple developmental processes. For example, removal of one copy of 
CycY enhances the adult longevity and dorsal midline fusion defects induced by 
expression of truncated Snr1 in the heterozygous Snr1 null background. Knockdown of 
CycY in the wing enhances the extra wing vein phenotype induced by Snr1 knockdown, 
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as well as the wing phenotype induced by Brm knockdown or overexpression of a Brm 
dominant negative mutant. The genetic interaction between CycY and members of the 
Brm complex, combined with the physical interaction between CycY and Snr1, suggests 
that CycY may promote Snr1 functions in the Brm complex to regulate gene expression 
in a cell-type specific manner. The examination of gene expression of a group of Brm 
complex targets, the Eig71E genes, however, suggested that CycY and Snr1 may also 
regulate gene expression differentially in a temporal-specific manner. This led to a 
model in which CycY promotes the activity of Snr1, which can either activate or repress 
transcription of specific genes depending on the time and tissue (Fig. 3-10). 
This is the first identification of a signaling pathway in which CycY may be 
involved in Drosophila. It helps explain some of the developmental defects that CycY 
null mutants displayed. However, whether the genetic interactions I observed are due to 
direct regulation of Brm complex activity by CycY or due to a function of CycY in a 
parallel signaling pathway is still unclear. My hypothesis is based on the assumption 
that CycY physically interacts with Snr1. However, I was unable to test this putative 
interaction in vivo due to lack of antibodies. Furthermore, I failed to show that Snr1 is a 
direct phosphorylation target of CycY/Cdk14 complex in vitro. The identification of the 
involvement of CycY in Wnt signaling in cultured human and Drosophila cells also 
suggested another way to interpret the genetic interaction between CycY and Snr1/Brm 
(see section 5.2.1). Testing for in vivo interactions between CycY and other Brm 
complex components may help clarify these issues. 
 
5.1.6 Model for CycY function 
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Based on data from this study and from others, I propose the following model for 
CycY functions (Figure 5-1). CycY may have different subcellular localizations that 
recruit Cdk14 to the vicinity of different substrates. Cytoplasmic or nuclear CycY/Cdk14 
complexes may phosphorylate Snr1 or other components of the Brm complex to 
regulate genes required at many developmental stages, including metamorphosis. 
Membrane-anchored CycY may recruit Cdk14 to phosphorylate membrane substrates, 
such as the Wg co-receptor Arrow. The phosphorylation of Arrow activates Wg 
signaling, which in turn regulates cell proliferation, differentiation, and pattern formation 
in a variety of developmental contexts. Although each of the two putative CycY/Cdk14 
substrates, Brm complex components and Arrow, could help explain some of the 
phenotypes of CycY mutants, neither of them has been confirmed to be a bona fide in 
vivo substrate. Even the partnership of CycY and Cdk14 has not been definitively 
determined in vivo. Thus further studies to identify the precise in vivo Cdk binding 
partner and substrates are required. 
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Figure 5-1. Model for CycY function. CycY may have different subcellular 
localizations that recruit Cdk14 to the vicinity of different substrates. Cytoplasmic or 
nuclear CycY/Cdk14 complexes may phosphorylate Snr1 or other components of the 
Brm complex to regulate genes required at many developmental stages. The regulation 
of Eig71E genes, for example, may partially contribute to the regulation of 
metamorphosis. CycY can also be tethered to the plasma membrane (PM) via an N-
terminal myristoylation signal. CycY recruits Cdk14 to the membrane where it 
phosphorylates the Wg co-receptor, Arrow, primarily during G2/M phase of the cell 
cycle. The phosphorylation of Arrow activates Wg signaling, which in turn regulates cell 
proliferation, differentiation, and pattern formation in a variety of developmental 
contexts. The Brm complex has been directly linked with Wg signaling through inhibition 
the expression of Wg targets. Other substrates and roles for CycY/Cdk14 have yet to be 
identified. 
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5.2 FUTURE DIRECTIONS 
Data presented in this dissertation represent an initial functional characterization 
of CycY. Many interesting CycY mutant defects were identified and described. The 
potential Cdk interacting partner and potential downstream regulatory targets were also 
revealed. However, the molecular mechanisms behind the role of CycY during these 
developmental processes are still to be elucidated. The following questions must be 
addressed to gain a better understanding of CycY functions. 
 
5.2.1 Does CycY/Eip63E play a role in Wg signaling in Drosophila? 
It has been reported recently that in both human and Drosophila cultured cells, 
membrane-anchored CycY recruits its Cdk partner, Cdk14, to the cell membrane to 
phosphorylate a membrane substrate, the Wnt/Wg co-receptor LRP6/Arrow. This was 
proposed to prime subsequent phosphorylation of LRP6 by CK1γ and thereby activate 
canonical Wnt signaling (Davidson et al., 2009; Jiang et al., 2009). However, this 
pathway has not been tested in vivo in Drosophila. Moreover, the phenotypes of CycY 
mutants are not typical of Wg pathway mutants. In Chapter 2 and Chapter 3, I showed 
that CycY is required for embryogenesis, larval growth, metamorphosis, and adult 
viability. Thus, it seems likely that at least some of the CycY phenotypes are due to 
defects in signaling pathways that are independent of Wg signals. 
Further genetic analysis will be necessary to test whether CycY/Eip63E is 
involved in Wg signaling in vivo. The tools generated in this study will be useful for this 
genetic analysis. For example, a well-known defect of Wg signaling pathway mutants is 
disrupted segmental patterning. The Drosophila embryonic ventral epidermis is 
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composed of two types of epidermal cells, denticle-secreting cells, which create short, 
thick hair-like structures, and smooth cuticle-secreting cells. Denticle-secreting cells 
form segmentally repeated belts separated by smooth-cuticle belts, the pattern of which 
is determined by the activation of several signaling pathways during embryogenesis, 
including Wg, Hedgehog, EGF, and Notch signaling pathways (Alexandre et al., 1999; 
Gritzan et al., 1999). Wg signaling is active in smooth cuticle-secreting cells, while 
inactive in denticle-secreting cells. Therefore, mutants of positive regulators of Wg 
signaling, such as arrow, wls, and Wg, show ectopic denticles, while mutants of 
negative regulators, such as bili and sgg, show ectopic smooth cuticles (Banziger et al., 
2006; Bejsovec and Wieschaus, 1993; Kategaya et al., 2009; Siegfried et al., 1992; 
Wehrli et al., 2000). Analyzing the ventral cuticle patterning, therefore, is a useful way to 
detect defects in Wg signaling (Alexandre, 2007). I have shown that a maternal and 
zygotic null of CycYE8 is embryonic lethal. However, no further analysis has been 
performed. The cuticle patterning deserves to be carefully examined in the future to see 
if CycY mutants display defects associated with disrupted Wg signaling. 
Another major morphological defect in mutants of Wg pathway components is the 
loss of wing or wing margin. For example, blocking Wg signaling at the wing margin by 
expressing a constitutively active form of Sgg causes a loss of the wing margin tissue 
(Collins and Treisman, 2000). Knocking down Wg or wls by dsRNA expressed under 
en-Gal4 control induces the loss of wing margin specifically in the posterior 
compartment of the wing (Boutros and Ahringer, 2008). Knockdown of CycY by en-
Gal4/RNAi, however, led to decreased wing size in the posterior region without 
generating a wing margin defect. This suggests that CycY has functions beyond Wg 
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signaling, even if it does regulate Wg signaling in some tissues. Further testing for 
genetic interactions between CycY and Wg signaling mutants should help establish 
whether and to what extent CycY plays a role in Wg signaling. 
I have shown that CycY genetically interacts with the Brm complex components, 
Snr1 and Brm. Interestingly, the Brm complex has been found to inhibit the expression 
of Wg targets (Collins and Treisman, 2000). This situation makes the interpretation of 
the genetic interactions between CycY, the Brm complex, and potential Wg pathway 
components difficult. The genetic interaction between CycY and the Brm complex, for 
example, could be explained by the action of CycY on the Brm complex or on the Wg 
pathway, or both. To distinguish these possibilities, the epistatic relationship between 
CycY, the Brm complex, and Wg targets should be investigated. If CycY functions in Wg 
signaling to regulate Wg target expression, it should be upstream of the Wg pathway 
transcription factor, β-catenin/Arm. If CycY functions through the Brm complex to 
indirectly regulate Wg target genes, it should be downstream of Arm. One can test the 
expression of Arm protein and Arm target genes, such as dll by utilizing a dll-LacZ fly 
strain, in CycY mutant to determine the epistatic relationship between them. 
  
5.2.2 What is the significance of the myristoylation signal and presumptive 
membrane localization to CycY function? 
Human CycY has been reported to have two isoforms, one with and one without 
the N-terminal myristoylation signal, which is required to anchor CycY to the cell 
membrane (Jiang et al., 2009; Li et al., 2009). The subcellular localization of 
endogenous Drosophila CycY has not been tested either in vitro or in vivo, although the 
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myristoylation signal does exist. Whether there is a non-membrane anchored isoform of 
Drosophila CycY has not been determined. To identify the existence of other isoforms of 
CycY, it will be useful to perform a Northern blot with a probe that recognizes the 3’ end 
of the CycY transcript. To test the subcellular localization of CycY in vivo, I have 
suggested in Chapter 4 (section 4.3.4) generation of transgenic flies with a CycY 
genomic transgene, into which a C-terminal GFP or myc tag should be inserted. The 
reason that a C-terminal tag must be used is that N-terminal tags block the 
myristoylation signal and the membrane localization in human CCNY. To test 
localization in vitro, similarly, CycY cDNA should be cloned into a cell culture expression 
vector with a C-terminal tag, for example pMK33-CTAP (Finley lab # 840).  
The N-terminal myristoylation signal of CycY has been shown to be crucial for 
recruiting Cdk14 to the membrane to phosphorylate LRP6 and activate Wnt signaling 
(Davidson et al., 2009). Is the membrane localization essential for all or part of the CycY 
functions in Drosophila? At this point, we do not know the subcellular localization of 
endogenous CycY, but consistent with data from human cells, an N-terminally tagged 
CycY localizes primarily to the cytoplasm. Interestingly, this form of CycY (myc-CycY) 
can successfully rescue the CycYE8 null mutant into the adult stage. This would seem to 
suggest that membrane localization and arrow phosphorylation are not necessary for 
CycY function in vivo. However, it is possible that a small fraction of myc-CycY spends 
some time attached to the membrane to recruit Cdk14 and phosphorylate arrow. It is 
also possible that the sgg kinase is sufficient to phosphorylate arrow in the absence of 
membrane-anchored CycY. To distinguish between these possibilities, I suggest 
generating transgenic flies that harbor genes to express either truncated CycY, which 
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lacks the N-terminal myristoylation signal, or a mutated CycY, CycYM2A, that should not 
localize to the membrane, and to test how well these flies rescue the CycYE8 null 
mutants. Such transgenic flies could also be used in genetic interaction assays with Wg 
pathway mutants to gain further insight into the relationship between CycY, membrane 
localization, and the Wg pathway. 
 
5.2.3 Is CycY involved in the chromatin modification mediated by the Brm 
complex? 
In this project, I identified genetic interactions suggesting that CycY and 
components of the Brm chromatin-remodeling complex function together to regulate 
multiple developmental processes. However, the molecular mechanisms that account 
for these interactions are still unknown. The physical interaction between CycY and 
Snr1 prompted me to hypothesize that CycY, together with its Cdk partner Cdk14, may 
phosphorylate Snr1 or other components of the Brm complex to regulate the activity of 
ATP-dependent chromatin remodeling. Several experiments could be used to test this 
hypothesis. First, one could test whether CycY interacts with other components of the 
Brm complex by Y2H or co-AP assays from fly cells. Ideally any interactions detected 
should be confirmed in vivo by pull-down assays; however, this will require antibodies 
against CycY and Brm complex components. Second, it would be helpful in 
understanding the function of the CycY-Snr1 interaction if one could refine the physical 
interaction between them. A mutagenic PCR approach could be used to identify a CycY 
mutant unable to interact with Snr1, but still able to interact with Eip63E. This mutant 
form of CycY could then be used to test how well it mimics wild type CycY. Third, it 
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would be useful to establish an in vitro assay system to test the influence of CycY on 
transcription of Brm complex targets. For example, stg transcription is directly regulated 
by the Brm complex in Drosophila S2 cells. Several questions should be addressed. For 
instance, how is the transcription of stg regulated in the absence of CycY? Does the 
Brm complex still bind to the stg promoter in the absence of CycY? These questions 
can be answered by doing RT-qPCR of stg and ChIP with Brm Ab.  
 
5.2.4 What other signaling pathways is CycY/Cdk14 complex involved in? 
The work described in this dissertation and from another group suggested that 
CycY may be involved in Brm-mediated chromatin remodeling (Chapter 3) and Wg 
signaling (Davidson et al., 2009). Considering the limited number of cellular kinases and 
the huge number of phosphorylation events in cells (de la Fuente van Bentem et al., 
2008), I hypothesis that CycY may be involved in other signaling pathways by 
phosphorylating other substrates. I base this hypothesis in part on the fact that CycY is 
required for a broad range of developmental processes that appears to exceed the 
range of processes that requires Wg and Brm complex. This hypothesis could be tested 
in several ways. One could identify other CycY interaction partners by TAP purification 
and LC-MS/MS by using Drosophila cell lines or transgenic flies that stably express C-
terminally TAP-tagged CycY. In addition, it would be very informative if one could 
identify in vivo CycY-dependant phosphorylation targets on a proteome-wide scale by 
quantitative MS (Smolka et al., 2005).  
 
5.2.5 Implications for understanding human diseases 
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It is intriguing that CycY has been connected with several intestine-related 
human diseases. Recently, CCNY was identified as a potential susceptibility factor for 
inflammatory bowel disease (IBD), a complicated genetic disorder affecting the 
intestinal mucosa. A single nucleotide polymorphism (SNP) located in an intron of 
CCNY was found to be strongly associated with the two IBD subphenotypes, Crohn’s 
disease and ulcerative colitis (Franke et al., 2008; Weersma et al., 2009). Another study 
found that human CycY is significantly upregulated in metastatic colorectal cancer cells 
(Ying-Tao et al., 2005). Davidson et al recently found that CycY binds to and activates 
Cdk14 to phosphorylate Wg/Wnt co-receptor LRP6/Arrow to activate Wg/Wnt signaling 
(Davidson et al., 2009). Interestingly, adenomatous polyposis coli (APC), a component 
of Wnt signaling pathway, is a tumor suppressor gene, which encodes a cytoplasmic 
protein that can bind to and promote the degradation of β-catenin. APC mutation is a 
common initiating factor in most human colorectal tumors (Kinzler and Vogelstein, 1996). 
Although CycY has been implicated in these human diseases, it is still unclear how 
CycY is involved. The generation of CycY null and tissue-specific knockdown animal 
models described in this dissertation provides valuable tools that may help us to further 
understand CycY’s cellular functions and potential roles in these human diseases. For 
example, we know that CycY is highly conserved between Drosophila and human, but 
we do not know whether they are functionally interchangeable. To test this, one could 
generate transgenic flies that harbor human CCNY to see whether CycYE8 null mutant 
phenotypes can be rescued. One SNP has been identified in an intron of CCNY in 
patients with IBD. However, the molecular consequence of this mutation has not been 
determined. Does this have any impact on the transcription or translation of CCNY? 
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Once this has been determined, further testing the behavior of CycY null mutant flies 
with CCNY mutant transgenes may shed some light on the mechanism of the 
inflammatory bowel disease.  
 
This study initiated an interesting discussion about the function of a novel 
conserved cyclin, CycY. The more I read, work, write, and think about it, the stronger I 
feel that there is much to be elucidated about CycY functions in the future.  
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APPENDICES 
 
Appendix A. Fly strains used in the study described in Chapter 2. 
Finely 
lab # 
Stock center & 
numbers Alias or genotypes References 
352 Bloomington 11374 crol04418 (D'Avino and Thummel, 1998) 
286 Bloomington 4513 Eip63E81 (Stowers et al., 2000)
9 Bloomington 3687 Df(3L)GN50 (Eip63EGN50) (Stowers et al., 2000)
232 Bloomington 7574 Df(3L)Exel6095 (Eip63EDf6095) - 
606 Bloomington 7575 Df(3L)Exel6096 (Eip63EDf6096) - 
103 Bloomington 3664 P{Δ2-3} (Robertson et al., 1988) 
422 Bloomington 2121 ovoD1 neoFRT40A (Chou et al., 1993) 
162 Bloomington 5138 Tubulin-Gal4 - 
197 Bloomington 7513 Df(2L)Exel6030 (CycYDf6030) this study 
208 Harvard Exelixis d03228 d03228 this study 
355 Bloomington 8403 FRT40A - 
358 Bloomington 1929 hs-FLP - 
12 Bloomington 4533 w; Sco/CyO Act5C-GFP - 
41 - w; CyO/Sp; TM3 Ser/Sb VanBerkum’s lab 
692 - w; CycYE8/CyO; TM3 Ser/Sb this study 
693 - w; CycYE8/CyO, Act5C-GFP this study 
702 - w; CycYE8 FRT40A/CyO this study 
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Appendix B. Plasmids used or constructed in the study described in Chapter 2. 
Plasmids 
Finely lab # Plasmids Alias Source or References 
289 pCaspeR2 (Thummel et al., 1988) 
977 pCaspeR2-CycY This study 
339 pCaspeR-hs (Thummel et al., 1988) 
1006 pCaspeR-hs-CycY This study 
966 pMT-Gal4 (Klueg et al., 2002) 
812 pAS1 (A. Soans, and R.L.F., unpublished) 
897 pAS1-CycY This study 
986 pAS1-CycY S389A This study 
985 pAS1-CycY S388/389A This study 
991 pAS1-Cyc39 S389E This study 
1000 pAS1-Cyc39 S388E This study 
961 pAS1-Eip63E This study 
1016 pAS1-Eip63E (B1, G243A) This study 
903 pAS1-Eip63E(B1, K234M) This study 
893 pAS1-β-tubulin This study 
904 pAS1-GFP This study 
894 pAS1-Cdk2 This study 
895 pAS1-Cdk4 This study 
896 pAS1-Cdk5 This study 
898 pAS1-koko This study 
899 pAS1-CycD This study 
900 pAS1-CycE This study 
901 pAS1-CycK This study 
902 pAS1-Dap This study 
905 pAS1-p35 This study 
841 pUAST-NTAP (Veraksa et al., 2005) 
844 pDL4 This study 
928 pDL4-CycY This study 
983 pDL4-CycY S388/389A This study 
984 pDL4-CycY S389A This study 
992 pDL4-CycY S389E This study 
999 pDL4-CycY S388E This study 
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933 pDL4-Eip63E This study 
934 pDL4-Eip63E G243A This study 
936 pDL4-Eip63E I249L This study 
937 pDL4-Eip63E (B1 K234M) This study 
924 pDL4-Cdc2rk This study 
925 pDL4-Cdk2 This study 
926 pDL4-Cdk4 This study 
927 pDL4-Cdk5 S. Guest and H. Zhang 
923 pDL4-β-tubulin This study 
938 pDL4-GFP This study 
931 pDL4-CycK This study 
930 pDL4-CycD This study 
929 pDL4-koko This study 
932 pDL4-Dap This study 
939 pDL4-p35 This study 
910 pDL2 This study 
914 pDL2-CycY This study 
919 pDL2-Eip63E (A1) This study 
911 pDL2-Cdc2rk This study 
912 pDL2-Cdk2 This study 
913 pDL2-Cdk4 This study 
915 pDL2-Koko This study 
916 pDL2-Cyclin D This study 
917 pDL2-Cyclin J This study 
918 pDL2-Cyclin K This study 
920 pDL2-Side This study 
921 pDL2-tinman This study 
922 pDL2-tintin This study 
969 pCeMM-NTAP (GS) (Burckstummer et al., 2006) 
975 pDL5 This study 
979 pDL5-CycY This study 
980 pDL5-Snr1 This study 
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Appendix C. Transgenic fly strains generated for the study described in Chapter 
2. 
Finley 
lab # Alias Genotypes 
Plasmids for P-element 
transformation 
Used in this 
study? 
636 2T1 UAS-CycY pAS1-CycY No 
637 2T11 w; UAS-CycY/CyO; TM3 Ser/Sb pAS1-CycY No 
638 2T35 w; CyO/Sp; UAS-CycY/TM3 Ser pAS1-CycY No 
639 2T44 w; CyO/Sp; UAS-CycY/TM3 Ser pAS1-CycY Yes 
640 2T46 w; CyO/Sp; UAS-CycY/TM3 Ser pAS1-CycY No 
642 2T44H w; CyO/Sp; UAS-CycY/UAS-CycY pAS1-CycY Yes 
643 2T46H w; CyO/Sp; UAS-CycY/UAS-CycY pAS1-CycY No 
655 3T1 P{CycY}; CyO/Sp; TM3 Ser/Sb pCaspeR2-CycY No 
656 3T2 P{CycY}; CyO/Sp; TM3 Ser/Sb pCaspeR2-CycY No 
657 3T11 w; P{CycY}/CyO; TM3 Ser/Sb pCaspeR2-CycY No 
658 3T12 w; P{CycY}/CyO; TM3 Ser/Sb pCaspeR2-CycY No 
659 3T13 w; P{CycY}/CyO; TM3 Ser/Sb pCaspeR2-CycY No 
660 3T21 w; CyO/Sp; P{CycY}/TM3 Ser pCaspeR2-CycY Yes 
661 3T22 w; CyO/Sp; P{CycY}/TM3 Ser pCaspeR2-CycY No 
662 3T27 w; CyO/Sp; P{CycY}/TM3 Ser pCaspeR2-CycY Yes 
663 4T1 hs-CyY; CyO/Sp; TM3 Ser/Sb pCaspeR-hs-CycY No 
664 4T11 w; hs-CycY/CyO; TM3 Ser/Sb pCaspeR-hs-CycY No 
665 4T12 w; hs-CycY/CyO; TM3 Ser/Sb pCaspeR-hs-CycY No 
666 4T13 w; hs-CycY/CyO; TM3 Ser/Sb pCaspeR-hs-CycY No 
667 4T21 w; CyO/Sp; hs-CycY/TM3 Ser pCaspeR-hs-CycY No 
668 4T22 (G6.1) w; CyO/Sp; hs-CycY/TM3 Ser pCaspeR-hs-CycY Yes 
669 4T23 w; CyO/Sp; hs-CycY/TM3 Ser pCaspeR-hs-CycY No 
699 E8;G6.1/G6.1 w; CycYE8/CyO; hs-CycY/hs-CycY pCaspeR-hs-CycY Yes 
700 E8;G6.1/Ser w; CycYE8/CyO; hs-CycY/TM3 Ser pCaspeR-hs-CycY Yes 
670 5T1-1 UAS-Eip63E; CyO/Sp; TM3 Ser/Sb pAS1-Eip63E No 
671 5T1-2 UAS-Eip63E; CyO/Sp; TM3 Ser/Sb pAS1-Eip63E No 
672 5T11 w; UAS-Eip63E/CyO; TM3 Ser/Sb pAS1-Eip63E No 
673 5T12 w; UAS-Eip63E/CyO; TM3 Ser/Sb pAS1-Eip63E No 
674 5T21 w; CyO/Sp; UAS-Eip63E/TM3 Ser pAS1-Eip63E No 
675 5T22 w; CyO/Sp; UAS-Eip63E/TM3 Ser pAS1-Eip63E No 
676 5T23 w; CyO/Sp; UAS-Eip63E/TM3 Ser pAS1-Eip63E No 
677 5T24 w; CyO/Sp; UAS-Eip63E/TM3 Ser pAS1-Eip63E No 
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678 6T1 UAS-Eip63E G243A; CyO/Sp; TM3 Ser/Sb pAS1-Eip63E (G243A) No 
679 6T2 UAS-Eip63E G243A; CyO/Sp; TM3 Ser/Sb pAS1-Eip63E (G243A) No 
680 6T3 UAS-Eip63E G243A; CyO/Sp; TM3 Ser/Sb pAS1-Eip63E (G243A) No 
681 6T4 UAS-Eip63E G243A; CyO/Sp; TM3 Ser/Sb pAS1-Eip63E (G243A) No 
682 6T11 w; CyO/UAS-Eip63E G243A; TM3 Ser/Sb pAS1-Eip63E (G243A) No 
683 6T12 w; CyO/UAS-Eip63E G243A; TM3 Ser/Sb pAS1-Eip63E (G243A) No 
684 6T13 w; CyO/UAS-Eip63E G243A; TM3 Ser/Sb pAS1-Eip63E (G243A) No 
685 6T14 w; CyO/UAS-Eip63E G243A; TM3 Ser/Sb pAS1-Eip63E (G243A) No 
686 6T15 w; CyO/UAS-Eip63E G243A; TM3 Ser/Sb pAS1-Eip63E (G243A) No 
687 6T21 w; CyO/Sp; UAS-Eip63E G243A/TM3 Ser pAS1-Eip63E (G243A) No 
688 6T22 w; CyO/Sp; UAS-Eip63E G243A/TM3 Ser pAS1-Eip63E (G243A) No 
689 6T23 w; CyO/Sp; UAS-Eip63E G243A/TM3 Ser pAS1-Eip63E (G243A) No 
690 6T24 w; CyO/Sp; UAS-Eip63E G243A/TM3 Ser pAS1-Eip63E (G243A) No 
691 6T25 w; CyO/Sp; UAS-Eip63E G243A/TM3 Ser pAS1-Eip63E (G243A) No 
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Appendix D. Primer pairs used to characterize the deletion after P-element mobilization. 
Primer pairs Region to be amplified 
DL20/DL17 Span the whole P-element inserted region 
DL44/DL17 The right end of the P-element 
DL45/DL20 The left end of the P-element 
DL83/DL17 CycY gene region 
DL78/DL58 CycY gene region 
DL77/DL58 CycY gene region 
DL77/DL21 CycY gene region 
DL78/DL17 CycY gene region 
DL83/DL57 CycY gene region 
DL72/DL84 Crol gene region 
DL74/DL82 Crol gene region 
DL56/DL81 Crol gene region 
DL73/DL80 Crol gene region 
DL55/DL79 Crol gene region 
DL96/DL97 Crol gene region 
DL96/DL98 Crol gene region 
DL98/DL106 Crol gene region 
DL107/DL106 Crol gene region 
DL107/DL104 Crol gene region 
DL93/DL95 Pde1c gene region 
DL94/DL95 Pde1c gene region 
DL75/DL59 Pde1c gene region 
DL72/DL57 Crol and CycY gene region 
DL72/DL58 Crol and CycY gene region 
DL20/DL58 Crol and CycY gene region 
DL99/DL101 Intergene between CycY and Pde1c 
DL100/DL103 Intergene between CycY and Pde1c 
DL76/DL21 Intergene between CycY and Pde1c 
DL72/DL59 Crol, CycY, and Pde1c gene region 
DL20/DL59 Crol, CycY, and Pde1c gene region 
DL98/DL99 Crol, CycY, and Pde1c gene region 
DL94/DL98 Crol, CycY, and Pde1c gene region 
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Appendix E. Sequences of primers used in the study described in Chapter 2. 
Primers Finley lab # Primers Alias Sequences 
469 DL17 5’ TACTCCCGGTGGCAATAG 
648 DL20 5' GTGCGATTGCGTTGTTCTTA 
649 DL21 5' CGTAGGGAAATTCGAGGTGG 
664 DL42 5' CAAGGCGGTTTATCTGATCG 
522 DL43 5' AATGATTCGCAGTGGAAGGCT 
523 DL44 5' CACCCAAGGCTCTGCTCCCACAAT 
524 DL45 5' CGACACTCAGAATACTATTCC 
525 DL46 5' AATTTGCGAGTACGCAAAGC 
669 DL55 5’ TTTGCCTTACATTGTCTCTC 
670 DL56 5’ ATGACAAGGGACACGAAAAT 
671 DL57 5’ CCAATTGCCAAACGAAAGAT 
672 DL58 5’ ACCCAATAATCCCGATTTGG 
673 DL59 5' AGAGGCATTGCAGGATATG 
686 DL72 5' CATCCCATCATATCCGACC 
687 DL73 5' GTAACACGAATCCCCTAACC 
688 DL74 5’ CCGCTGCTAATTGATGATTG 
689 DL75 5’ CTCGGCATCTGAAAACAGG 
690 DL76 5’ GCTTTGAGCGTTCAAGTTTG 
691 DL77 5’ GAGCACGACTCTAACTTCTTC 
692 DL78 5’ CCAGGTAGACTAGCGTGATG 
693 DL79 5’ CCTGTACTCGCTTGTCTCTC 
694 DL80 5’ GATCATTCTTGTTTCTGGACC 
695 DL81 5’ AAACCAGGACCTATGCAAAC 
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696 DL82 5’ GGATCTGGACACAAGAATGC 
697 DL83 5’ AATCGATTTGTGCCTGAAGC 
698 DL84 5’ CCGCGTCTCATTCAGTTTTC 
707 DL93 5’ TCACCTGTTTTCAGATGCCGAG 
708 DL94 5’ GGGCCAAGCACAAATACAAACG 
709 DL95 5’ GATCGACGCGTCTGTCGTTCC 
710 DL96 5’ AATCGCACGCACACACACACATG 
711 DL97 5’ ACAAGGCGGTTTATCTGATCGG 
712 DL98 5’ TGGTGAACGGCGAACAGAGC 
713 DL99 5’ TCAAGAAAGGAACGACAGACG 
808 RA19 5’ TACTATTCCTTTCACTCGCACTTATTG 
714 DL100 5’ GGGACAAAAGTGAGAGCAG 
715 DL101 5’ CTGCTCTCACTTTTGTCCC 
716 DL102 5’ GCGGATGTCTACTAGTAGCC 
717 DL103 5’ GGCTACTAGTAGACATCCGC 
718 DL104 5’ GTAATTGGAGTAAGTGCAGGTG 
719 DL105 5’ CACCTGCACTTACTCCAATTAC 
720 DL106 5’ CGATCAGATAAACCGCCTTG 
721 DL107 5’ TTGAACTTCCTAAGTGTGGC 
722 DL108 5’ AGGAGAATGGCACCCAAC 
891 5’ RT-F 5' TTGACTGTATCGCCGGAATTC 
892 3’ RT-R 5' CCGGAATTAGCTTGGCTGCAG 
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Appendix F. CycY and Eip63E null mutant pupae are smaller than wild-type pupae. A 
collection of 30 to 40 pupae of CycYE8/+ (A), CycYE8 (B), CycYE8/+; P{CycY} (C), CycYE8; 
P{CycY} (D), Eip63EGN50/+ and Eip63E81/+ (E), Eip63EGN50/Eip63E81 (F), CycYE8/+ and 
Df(2L)Exel6030/+ (G), CycYE8/Df(2L)Exel6030 (H), CycYE8/+; P{CycY} and Df(2L)Exel6030/+; 
P{CycY} (I), CycYE8/Df(2L)Exel6030; P{CycY} (J) were photographed and the relative pupal 
length on the image was measured. Images A-F were taken at the same magnification and 
images G-J were taken at the same magnification. 
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Appendix G. Fly strains used in the study described in chapter 3 
Finely 
lab # 
Stock center & 
numbers Alias or genotypes References 
210 Bloomington 1104 GMR-Gal4 (Freeman, 1996) 
284 Bloomington 6356 en-Gal4 (Brand and Perrimon, 1993; Sigrist and Lehner, 1997) 
446 Bloomington 1774 69B-Gal4 (Brand and Perrimon, 1993) 
161 Bloomington 1973 e22c-Gal4 (Zraly et al., 2003) 
290 Bloomington 4414 Act5C-Gal4 - 
424 - UAS-Snr1-2, Snr1R3 (Zraly et al., 2003) 
448 - UAS-BrmK804R (Elfring et al., 1998) 
434 - y
1w* hs-FLP; Ubi-GFP 
FRT40A Dr. Dongbin Xu 
407 VDRC 60008 UAS-dicer2 (Lee et al., 2004) 
482 VDRC 12644 UAS-Snr1i (Terriente-Felix and de Celis, 2009) 
484 VDRC 37720 UAS-Brmi (Terriente-Felix and de Celis, 2009) 
692 - CycYE8 (Liu and Finley Jr, 2010) 
702 - CycYE8 FRT40A (Liu and Finley Jr, 2010) 
642 - UAS-CycY (Liu and Finley Jr, 2010) 
668 - hs-CycY (Liu and Finley Jr, 2010) 
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Appendix H. Plasmids used or constructed for the study described in chapter 3 
Plasmids Finely lab # Plasmids Alias Source or References 
955 pWIZ (Lee and Carthew, 2003) 
952 pWIZ-CycYiN This study 
953 pWIZ-CycYiC This study 
766 pTLJ03 (Parrish et al., 2004) 
943 pTLJ03-Eip63E A1 This study 
944 pTLJ03-Eip63E A1 I249L This study 
945 pTLJ03-Eip63E B1 This study 
946 pTLJ03-Eip63E B1 I249L This study 
947 pTLJ03-Eip63E(B1, K234M) This study 
948 pTLJ03-Snr1 This study 
949 pTLJ03-Snr1(T102/198A) This study 
950 pTLJ03-Snr1(T102A) This study 
978 pTLJ03-CycY This study 
981 pTLJ03-CycY S388/389A This study 
982 pTLJ03-CycY S389A This study 
990 pTLJ03-CycY S389E This study 
998 pTLJ03-CycY S388E This study 
378 pET-28a(+) - 
1011 pET28a-Eip63E This study 
1012 pET28a-Snr1 This study 
1017 pET28a-CycY This study 
1029 pET28a-nCycY This study 
1007 pMal-c2 - 
1009 pMalc2-Eip63E This study 
1010 pMalc2-Snr1 This study 
1030 pMalc2-nCycY This study 
1033 pMalc2-Snr1 T102/198A This study 
1034 pMalc2-Snr1 T102A This study 
1035 pMalc2-Snr1 T198A This study 
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Appendix I. Transgenic fly strains generated for the study described in chapter 3  
Finley 
lab # Alias Genotypes 
Plasmids for P-element 
transformation 
Used in 
this study? 
644 3R2 CycYi pWIZ-CycYiC No 
645 3R22 w; CycYiC2/CyO; Ser/Sb pWIZ-CycYiC Yes 
646 3R22H w; CycYiC2; Ser/Sb pWIZ-CycYiC Yes 
647 3R23 w; CycYi/CyO; Ser/Sb pWIZ-CycYiC No 
648 3R51 w; Sp/CyO; Ser/CycYi pWIZ-CycYiC No 
649 3R52 w; Sp/CyO; Ser/CycYiC1 pWIZ-CycYiC Yes 
650 3R53 w; Sp/CyO; Ser/CycYi pWIZ-CycYiC No 
651 3R54 w; Sp/CyO; Ser/CycYi pWIZ-CycYiC No 
652 3R21B1 w; CycYi/CyO Act5C-GFP; Ser/Sb pWIZ-CycYiC Yes 
653 3R22B1 w; CycYi/CyO Act5C-GFP; Ser/Sb pWIZ-CycYiC Yes 
654 3R23B1 w; CycYi/CyO Act5C-GFP; Ser/Sb pWIZ-CycYiC Yes 
752 2R2 CycYi pWIZ-CycYiN Yes 
753 2R21 w; CyO/CycYiN1; Ser/Sb pWIZ-CycYiN Yes 
754 2R22 w; CyO/CycYi; Ser/Sb pWIZ-CycYiN Yes 
755 2R51 w; CyO/Sp; CycYiN2/Ser pWIZ-CycYiN Yes 
756 2R52 w; CyO/Sp; CycYi/Ser pWIZ-CycYiN Yes 
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Appendix J. Wing imaginal discs upon knockdown of CycY do not show 
abnormal proportion of apoptotic cells. Wing imaginal discs (en-Gal4/+; UAS-
CycYiC1/UAS-GFP) were stained with GFP (Green, A), TUNEL (Red, B), and DAPI 
(Blue, C). 
  
195
 Appendix K. Fly strains used in the study described in Chapter 4 
Finley 
lab # 
Stock center & 
numbers Alias or genotypes References or sources 
434 - y1w* hs-FLP; Ubi-GFP FRT40A Dr. Dongbin Xu 
435 - y1w* ey-FLP; Ubi-GFP FRT40A Dr. Dongbin Xu 
442 - y1w*;Sp/CyO [y+];TM2/TM6B Tb Dr. Lei Zhang 
711 - y1w*; CyO [y+]/Sp; TM6B Tb/Sb this study 
704 - y1w*; FRT40A/CyO [y+]; TM6B Tb/Sb this study 
705 - y1w*; CycYE8/CyO [y+]; TM6B Tb/Sb this study 
777 - y
1w*; CycYE8/CyO [y+]; TM6B 
Tb/Eip63E81 this study 
778 - y
1w*; CycYDf6030/CyO [y+]; TM6B 
Tb/Eip63EDf6096 this study 
779 - y
1w*; CycYDf6030/CyO [y+]; TM6B 
Tb/Eip63EDf6095 this study 
437 Bloomington 5885 Sgs3-GFP (Biyasheva et al., 2001) 
706 - y
1w*; CyO [y+]/Sp; sgs3-GFP/TM6B 
Tb this study 
710 - y
1w*; CycYE8/CyO [y+]; sgs3-
GFP/TM6B Tb this study 
535 - w*; Atg1∆3D/TM6B Thomas P. Neufeld’s lab 
717 - y
1w*; CycYE8/CyO [y+]; Atg1∆3D/TM6B 
Tb this study 
534 - y1w*; TOR∆6B/CyO Thomas P. Neufeld’s lab 
718 - y
1w*; TOR∆6B/CyO [y+]; CycYiC1/TM6B 
Tb 
this study (also see 
Chapter 3 for details 
bout CycYiC1) 
719 - y
1w*; TOR∆6B/CyO [y+]; Tub-
Gal4/TM6B Tb this study 
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DETERMINATION OF THE ESSENTIAL FUNCTIONS OF A CONSERVED CYCLIN, 
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The Drosophila gene CG14939 encodes a member of a highly conserved family 
of cyclins, the Y type cyclins, which have not been functionally characterized in any 
organism. Here I report the generation and phenotypic characterization of a null mutant 
of CG14939, which we rename Cyclin Y (CycY). I show that the null mutant, CycYE8, is 
homozygous lethal with most mutant animals arresting during pupal development. The 
mutant exhibits delayed larval growth and major developmental defects during 
metamorphosis. Heat shock-induced expression of CycY at different times during 
development resulted in variable levels of rescue, the timing of which suggests a key 
function for zygotic CycY during the transition from third instar larvae to prepupae. CycY 
also plays an essential role during embryogenesis since zygotic null embryos from null 
mothers fail to hatch into first instar larvae. Furthermore I show that CycY is required for 
adult viability, especially in males. I provide evidence that the CycY protein (CycY) 
interacts with Eip63E, a Cyclin-dependent kinase (Cdk) for which no cyclin partner had 
previously been identified. Like CycY, the Eip63E gene has essential functions during 
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embryogenesis, larval development, and metamorphosis. My data suggest that 
CycY/Eip63E form a cyclin/Cdk complex that is essential for several developmental 
processes. 
To gain insight into the cellular functions of CycY and to identify signaling 
pathways to which it belongs, I used RNA interference (RNAi) to knock down CycY 
expression in specific tissues. I show that CycY is required for wing growth and wing 
vein development. I also show that CycY genetically interacts with Snr1 and Brm, two 
components of the Brm ATP-dependent chromatin remodeling complex, and that CycY 
can physically interact with Snr1. Furthermore, I show that downstream targets of the 
Brm complex are misregulated in CycY mutants. Taken together, these data suggest 
that CycY may be involved in gene regulation by modulating Brm complex activity. 
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